Search Results

You searched for "breast cancer". We found 10 journal(s).

 

Cancer Management and Research

OncoTargets and Therapy

Oncolytic Virotherapy

Biologics: Targets and Therapy

You searched for "breast cancer". We found 6722 paper(s).

 

Review: propensity score methods with application to the HELP clinic clinical study

Rai SN, Wu X, Srivastava DK, Craycroft JA, Rai JP, Srivastava S, James RF, Boakye M, Bhatnagar A, Baumgartner R

Open Access Medical Statistics 2018, 8:11-23

lincROR influences the stemness and crizotinib resistance in EML–ALK+ non-small-cell lung cancer cells

Yang Y, Huang J, Xie N, Huang H, Xu S, Cai J, Qi S

OncoTargets and Therapy 2018, 11:3649-3657

The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer

Guo X, Zhang C, Guo Q, Xu Y, Feng G, Li L, Han X, Lu F, Ma Y, Wang X, Wang G

Cancer Management and Research 2018, 10:1639-1646

Decreased expression of TRPV1 in renal cell carcinoma: association with tumor Fuhrman grades and histopathological subtypes

Wu YY, Liu XY, Zhuo DX, Huang HB, Zhang FB, Liao SF

Cancer Management and Research 2018, 10:1647-1655

Cancer risk assessment in modern radiotherapy workflow with medical big data

Jin F, Luo HL, Zhou J, He YN, Liu XF, Zhong MS, Yang H, Li C, Li QC, Huang X, Tian XM, Qiu D, He GL, Yin L, Wang Y

Cancer Management and Research 2018, 10:1665-1675

Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis

Yan H, Xie H, Ying Y, Li J, Wang X, Xu X, Zheng X

Cancer Management and Research 2018, 10:1627-1638

Role of key players in paradigm shifts of prostate cancer bone metastasis

Sohail A, Sherin L, Butt SI, Javed S, Li Z, Iqbal S, Be'g OA

Cancer Management and Research 2018, 10:1619-1626

Clinical empathy with cancer patients: a content analysis of oncology nurses’ perception

Rohani C, Sedaghati Kesbakhi M, Mohtashami J

Patient Preference and Adherence 2018, 12:1089-1098

Optimal management of resected gastric cancer

Giampieri R, Del Prete M, Cantini L, Baleani MG, Bittoni A, Maccaroni E, Berardi R

Cancer Management and Research 2018, 10:1605-1618

Global time trends in the incidence of esophageal squamous cell carcinoma

Wang QL, Xie SH, Wahlin K, Lagergren J

Clinical Epidemiology 2018, 10:717-728

X-ray radiation-induced and targeted photodynamic therapy with folic acid-conjugated biodegradable nanoconstructs

Clement S, Chen W, Deng W, Goldys EM

International Journal of Nanomedicine 2018, 13:3553-3570

Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer

De Luca R, Blasi L, Alù M, Gristina V, Cicero G

Drug Design, Development and Therapy 2018, 12:1769-1775

The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER

Tang J, Kong D, Cui Q, Wang K, Zhang D, Liao X, Gong Y, Wu G

OncoTargets and Therapy 2018, 11:3551-3560

Combined small-cell lung carcinoma

Qin J, Lu H

OncoTargets and Therapy 2018, 11:3505-3511

Prognostic value of miR-17-5p in cancers: a meta-analysis

Kong W, Cheng Y, Liang H, Chen Q, Xiao C, Li K, Huang Z, Zhang J

OncoTargets and Therapy 2018, 11:3541-3549

Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer

Rodallec A, Brunel JM, Giacometti S, Maccario H, Correard F, Mas E, Orneto C, Savina A, Bouquet F, Lacarelle B, Ciccolini J, Fanciullino R

International Journal of Nanomedicine 2018, 13:3451-3465

Complexes formed by mutant p53 and their roles in breast cancer

Bellazzo A, Sicari D, Valentino E, Del Sal G, Collavin L

Breast Cancer: Targets and Therapy 2018, 10:101-112

Knowledge, attitude, and practice toward the daily management of PICC in critically ill cancer patients discharged from intensive care units

Chen J, Zhao H, Xia Z, Zhang Y, Lv X, Zhou X, Dong X, Li J, Jiang H, Huang Y, Huang H

Cancer Management and Research 2018, 10:1565-1574

Synaptopodin-2 plays an important role in the metastasis of breast cancer via PI3K/Akt/mTOR pathway

Xia E, Zhou X, Bhandari A, Zhang X, Wang O

Cancer Management and Research 2018, 10:1575-1583

INHBA upregulation correlates with poorer prognosis in patients with esophageal squamous cell carcinoma

Lyu S, Jiang C, Xu R, Huang Y, Yan S

Cancer Management and Research 2018, 10:1585-1596

An increased number of negative lymph nodes is associated with a higher immune response and longer survival in colon cancer patients

He WZ, Xie QK, Hu WM, Kong PF, Yang L, Yang YZ, Jiang C, Yin CX, Qiu HJ, Zhang HZ, Zhang B, Xia LP

Cancer Management and Research 2018, 10:1597-1604

Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment

Peng Y, Huang J, Xiao H, Wu T, Shuai X

International Journal of Nanomedicine 2018, 13:3467-3480

Comparison of NSAIDs activity in COX-2 expressing and non-expressing 2D and 3D pancreatic cancer cell cultures

Čeponytė U, Paškevičiūtė M, Petrikaitė V

Cancer Management and Research 2018, 10:1543-1551

MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS

Chang J, Xu W, Du X, Hou J

OncoTargets and Therapy 2018, 11:3461-3473

The association of pretreatment serum albumin with outcomes in bladder cancer: a meta-analysis

Li J, Cheng Y, Liu G, Ji Z

OncoTargets and Therapy 2018, 11:3449-3459

STAT3 induces colorectal carcinoma progression through a novel miR-572-MOAP-1 pathway

Wang N, He X, Zhou R, Jia G, Qiao Q

OncoTargets and Therapy 2018, 11:3475-3484

Current understanding of reovirus oncolysis mechanisms

Phillips MB, Stuart JD, Rodríguez Stewart RM, Berry JTL, Mainou BA, Boehme KW

Oncolytic Virotherapy 2018, 7:53-63

A nomogram to predict overall survival for biliary tract cancer

Song W, Zhu Z, Wu Q, Lv C, Wang Y, Chen L, Miao D

Cancer Management and Research 2018, 10:1535-1541

Multifocality is associated with central neck lymph node metastases in papillary thyroid microcarcinoma

Zheng W, Wang K, Wu J, Wang W, Shang J

Cancer Management and Research 2018, 10:1527-1533

Significance of prolonged QTc in acute exacerbations of COPD requiring hospitalization

Van Oekelen O, Vermeersch K, Everaerts S, Vandenberk B, Willems R, Janssens W

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1937-1947

Risk assessment of night-eating syndrome occurrence in women in Poland, considering the obesity factor in particular

Olejniczak D, Bugajec D, Staniszewska A, Panczyk M, Kielan A, Czerw A, Mańczuk M, Juszczyk G, Skonieczna J, Brytek-Matera A

Neuropsychiatric Disease and Treatment 2018, 14:1521-1526

Perceptions and attitudes toward clinical trials in adolescent and young adults with cancer: a systematic review

Forcina V, Vakeesan B, Paulo CB, Mitchell L, Bell JAH, Tam S, Wang K, Gupta AA, Lewin J

Adolescent Health, Medicine and Therapeutics 2018, 9:87-94

A two-microRNA signature as a diagnostic and prognostic marker of pancreatic adenocarcinoma

Yu Y, Feng X, Cang S

Cancer Management and Research 2018, 10:1507-1515

Twenty-gene-based prognostic model predicts lung adenocarcinoma survival

Zhao K, Li Z, Tian H

OncoTargets and Therapy 2018, 11:3415-3424

Identification of CD24 as a marker for tumorigenesis of melanoma

Tang MR, Guo JY, Wang D, Xu N

OncoTargets and Therapy 2018, 11:3401-3406

Genetic polymorphisms in the TERT gene and susceptibility to non-small cell lung cancer in a Chinese Han population

Li C, Wang X, Li Y, Zhang X, Sun M, Liu S, Sun L, Shi L, Yao Y

Cancer Management and Research 2018, 10:1487-1495

Expression and clinical significance of autophagic protein LC3B and EMT markers in gastric cancer

Wang JY, Wu T, Ma W, Li S, Jing WJ, Ma J, Chen DM, Guo XJ, Nan KJ

Cancer Management and Research 2018, 10:1479-1486

Expression and functional characterization of FOXM1 in non-small cell lung cancer

Zhang Y, Qiao W, Shan L

OncoTargets and Therapy 2018, 11:3385-3393

Extramedullary hematopoiesis secondary to malignant solid tumors: a case report and literature review

Bao Y, Liu Z, Guo M, Li B, Sun X, Wang L

Cancer Management and Research 2018, 10:1461-1470

Prognostic value of spleen tyrosine kinase in human solid tumors

Ni B, Li S, Liu Y, Huang Y, Li Z

OncoTargets and Therapy 2018, 11:3377-3384

Exploring the effectiveness of crisis counseling and psychoeducation in relation to improving mental well-being, quality of life and treatment compliance of breast cancer patients in Qatar

Al-Sulaiman RJ, Bener A, Doodson L, Bujassoum Al Bader S, Ghuloum S, Lemaux A, Bugrein H, Alassam R, Karim A

International Journal of Women's Health 2018, 10:285-298

RNA interference: new mechanistic and biochemical insights with application in oral cancer therapy

Buduru S, Zimta AA, Ciocan C, Braicu C, Dudea D, Irimie AI, Berindan-Neagoe I

International Journal of Nanomedicine 2018, 13:3397-3409

Poor prognosis and SATB1 overexpression in solid tumors: a meta-analysis

Wang S, Zeng J, Xiao R, Xu G, Liu G, Xiong D, Ye Y, Chen B, Wang H, Luo Q, Huang Z

Cancer Management and Research 2018, 10:1471-1478

Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends

Sohail MF, Rehman M, Sarwar HS, Naveed S, Salman O, Bukhari NI, Hussain I, Webster TJ, Shahnaz G

International Journal of Nanomedicine 2018, 13:3145-3161

LncRNAs and EGFRvIII sequestered in TEPs enable blood-based NSCLC diagnosis

Luo CL, Xu ZG, Chen H, Ji J, Wang YH, Hu W, Wang K, Zhang WW, Yuan CH, Wang FB

Cancer Management and Research 2018, 10:1449-1459

Notch signaling pathway mediates Doxorubicin-driven apoptosis in cancers

Huang Z, Lin S, Long C, Zhou X, Fan Y, Kuang X, He J, Ning J, Zhang H, Zhang Q, Shen H

Cancer Management and Research 2018, 10:1439-1448

Melanoma treatment in review

Domingues B, Lopes JM, Soares P, Pópulo H

ImmunoTargets and Therapy 2018, 7:35-49

Meta-analysis of segmentectomy versus wedge resection in stage IA non-small-cell lung cancer

Xue WF, Duan GC, Zhang XP, Zhang H, Zhao QT, Xin ZF

OncoTargets and Therapy 2018, 11:3369-3375

Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells

Dong H, Wen ZF, Chen L, Zhou N, Liu H, Dong S, Hu HM, Mou YB

International Journal of Nanomedicine 2018, 13:3353-3365

Influence of TS (rs34743033) and RUNX1 (rs2014300) gene polymorphisms on survival outcomes of fluorouracil-based chemotherapy in Chinese advanced gastric cancer patients

Han R, Wei J, Zhang H, Su X, Chu X, Chen Y, Gong Y, Wang X, Shi J, Chen J

Cancer Management and Research 2018, 10:1429-1437

Ferulic acid dimer as a non-opioid therapeutic for acute pain

Priebe A, Hunke M, Tonello R, Sonawane Y, Berta T, Natarajan A, Bhuvanesh N, Pattabiraman M, Chandra S

Journal of Pain Research 2018, 11:1075-1085

Factors associated with lung cancer in COPD patients

Sandelin M, Mindus S, Thuresson M, Lisspers K, Ställberg B, Johansson G, Larsson K, Janson C

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1833-1839

Ablation of MCM10 using CRISPR/Cas9 restrains the growth and migration of esophageal squamous cell carcinoma cells through inhibition of Akt signaling

Yan J, Du P, Jia Y, Chang Z, Gan S, Xu X, Wang Y, Qin Y, Kan Q

OncoTargets and Therapy 2018, 11:3323-3333

Identification of PGAM1 as a putative therapeutic target for pancreatic ductal adenocarcinoma metastasis using quantitative proteomics

Liu X, Weng Y, Liu P, Sui Z, Zhou L, Huang Y, Zhang L, Zhang Y, Tan X

OncoTargets and Therapy 2018, 11:3345-3357

Effect of AQP-5 silencing by siRNA interference on chemosensitivity of breast cancer cells

Li X, Pei B, Wang H, Tang C, Zhu W, Jin F

OncoTargets and Therapy 2018, 11:3359-3368

Comparison of detection methods of EGFR T790M mutations using plasma, serum, and tumor tissue in EGFR-TKI-resistant non-small cell lung cancer

Kobayashi K, Naoki K, Manabe T, Masuzawa K, Hasegawa H, Yasuda H, Kawada I, Soejima K, Betsuyaku T

OncoTargets and Therapy 2018, 11:3335-3343

Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook

Gopalakrishnan D, Koshkin VS, Ornstein MC, Papatsoris A, Grivas P

Therapeutics and Clinical Risk Management 2018, 14:1019-1040

Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer

Ni J, Peng Y, Yang F, Xi X, Huang X, He C

OncoTargets and Therapy 2018, 11:3303-3312

Novel quinazoline-based sulfonamide derivative (3D) induces apoptosis in colorectal cancer by inhibiting JAK2–STAT3 pathway

Al-Obeed O, Vaali-Mohammed MA, Eldehna WM, Al-Khayal K, Mahmood A, Abdel-Aziz HA, Zubaidi A, Alafeefy A, Abdulla M, Ahmad R

OncoTargets and Therapy 2018, 11:3313-3322

RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells

Lee SG, Kim CH, Sung SW, Lee ES, Goh MS, Yoon HY, Kang MJ, Lee S, Choi YW

International Journal of Nanomedicine 2018, 13:3263-3278

A biomimetic nanoparticle-enabled toxoid vaccine against melittin

Kang T, Li C, Du T, Wu Y, Yang Y, Liu X, Zhang Q, Xu X, Gou M

International Journal of Nanomedicine 2018, 13:3251-3261

Is preoperative hypocholesterolemia a risk factor for severe postoperative pain? Analysis of 1,944 patients after laparoscopic colorectal cancer surgery

Oh TK, Kang SB, Song IA, Hwang JW, Do SH, Kim JH, Oh AY

Journal of Pain Research 2018, 11:1057-1065

Obesity-associated miR-27a upregulation promotes hepatocellular carcinoma metastasis through suppressing SFRP1

Chen Y, Zhang F, Zhao Y, He K, Zheng X, Pan Y, Shao D, Shang P, Yang Y, Zhang D, Xie Y, Yao X, Chen L, Li J, Zhang X

OncoTargets and Therapy 2018, 11:3281-3292

A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma

Xie H, Tian S, Yu H, Yang X, Liu J, Wang H, Feng F, Guo Z

OncoTargets and Therapy 2018, 11:3257-3265

Chitosan gold nanoparticles induce cell death in HeLa and MCF-7 cells through reactive oxygen species production

Martínez-Torres AC, Zarate-Triviño DG, Lorenzo-Anota HY, Ávila-Ávila A, Rodríguez-Abrego C, Rodríguez-Padilla C

International Journal of Nanomedicine 2018, 13:3235-3250

Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer

Chiorean EG, Von Hoff D, Wan Y, Margunato-Debay S, Botteman M, Goldstein D

Cancer Management and Research 2018, 10:1389-1396

Prognostic value and clinical significance of long noncoding RNA CASC2 in human malignancies: a meta-analysis

Cai J, Zuo X, Chen Z, Zhao W, Zhu Y, Zhang Z, Ye X

Cancer Management and Research 2018, 10:1403-1412

Association of VDR gene TaqI polymorphism with the susceptibility to prostate cancer in Asian population evaluated by an updated systematic meta-analysis

Chen L, Wei J, Zhang S, Lou Z, Wang X, Ren Y, Qi H, Xie Z, Chen Y, Chen F, Wu Q, Fan X, Xu H, Huang S, Weng G

OncoTargets and Therapy 2018, 11:3267-3280

Tumor necrosis factor α-induced protein 3 (A20) is dysregulated in pediatric Crohn disease

Zaidi D, Huynh HQ, Carroll MW, Baksh S, Wine E

Clinical and Experimental Gastroenterology 2018, 11:217-231

Surgical injury: comparing open surgery and laparoscopy by markers of tissue damage

Máca J, Peteja M, Reimer P, Jor O, Šeděnková V, Panáčková L, Ihnát P, Burda M, Ševčík P

Therapeutics and Clinical Risk Management 2018, 14:999-1006

Prognostic role of plasma mammaglobin A expression in breast carcinoma patients: a meta-analysis

Hu YY, Liu P, Wu D, Jiang YH

OncoTargets and Therapy 2018, 11:3245-3255

Tumor-infiltrating lymphocyte as a prognostic biomarker in stage IV colorectal cancer should take into account the metastatic status and operation modality

Xie QK, He WZ, Hu WM, Yang L, Jiang C, Kong PF, Yang YZ, Yang Q, Zhang HZ, Zhang B, Xia LP

Cancer Management and Research 2018, 10:1365-1375

Polymorphism in lncRNA AC008392.1 and its interaction with smoking on the risk of lung cancer in a Chinese population

Lv X, Cui Z, Li H, Li J, Yang Z, Bi Y, Gao M, Zhou B, Yin Z

Cancer Management and Research 2018, 10:1377-1387

Prognostic significance of galectin-1 and vasculogenic mimicry in patients with gastric cancer

You X, Wang Y, Wu J, Liu Q, Chen D, Tang D, Wang D

OncoTargets and Therapy 2018, 11:3237-3244

Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy

Pan H, Liu J, Deng W, Xing J, Li Q, Wang Z

International Journal of Nanomedicine 2018, 13:3189-3201

Clinical effect of MUC1 and its relevance to BRAF V600E mutation in papillary thyroid carcinoma: a case–control study

Li Q, Jin W, Jin Y, Zheng Z, Zhou X, Wang Q, Ye D, Sun Y, Zhang X, Wang O, Chen E, Cai Y

Cancer Management and Research 2018, 10:1351-1358

Age distribution and age-related outcomes of olfactory neuroblastoma: a population-based analysis

Yin ZZ, Wang YY, Wu YM, Zhang XM, Wang FM, Wang PG, Tao Z, Yuan ZY

Cancer Management and Research 2018, 10:1359-1364

Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy

Lorusso D, Tripodi E, Maltese G, Lepori S, Sabatucci I, Bogani G, Raspagliesi F

Drug Design, Development and Therapy 2018, 12:1501-1509

Periostin overexpression is associated with worse prognosis in nasopharyngeal carcinoma from endemic area: a cohort study

Wei YC, Yang SF, Chang SL, Chen TJ, Lee SW, Chen HS, Lin LC, Li CF

OncoTargets and Therapy 2018, 11:3205-3213

Knockdown of KIF26B inhibits breast cancer cell proliferation, migration, and invasion

Gu S, Liang H, Qi D, Mao L, Mao G, Qian L, Zhang S

OncoTargets and Therapy 2018, 11:3195-3203

A large and aggressive fibromatosis in the axilla: a rare case report and review of the literature

Duan M, Xing H, Wang K, Niu C, Jiang C, Zhang L, Ezzat S, Zhang L

OncoTargets and Therapy 2018, 11:3179-3184

CEACAM6 is associated with osteosarcoma metastasis and facilitates epithelial–mesenchymal transition in osteosarcoma cells

Wang Z, Luo C, Wang H, Yan X, Liu W, Meng Z

OncoTargets and Therapy 2018, 11:3159-3166

Recent advances on the progressive mechanism and therapy in castration-resistant prostate cancer

Wang K, Ruan H, Xu T, Liu L, Liu D, Yang H, Zhang X, Chen K

OncoTargets and Therapy 2018, 11:3167-3178

High SRPX2 protein expression predicts unfavorable clinical outcome in patients with prostate cancer

Zhang M, Li X, Fan Z, Zhao J, Liu S, Zhang M, Li H, Goscinski MA, Fan H, Suo Z

OncoTargets and Therapy 2018, 11:3149-3157

Emerging role of long non-coding RNAs in cisplatin resistance

Hu Y, Zhu QN, Deng JL, Li ZX, Wang G, Zhu YS

OncoTargets and Therapy 2018, 11:3185-3194

Unplanned reoperation after radical gastrectomy for gastric cancer: causes, risk factors, and long-term prognostic influence

Zuo X, Cai J, Chen Z, Zhang Y, Wu J, Wu L, Wang J

Therapeutics and Clinical Risk Management 2018, 14:965-972

Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery

Li X, Sui Z, Li X, Xu W, Guo Q, Sun J, Jing F

International Journal of Nanomedicine 2018, 13:3053-3067

Lifetime risks, loss of life expectancy, and health care expenditures for 19 types of cancer in Taiwan

Wu TY, Chung CH, Lin CN, Hwang JS, Wang JD

Clinical Epidemiology 2018, 10:581-591

miR-134 increases the antitumor effects of cytarabine by targeting Mnks in acute myeloid leukemia cells

Chen K, Chen Y, Chen Z, Shi Y, He Z, Ding B, Wang C, Yu L

OncoTargets and Therapy 2018, 11:3141-3147

A carbon nanotube-gemcitabine-lentinan three-component composite for chemo-photothermal synergistic therapy of cancer

Zhang P, Yi W, Hou J, Yoo S, Jin W, Yang Q

International Journal of Nanomedicine 2018, 13:3069-3080

High frequency of bladder cancer after nephroureterectomy: justification for adjuvant intravesical treatment?

Mekayten M, Yutkin V, Duvdevani M, Pode D, Hidas G, Landau EH, Youssef F, Gofrit ON

Research and Reports in Urology 2018, 10:33-38

Overexpression of MCPH1 inhibits the migration and invasion of lung cancer cells

Wu X, Liu W, Liu X, Ai Q, Yu J

OncoTargets and Therapy 2018, 11:3111-3117

The incidence and predictors of symptomatic venous thromboembolism associated with peripherally inserted central catheters in patients with nasopharyngeal carcinoma

Liang YJ, He Y, Li JM, Chen LM, Chen LP, Wang C, Ji L, Li ZX, Tang LQ, Chen QY, Fan YY, Hu W

OncoTargets and Therapy 2018, 11:3119-3127

Construction of a specific SVM classifier and identification of molecular markers for lung adenocarcinoma based on lncRNA-miRNA-mRNA network

Zhao J, Cheng W, He X, Liu Y, Li J, Sun J, Li J, Wang F, Gao Y

OncoTargets and Therapy 2018, 11:3129-3140

Downregulation of CPT2 promotes tumorigenesis and chemoresistance to cisplatin in hepatocellular carcinoma

Lin MH, Lv D, Zheng YL, Wu ML, Xu C, Zhang Q, Wu LH

OncoTargets and Therapy 2018, 11:3101-3110

Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancer

Xie L, Lin C, Zhang Q, Piao H, Bigner DD, Zhang Z, Bao X

Cancer Management and Research 2018, 10:1329-1340

nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial

Gridelli C, Chen T, Ko A, O'Brien ME, Ong TJ, Socinski MA, Postmus PE

Drug Design, Development and Therapy 2018, 12:1445-1451

Impact of parental cancer on IQ, stress resilience, and physical fitness in young men

Chen R, Fall K, Czene K, Kennedy B, Valdimarsdóttir U, Fang F

Clinical Epidemiology 2018, 10:593-604

Inhibition of survivin enhances radiosensitivity of esophageal cancer cells by switching radiation-induced senescence to apoptosis

Liu X, Zhao Y, Zhang W, Gao Y, Huo M, Liu M, Xiao Z, Liang S, Xu N, Zhu H

OncoTargets and Therapy 2018, 11:3087-3100

An integrated analysis of key microRNAs, regulatory pathways and clinical relevance in bladder cancer

Li D, Hao X, Song Y

OncoTargets and Therapy 2018, 11:3075-3085

Gene expression and prognosis of NOX family members in gastric cancer

You X, Ma M, Hou G, Hu Y, Shi X

OncoTargets and Therapy 2018, 11:3065-3074

Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer

Cicero G, De Luca R, Dieli F

OncoTargets and Therapy 2018, 11:3059-3063

Bilirubin detoxification using different phytomaterials: characterization and in vitro studies

Mathew BT, Raji S, Dagher S, Hilal-Alnaqbi A, Mourad AHI, Al-Zuhair S, Al Ahmad M, El-Tarabily KA, Amin A

International Journal of Nanomedicine 2018, 13:2997-3010

Estimation of population-based utility weights for gastric cancer-related health states

Lee HJ, Ock M, Kim KP, Jo MW

Patient Preference and Adherence 2018, 12:909-918

High expression of USP22 predicts poor prognosis and advanced clinicopathological features in solid tumors: a meta-analysis

Yang XH, Zang H, Luo Y, Wu J, Fang Z, Zhu W, Li Y

OncoTargets and Therapy 2018, 11:3035-3046

Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2− advanced breast cancer

Tremblay G, Chandiwana D, Dolph M, Hearnden J, Forsythe A, Monaco M

Cancer Management and Research 2018, 10:1319-1327

Intra-arterial chemotherapy improved survival of stage 2–3 gallbladder cancer after curative resection

Chen C, Feng W, Zheng Y, Bao Y, Feng M

OncoTargets and Therapy 2018, 11:2975-2979

Expression of HSP90AA1/HSPA8 in hepatocellular carcinoma patients with depression

Xiang X, You XM, Li LQ

OncoTargets and Therapy 2018, 11:3013-3023

The role of HIF-1α in chemo-/radioresistant tumors

Xia Y, Jiang L, Zhong T

OncoTargets and Therapy 2018, 11:3003-3011

Ovol2 induces mesenchymal–epithelial transition via targeting ZEB1 in osteosarcoma

Liu J, Wu Q, Wang Y, Wei Y, Wu H, Duan L, Zhang Q, Wu Y

OncoTargets and Therapy 2018, 11:2963-2973

The methylation profiles of PRDM promoters in non–small cell lung cancer

Tan SX, Hu RC, Xia Q, Tan YL, Liu JJ, Gan GX, Wang LL

OncoTargets and Therapy 2018, 11:2991-3002

LGR6 promotes the progression of gastric cancer through PI3K/AKT/mTOR pathway

Ke J, Ma P, Chen J, Qin J, Qian H

OncoTargets and Therapy 2018, 11:3025-3033

Adherence to endocrine therapy among Chinese patients with breast cancer: current status and recommendations for improvement

Gao P, You L, Wu D, Shi A, Miao Q, Rana U, Martin DP, Du Y, Zhao G, Han B, Zheng C, Fan Z

Patient Preference and Adherence 2018, 12:887-897

Ceftriaxone and clavulanic acid induce antiallodynia and anti-inflammatory effects in rats using the carrageenan model

Ochoa-Aguilar A, Ventura-Martinez R, Sotomayor-Sobrino MA, Jaimez R, Coffeen U, Jiménez-González A, Balcázar-Ochoa LG, Pérez-Medina-Carballo R, Rodriguez R, Plancarte-Sánchez R

Journal of Pain Research 2018, 11:977-985

Downregulation of STARD8 in gastric cancer and its involvement in gastric cancer progression

Zhang S, Chang X, Ma J, Chen J, Zhi Y, Li Z, Dai D

OncoTargets and Therapy 2018, 11:2955-2961

Improvement of decision-making criteria for the care of elderly cancer patients by general practitioners (Lorraine, France)

Niemier JY, Claudot F, Nguyen-Thi PL, Hubert JM, Rousselot H, Benetos A, Perret-Guillaume C

Clinical Interventions in Aging 2018, 13:995-1002

Design and preparation of derivatives of oleanolic and glycyrrhetinic acids with cytotoxic properties

Wang R, Li Y, Huai XD, Zheng QX, Wang W, Li HJ, Huai QY

Drug Design, Development and Therapy 2018, 12:1321-1336

Association of FGFR2 and PI3KCA genetic variants with the risk of breast cancer in a Chinese population

Wang Y, Zhang H, Lin M, Wang Y

Cancer Management and Research 2018, 10:1305-1311

Associated factors for oral health problems in a sample of Saudi cancer patients

Yenugadhati N, Albalawi AN, Qureshey AT, Qureshey ET, Al-Jahdali H, Jazieh AR, Ahmed AE

Cancer Management and Research 2018, 10:1285-1293

Response to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden

Parikh AR, Ali SM, Schrock AB, Albacker LA, Miller VA, Stephens PJ, Crilley P, Markman M

Lung Cancer: Targets and Therapy 2018, 9:45-47

Stimuli-responsive polymeric micelles for drug delivery and cancer therapy

Zhou Q, Zhang L, Yang T, Wu H

International Journal of Nanomedicine 2018, 13:2921-2942

Elimination of mouse tumor cells from neonate spermatogonial cells utilizing cisplatin-entrapped folic acid-conjugated poly(lactic-co-glycolic acid) nanoparticles in vitro

Shabani R, Ashjari M, Ashtari K, Izadyar F, Behnam B, Khoei S, Asghari-Jafarabadi M, Koruji M

International Journal of Nanomedicine 2018, 13:2943-2954

Vicenin-2 inhibits Wnt/β-catenin signaling and induces apoptosis in HT-29 human colon cancer cell line

Yang D, Zhang X, Zhang W, Rengarajan T

Drug Design, Development and Therapy 2018, 12:1303-1310

Indirubin inhibits cell proliferation, migration, invasion and angiogenesis in tumor-derived endothelial cells

Li Z, Zhu C, An B, Chen Y, He X, Qian L, Lan L, Li S

OncoTargets and Therapy 2018, 11:2937-2944

High neutrophil to lymphocyte ratio and decreased CD69+NK cells represent a phenotype of high risk in early-stage breast cancer patients

Mandó P, Rizzo M, Roberti MP, Juliá EP, Pampena MB, Pérez de la Puente C, Loza CM, Ponce C, Nadal J, Coló FA, Mordoh J, Levy EM

OncoTargets and Therapy 2018, 11:2901-2910

Downregulation of PDIA3 inhibits proliferation and invasion of human acute myeloid leukemia cells

Ye Q, Fu P, Dou J, Wang N

OncoTargets and Therapy 2018, 11:2925-2935

Mechanisms of oxidative stress, apoptosis, and autophagy involved in graphene oxide nanomaterial anti-osteosarcoma effect

Tang Z, Zhao L, Yang Z, Liu Z, Gu J, Bai B, Liu J, Xu J, Yang H

International Journal of Nanomedicine 2018, 13:2907-2919

Recent advances in functional nanostructures as cancer photothermal therapy

Hussein EA, Zagho MM, Nasrallah GK, Elzatahry AA

International Journal of Nanomedicine 2018, 13:2897-2906

Exploring factors that might influence primary-care provider discussion of and recommendation for prostate and colon cancer screening

Kistler CE, Vu M, Sutkowi-Hemstreet A, Gizlice Z, Harris RP, Brewer NT, Lewis CL, Dolor RJ, Barclay C, Sheridan SL

International Journal of General Medicine 2018, 11:179-190

Describing the association between socioeconomic inequalities and cancer survival: methodological guidelines and illustration with population-based data

Belot A, Remontet L, Rachet B, Dejardin O, Charvat H, Bara S, Guizard AV, Roche L, Launoy G, Bossard N

Clinical Epidemiology 2018, 10:561-573

miR-598 acts as a tumor suppressor in human gastric cancer by targeting IGF-1R

Liu N, Yang H, Wang H

OncoTargets and Therapy 2018, 11:2911-2923

Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers

Patra A, Satpathy S, Shenoy AK, Bush JA, Kazi M, Hussain MD

International Journal of Nanomedicine 2018, 13:2869-2881

Emerging biomarkers in the diagnosis of prostate cancer

Filella X, Fernández-Galan E, Fernández Bonifacio R, Foj L

Pharmacogenomics and Personalized Medicine 2018, 11:83-94

Role of Lactobacillus in cervical cancer

Yang X, Da M, Zhang W, Qi Q, Zhang C, Han S

Cancer Management and Research 2018, 10:1219-1229

Diagnostic accuracy of droplet digital PCR for detection of EGFR T790M mutation in circulating tumor DNA

Zhang R, Chen B, Tong X, Wang Y, Wang C, Jin J, Tian P, Li W

Cancer Management and Research 2018, 10:1209-1218

Dichloroacetate enhances the antitumor efficacy of chemotherapeutic agents via inhibiting autophagy in non-small-cell lung cancer

Lu X, Zhou D, Hou B, Liu QX, Chen Q, Deng XF, Yu ZB, Dai JG, Zheng H

Cancer Management and Research 2018, 10:1231-1241

Bacillus Calmette–Guérin and anti-PD-L1 combination therapy boosts immune response against bladder cancer

Wang Y, Liu J, Yang X, Liu Y, Liu Y, Li Y, Sun L, Yang X, Niu H

OncoTargets and Therapy 2018, 11:2891-2899

RIP1 regulates TNF-α-mediated lymphangiogenesis and lymphatic metastasis in gallbladder cancer by modulating the NF-κB-VEGF-C pathway

Li C, Jiang X, Lin B, Hong H, Zhu S, Jiang L, Wang X, Tang N, She F, Chen Y

OncoTargets and Therapy 2018, 11:2875-2890

circSMAD2 inhibits the epithelial–mesenchymal transition by targeting miR-629 in hepatocellular carcinoma

Zhang XW, Luo P, Jing W, Zhou H, Liang CZ, Tu JC

OncoTargets and Therapy 2018, 11:2853-2863

Peritoneal carcinomatosis index as a predictor of diaphragmatic involvement in stage III and IV ovarian cancer

Llueca A, Serra A, Herraiz JL, Rivadulla I, Gomez-Quiles L, Gilabert-Estelles J, Escrig J

OncoTargets and Therapy 2018, 11:2771-2777

A comparison of cotton and flocked swabs for vaginal self-sample collection

Viviano M, Willame A, Cohen M, Benski AC, Catarino R, Wuillemin C, Tran PL, Petignat P, Vassilakos P

International Journal of Women's Health 2018, 10:229-236

Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis

Zhou X, Huang X, Liang S, Tang S, Wu S, Huang T, Mo Z, Wang Q

OncoTargets and Therapy 2018, 11:2815-2830

Advances of exosome in the development of ovarian cancer and its diagnostic and therapeutic prospect

Shen J, Zhu X, Fei J, Shi P, Yu S, Zhou J

OncoTargets and Therapy 2018, 11:2831-2841

NDRG3 facilitates colorectal cancer metastasis through activating Src phosphorylation

Li T, Sun R, Lu MD, Chang J, Meng X, Wu H

OncoTargets and Therapy 2018, 11:2843-2852

Decreased survival in patients with carcinoma of axillary tail versus upper outer quadrant breast cancers: a SEER population-based study

Gou ZC, Liu XY, Xiao Y, Zhao S, Jiang YZ, Shao ZM

Cancer Management and Research 2018, 10:1133-1141

Preoperative serum apolipoprotein A-I levels predict long-term survival in non-muscle-invasive bladder cancer patients

Shang Z, Wang J, Wang X, Yan H, Cui B, Jia C, Wang Q, Cui X, Li J, Ou T

Cancer Management and Research 2018, 10:1177-1190

The lncRNA myocardial infarction associated transcript-centric competing endogenous RNA network in non-small-cell lung cancer

Zheng C, Li X, Qian B, Feng N, Gao S, Zhao Y, Zhou B

Cancer Management and Research 2018, 10:1155-1162

Prognostic factors for survival among patients with primary bone sarcomas of small bones

Wang Z, Li S, Li Y, Lin N, Huang X, Liu M, Pan WB, Yan XB, Sun LL, Li HY, Li BH, Qu H, Wu Y, Lin P, Ye ZM

Cancer Management and Research 2018, 10:1191-1199

Overexpression of chloride channel-3 predicts unfavorable prognosis and promotes cellular invasion in gastric cancer

Peng J, Chen W, Chen J, Yuan Y, Zhang J, He Y

Cancer Management and Research 2018, 10:1163-1175

MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project

Tagliabue E, Gandini S, Bellocco R, Maisonneuve P, Newton-Bishop J, Polsky D, Lazovich D, Kanetsky PA, Ghiorzo P, Gruis NA, Landi MT, Menin C, Fargnoli MC, García-Borrón JC, Han J, Little J, Sera F, Raimondi S

Cancer Management and Research 2018, 10:1143-1154

Aloperine executes antitumor effects through the induction of apoptosis and cell cycle arrest in prostate cancer in vitro and in vivo

Ling Z, Guan H, You Z, Wang C, Hu L, Zhang L, Wang Y, Chen S, Xu B, Chen M

OncoTargets and Therapy 2018, 11:2735-2743

ZNF418 overexpression protects against gastric carcinoma and prompts a good prognosis

Hui H, Hu Z, Jiang C, Wu J, Gao Y, Wang X

OncoTargets and Therapy 2018, 11:2763-2770

Upregulation of circ_0066444 promotes the proliferation, invasion, and migration of gastric cancer cells

Rong D, Dong C, Fu K, Wang H, Tang W, Cao H

OncoTargets and Therapy 2018, 11:2753-2761

Leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter

Zhang Q, Huang R, Tang Q, Yu Y, Huang Q, Chen Y, Wang G, Wang X

OncoTargets and Therapy 2018, 11:2745-2752

Association between angiogenesis and cytotoxic signatures in the tumor microenvironment of gastric cancer

Feng Y, Dai Y, Gong Z, Cheng JN, Zhang L, Sun C, Zeng X, Jia Q, Zhu B

OncoTargets and Therapy 2018, 11:2725-2733

Andrographolide potentiates the antitumor effect of topotecan in acute myeloid leukemia cells through an intrinsic apoptotic pathway

Hodroj MH, Jardaly A, Abi Raad S, Zouein A, Rizk S

Cancer Management and Research 2018, 10:1079-1088

A review of soft-tissue sarcomas: translation of biological advances into treatment measures

Hoang NT, Acevedo LA, Mann MJ, Tolani B

Cancer Management and Research 2018, 10:1089-1114

Mutation analysis of BRCA1/2 mutations with special reference to polymorphic SNPs in Indian breast cancer patients

Shah ND, Shah PS, Panchal YY, Katudia KH, Khatri NB, Ray HSP, Bhatiya UR, Shah SC, Shah BS, Rao MV

The Application of Clinical Genetics 2018, 11:59-67

Psychological factors as predictors of early postoperative pain after open nephrectomy

Mimic A, Bantel C, Jovicic J, Mimic B, Kisic-Tepavcevic D, Durutovic O, Ladjevic N

Journal of Pain Research 2018, 11:955-966

Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis

Al-Fayoumi S, Hashiguchi T, Shirakata Y, Mascarenhas J, Singer JW

Journal of Experimental Pharmacology 2018, 10:9-17

High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry

Robsahm TE, Helsing P, Nilssen Y, Vos L, Rizvi SMH, Akslen LA, Veierød MB

Clinical Epidemiology 2018, 10:537-548

Association between NR5A2 and the risk of pancreatic cancer, especially among Caucasians: a meta-analysis of case–control studies

Chen Q, Yuan H, Shi GD, Wu Y, Liu D, Lin YT, Chen L, Ge W, Jiang K, Miao Y

OncoTargets and Therapy 2018, 11:2709-2723

Insight into resistance mechanism of anaplastic lymphoma kinase to alectinib and JH-VIII-157-02 caused by G1202R solvent front mutation

Wang H, Wang Y, Guo W, Du B, Huang X, Wu R, Yang B, Lin X, Wu Y

Drug Design, Development and Therapy 2018, 12:1183-1193

Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study

Bai Y, Gao XS, Qin SB, Chen JY, Su MM, Liu Q, Qin XB, Ma MW, Zhao B, Gu XB, Xie M, Cui M, Qi X, Li XY

OncoTargets and Therapy 2018, 11:2571-2579

WWC3 inhibits epithelial–mesenchymal transition of lung cancer by activating Hippo-YAP signaling

Han Q, Kremerskothen J, Lin X, Zhang X, Rong X, Zhang D, Wang E

OncoTargets and Therapy 2018, 11:2581-2591

Predicting initial margin status in breast cancer patients during breast-conserving surgery

Pan Z, Zhu L, Li Q, Lai J, Peng J, Su F, Li S, Chen K

OncoTargets and Therapy 2018, 11:2627-2635

Delivery of bevacizumab by intracranial injection: assessment in glioma model

Liu YX, Liu WJ, Zhang HR, Zhang ZW

OncoTargets and Therapy 2018, 11:2673-2683

Chelerythrine induced cell death through ROS-dependent ER stress in human prostate cancer cells

Wu S, Yang Y, Li F, Huang L, Han Z, Wang G, Yu H, Li H

OncoTargets and Therapy 2018, 11:2593-2601

The utilization of next-generation sequencing to detect somatic mutations and predict clinical prognosis of Chinese non-small cell lung cancer patients

Cao L, Long L, Li M, Yang H, Deng P, Mao X, Xiang J, Li B, Zhang T, Hu C

OncoTargets and Therapy 2018, 11:2637-2646

Are ovarian cancer stem cells the target for innovative immunotherapy?

Wang L, Xu T, Cui M

OncoTargets and Therapy 2018, 11:2615-2626

A 5-serum miRNA panel for the early detection of colorectal cancer

Guo S, Zhang J, Wang B, Zhang B, Wang X, Huang L, Liu H, Jia B

OncoTargets and Therapy 2018, 11:2603-2614

Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis

Zhang T, Feng F, Zhao W, Tian J, Yao Y, Zhou C, Dong S, Wang C, Zang C, Lv Q, Sun C

OncoTargets and Therapy 2018, 11:2647-2656

Fatal hemoptysis in patients with advanced esophageal cancer treated with apatinib

Wang W, Zhang L, Xie Y, Zhen TC, Su GZ, Zang Q

OncoTargets and Therapy 2018, 11:2565-2570

Whole-body computed tomography in trauma patients: optimization of the patient scanning position significantly shortens examination time while maintaining diagnostic image quality

Hickethier T, Mammadov K, Baeßler B, Lichtenstein T, Hinkelbein J, Smith L, Plum PS, Chon SH, Maintz D, Chang DH

Therapeutics and Clinical Risk Management 2018, 14:849-859

Perioperative chemotherapy with pemetrexed and cisplatin for pulmonary large-cell neuroendocrine carcinoma: a case report and literature review

Tang H, Wang HY, Xi SY, He CY, Chang YX, Wang QM, Wu YF

OncoTargets and Therapy 2018, 11:2557-2563

Is progression-free survival a more relevant endpoint than overall survival in first-line HR+/HER2− metastatic breast cancer?

Forsythe A, Chandiwana D, Barth J, Thabane M, Baeck J, Shor A, Tremblay G

Cancer Management and Research 2018, 10:1015-1025

Genetic variants in the exon region of versican predict survival of patients with resected early-stage hepatitis B virus-associated hepatocellular carcinoma

Liu X, Han C, Liao X, Yu L, Zhu G, Su H, Qin W, Lu S, Ye X, Peng T

Cancer Management and Research 2018, 10:1027-1036

Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative-intent surgery for hepatocellular carcinoma: experience from a developing country

Galun D, Bogdanovic A, Kovac Djokic J, Bulajic P, Loncar Z, Zuvela M

Cancer Management and Research 2018, 10:977-988

Prognostic factors for operable biliary tract cancer: serum levels of lactate dehydrogenase, a strong association with survival

Ma L, Qiu JR, Zhang YD, Qiu TZ, Wang B, Chen WS, Li X, Sun J, Wang K, Li XC, Gu YH, Shu YQ, Chen XF

OncoTargets and Therapy 2018, 11:2533-2543

The genetic association between iNOS and eNOS polymorphisms and gastric cancer risk: a meta-analysis

Zhu Y, Jiang HG, Chen ZH, Lu BH, Li J, Peng YP, Shen XN

OncoTargets and Therapy 2018, 11:2497-2507

Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis

Ren HY, Shen YF, Hu DX, He W, Zhou J, Cao YJ, Mao Y, Dou Y, Xiong W, Xiao Q, Zhang YH, Su XL

Cancer Management and Research 2018, 10:1005-1013

Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials

Meske DS, Lawal OD, Elder H, Langberg V, Paillard F, Katz N

Journal of Pain Research 2018, 11:923-934

Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer

Nguyen TV, Crosby CM, Heller GJ, Mendel ZI, Barry ME, Barry MA

Oncolytic Virotherapy 2018, 7:43-51

Durvalumab: a potential maintenance therapy in surgery-ineligible non-small-cell lung cancer

Shafique MR, Robinson LA, Antonia S

Cancer Management and Research 2018, 10:931-940

ITGA7 functions as a tumor suppressor and regulates migration and invasion in breast cancer

Bhandari A, Xia E, Zhou Y, Guan Y, Xiang J, Kong L, Wang Y, Yang F, Wang O, Zhang X

Cancer Management and Research 2018, 10:969-976

Inactivation of nuclear factor κB by MIP-based drug combinations augments cell death of breast cancer cells

Subramaniam M, Liew SK, In LLA, Awang K, Ahmed N, Nagoor NH

Drug Design, Development and Therapy 2018, 12:1053-1063

Rechallenge of oxaliplatin-containing regimens in the third- or later-line therapy for patients with heavily treated metastatic colorectal cancer

Yang Q, Huang YY, Jiang ZM, Wang HZ, Li WY, Zhang B, Xie DR

OncoTargets and Therapy 2018, 11:2467-2473

UCA1 promotes cell proliferation and invasion and inhibits apoptosis through regulation of the miR129–SOX4 pathway in renal cell carcinoma

Liu Q, Li Y, Lv W, Zhang G, Tian X, Li X, Cheng H, Zhu C

OncoTargets and Therapy 2018, 11:2475-2487

A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failure

Xiao W, Que Y, Peng RQ, Ding Y, Zhao JJ, Wen XZ, Weng DS, Zhang XS, Guan YX, Zhang X

OncoTargets and Therapy 2018, 11:2439-2443

The CXCL12 rs1801157 polymorphism and risk of colorectal cancer: a meta-analysis

Xu K, Dai H, Wang S, Zhang J, Liu T

OncoTargets and Therapy 2018, 11:2445-2452

Antidepressant medication use and nasopharyngeal cancer risk: a nationwide population-based study

Lin C, Chan HL, Hsieh YH, Liang H, Chiu WC, Lee Y, McIntyre RS, Chen VC

Neuropsychiatric Disease and Treatment 2018, 14:1101-1106

Role of miR-613 as a tumor suppressor in glioma cells by targeting SOX9

Sang S, Liu X, Sun D

OncoTargets and Therapy 2018, 11:2429-2438

Glypican-1-antibody-conjugated Gd-Au nanoclusters for FI/MRI dual-modal targeted detection of pancreatic cancer

Huang X, Fan C, Zhu H, Le W, Cui S, Chen X, Li W, Zhang F, Huang Y, Shi D, Cui Z, Shao C, Chen B

International Journal of Nanomedicine 2018, 13:2585-2599

Prognostic value of microRNAs in colorectal cancer: a meta-analysis

Gao S, Zhao ZY, Wu R, Zhang Y, Zhang ZY

Cancer Management and Research 2018, 10:907-929

A meta-analytic review of the association between two common SNPs in miRNAs and lung cancer susceptibility

Xiao S, Sun S, Long W, Kuang S, Liu Y, Huang H, Zhou J, Zhou Y, Lu X

OncoTargets and Therapy 2018, 11:2419-2427

Peptide SA12 inhibits proliferation of breast cancer cell lines MCF-7 and MDA-MB-231 through G0/G1 phase cell-cycle arrest

Yang LF, Liu HR, Long M, Wang X, Lin F, Gao ZW, Zhang HZ

OncoTargets and Therapy 2018, 11:2409-2417

A Phase Ib study of ruxolitinib + gemcitabine ± nab-paclitaxel in patients with advanced solid tumors

Bauer TM, Patel MR, Forero-Torres A, George TJ Jr, Assad A, Du Y, Hurwitz H

OncoTargets and Therapy 2018, 11:2399-2407

LDH-A promotes epithelial–mesenchymal transition by upregulating ZEB2 in intestinal-type gastric cancer

Zhang Y, Lin S, Chen Y, Yang F, Liu S

OncoTargets and Therapy 2018, 11:2363-2373

Peptide-functionalized quantum dots for potential applications in the imaging and treatment of obesity

Thovhogi N, Sibuyi NRS, Onani MO, Meyer M, Madiehe AM

International Journal of Nanomedicine 2018, 13:2551-2559

Developing and piloting an instrument to prioritize the worries of patients with acute myeloid leukemia

Bridges JFP, Oakes AH, Reinhart CA, Voyard E, O'Donoghue B

Patient Preference and Adherence 2018, 12:647-655

Liver-enriched activator protein 1 as an isoform of CCAAT/enhancer-binding protein beta suppresses stem cell features of hepatocellular carcinoma

Yang LH, Wang Y, Qiao S, Wang MJ, Chen F, Zi XY, Li JX, Zhang HB, Yu B, Hu YP

Cancer Management and Research 2018, 10:873-885

Association of two FOXP3 polymorphisms with breast cancer susceptibility in Chinese Han women

Tian T, Wang M, Zheng Y, Yang T, Zhu W, Li H, Lin S, Liu K, Xu P, Deng Y, Zhou L, Dai Z

Cancer Management and Research 2018, 10:867-872

Oxidative stress, aging, and diseases

Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, Gargiulo G, Testa G, Cacciatore F, Bonaduce D, Abete P

Clinical Interventions in Aging 2018, 13:757-772

Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer

Liu X, Xu T, Hu X, Chen X, Zeng K, Sun L, Wang S

Cancer Management and Research 2018, 10:857-865

MicroRNA-150 suppresses triple-negative breast cancer metastasis through targeting HMGA2

Tang W, Xu P, Wang H, Niu Z, Zhu D, Lin Q, Tang L, Ren L

OncoTargets and Therapy 2018, 11:2319-2332

Combination of long noncoding RNA MALAT1 and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer

Wang WW, Zhou XL, Song YJ, Yu CH, Zhu WG, Tong YS

OncoTargets and Therapy 2018, 11:2333-2344

Gold nanoparticle-based colorimetric method for the detection of prostate-specific antigen

Xia N, Deng D, Wang Y, Fang C, Li S

International Journal of Nanomedicine 2018, 13:2521-2530

Self-reported adherence and biomarker levels of CoQ10 and alpha-tocopherol

Vitolins MZ, Case LD, Rapp SR, Lively MO, Shaw EG, Naughton MJ, Giguere J, Lesser GJ

Patient Preference and Adherence 2018, 12:637-646

Effectiveness of afatinib after ineffectiveness of gefitinib in an advanced lung adenocarcinoma patient with a single EGFR exon 20 S768I mutation: a case report

Duan H, Peng Y, Cui H, Qiu Y, Li Q, Zhang J, Shen W, Sun C, Luo C

OncoTargets and Therapy 2018, 11:2303-2309

Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases

Darkovska-Serafimovska M, Serafimovska T, Arsova-Sarafinovska Z, Stefanoski S, Keskovski Z, Balkanov T

Journal of Pain Research 2018, 11:837-842

Preparation, characterization, in vitro and in vivo anti-tumor effect of thalidomide nanoparticles on lung cancer

Chen L, Ni X, Zhang H, Wu M, Liu J, Xu S, Yang L, Fu S, Wu J

International Journal of Nanomedicine 2018, 13:2463-2476

Fe3O4@Au composite magnetic nanoparticles modified with cetuximab for targeted magneto-photothermal therapy of glioma cells

Lu Q, Dai X, Zhang P, Tan X, Zhong Y, Yao C, Song M, Song G, Zhang Z, Peng G, Guo Z, Ge Y, Zhang K, Li Y

International Journal of Nanomedicine 2018, 13:2491-2505

A novel nomogram for the prediction of intrahepatic cholangiocarcinoma in patients with intrahepatic lithiasis complicated by imagiologically diagnosed mass

Chen G, Yu H, Wang Y, Li C, Zhou M, Yu Z, Zheng X, Wu X, Shan Y, Zhang Q, Zeng Q

Cancer Management and Research 2018, 10:847-856

Emergency treatment of complicated colorectal cancer

Tebala GD, Natili A, Gallucci A, Brachini G, Khan AQ, Tebala D, Mingoli A

Cancer Management and Research 2018, 10:827-838

Transoral robotic surgery for oropharyngeal cancer: patient selection and special considerations

Baskin RM, Boyce BJ, Amdur R, Mendenhall WM, Hitchcock K, Silver N, Dziegielewski PT

Cancer Management and Research 2018, 10:839-846

EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients

Lu HY, Qin J, Han N, Lei L, Xie F, Li C

OncoTargets and Therapy 2018, 11:2217-2226

Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review

Makita S, Maeshima AM, Maruyama D, Izutsu K, Tobinai K

OncoTargets and Therapy 2018, 11:2287-2293

Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine

De Lorenzo C, Paciello R, Riccio G, Rea D, Barbieri A, Coppola C, Maurea N

OncoTargets and Therapy 2018, 11:2241-2250

Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer

Shen H, Li F, Wang D, Yang Z, Yao C, Ye Y, Wang X

Drug Design, Development and Therapy 2018, 12:921-934

Combined use of fluorescence with a magnetic tracer and dilution effect upon sentinel node localization in a murine model

Kuwahata A, Ahmed M, Saeki K, Chikaki S, Kaneko M, Qiu W, Xin Z, Yamaguchi S, Kaneko A, Douek M, Kusakabe M, Sekino M

International Journal of Nanomedicine 2018, 13:2427-2433

Role of DiGeorge syndrome critical region gene 9, a long noncoding RNA, in gastric cancer

Ni C, Yang P, Guo J, Ye M

OncoTargets and Therapy 2018, 11:2259-2267

microRNA-26a induces a mitochondrial apoptosis mediated by p53 through targeting to inhibit Mcl1 in human hepatocellular carcinoma

Gao X, Zhu Y, Li JH, Wang X, Zhang X, Yi C, Yang X

OncoTargets and Therapy 2018, 11:2227-2239

Prediction of tumor mutation burden in breast cancer based on the expression of ER, PR, HER-2, and Ki-67

Xu J, Guo X, Jing M, Sun T

OncoTargets and Therapy 2018, 11:2269-2275

miR-488 inhibits cell growth and metastasis in renal cell carcinoma by targeting HMGN5

Wei X, Yu L, Kong X

OncoTargets and Therapy 2018, 11:2205-2216

The impact of moderate wine consumption on the risk of developing prostate cancer

Vartolomei MD, Kimura S, Ferro M, Foerster B, Abufaraj M, Briganti A, Karakiewicz PI, Shariat SF

Clinical Epidemiology 2018, 10:431-444

Global trends in nanomedicine research on triple negative breast cancer: a bibliometric analysis

Teles RHG, Moralles HF, Cominetti MR

International Journal of Nanomedicine 2018, 13:2321-2336

Calcification score versus arterial stenosis grading: comparison of two CT-based methods for risk assessment of anastomotic leakage after esophagectomy and gastric pull-up

Chang DH, Brinkmann S, Smith L, Becker I, Schroeder W, Hoelscher AH, Haneder S, Maintz D, Spiro JE

Therapeutics and Clinical Risk Management 2018, 14:721-727

Overexpression of HDAC9 is associated with poor prognosis and tumor progression of breast cancer in Chinese females

Huang Y, Jian W, Zhao J, Wang G

OncoTargets and Therapy 2018, 11:2177-2184

The role of Hippo signal pathway in breast cancer metastasis

Wei C, Wang Y, Li X

OncoTargets and Therapy 2018, 11:2185-2193

miR-30a suppresses osteosarcoma proliferation and metastasis by downregulating MEF2D expression

Du L, Chen T, Zhao K, Yang D

OncoTargets and Therapy 2018, 11:2195-2202

Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma

Liao X, Zhu G, Huang R, Yang C, Wang X, Huang K, Yu T, Han C, Su H, Peng T

Cancer Management and Research 2018, 10:787-803

Small ubiquitin-like modifier 1 modification of pyruvate kinase M2 promotes aerobic glycolysis and cell proliferation in A549 human lung cancer cells

An S, Huang L, Miao P, Shi L, Shen M, Zhao X, Liu J, Huang G

OncoTargets and Therapy 2018, 11:2097-2109

Prognostic and clinicopathological value of SIRT3 expression in various cancers: a systematic review and meta-analysis

Zhou Y, Cheng S, Chen S, Zhao Y

OncoTargets and Therapy 2018, 11:2157-2167

Preoperative apolipoprotein B/apolipoprotein A1 ratio: a novel prognostic factor for gastric cancer

Ma MZ, Yuan SQ, Chen Y, Zhou ZW

OncoTargets and Therapy 2018, 11:2169-2176

Multiple treatment modalities for brain metastasis in patients with EGFR-mutant non-small-cell lung cancer

Wang HY, Yu X, Fan Y, Jiang Y

OncoTargets and Therapy 2018, 11:2149-2155

Non-Hispanic Black-White disparities in pain and pain management among newly admitted nursing home residents with cancer

Mack DS, Hunnicutt JN, Jesdale BM, Lapane KL

Journal of Pain Research 2018, 11:753-761

Invasive meningococcal disease without meningitis: a forgotten diagnosis

Walayat S, Hussain N, Malik AH, Vazquez-Melendez E, Aulakh BS, Lynch T

International Medical Case Reports Journal 2018, 11:87-90

Genetic variants in the nucleotide excision repair pathway genes and gastric cancer susceptibility in a southern Chinese population

He J, Zhuo Z, Zhang A, Zhu J, Hua R, Xue W, Zhang S, Zhang J, Li X, Jia W

Cancer Management and Research 2018, 10:765-774

MicroRNA-142-3p is involved in regulation of MGMT expression in glioblastoma cells

Lee YY, Yarmishyn AA, Wang ML, Chen HY, Chiou S, Yang YP, Lin C, Huang PI, Chen YW, Ma HI, Chen M

Cancer Management and Research 2018, 10:775-785

Quantitative assessment of the clinical susceptibility of calcium-sensing receptor polymorphisms in cancer patients

Huang H, Li T, Liao D, Zhu Z, Dong Y

Cancer Management and Research 2018, 10:755-763

Dual-responsive dithio-polydopamine coated porous CeO2 nanorods for targeted and synergistic drug delivery

Zhang Y, Wu X, Hou C, Shang K, Yang K, Tian ZM, Pei Z, Qu Y, Pei Y

International Journal of Nanomedicine 2018, 13:2161-2173

Silica nanoparticle-induced oxidative stress and mitochondrial damage is followed by activation of intrinsic apoptosis pathway in glioblastoma cells

Kusaczuk M, Krętowski R, Naumowicz M, Stypułkowska A, Cechowska-Pasko M

International Journal of Nanomedicine 2018, 13:2279-2294

Albumin/globulin ratio is negatively correlated with PD-1 and CD25 mRNA levels in breast cancer patients

Liu C, Wang W, Meng XY, Sun B, Cong Y, Liu JN, Wang Q, Liu GX, Wu SK

OncoTargets and Therapy 2018, 11:2131-2139

Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation

Guo W, Tan HY, Wang N, Wang XB, Feng YB

Cancer Management and Research 2018, 10:715-734

Self- versus physician-collected samples for the follow-up of human papillomavirus-positive women in sub-Saharan Africa

Viviano M, Tran PL, Kenfack B, Catarino R, Akaaboune M, Temogne L, Tincho Foguem E, Vassilakos P, Petignat P

International Journal of Women's Health 2018, 10:187-194

Combination of SIRT1 and Src overexpression suggests poor prognosis in luminal breast cancer

Tan J, Liu Y, Maimaiti Y, Wang C, Yan Y, Zhou J, Ruan S, Huang T

OncoTargets and Therapy 2018, 11:2051-2061

Role of the NFκB-signaling pathway in cancer

Xia LZ, Tan SM, Zhou YJ, Lin JG, Wang HR, Oyang LD, Tian YT, Liu L, Su M, Wang H, Cao D, Liao QJ

OncoTargets and Therapy 2018, 11:2063-2073

Investigation of LEP and LEPR polymorphisms with the risk of hepatocellular carcinoma: a case–control study in Eastern Chinese Han population

Zhang S, Jiang J, Chen Z, Wang Y, Tang W, Liu C, Liu L, Chen Y

OncoTargets and Therapy 2018, 11:2083-2089

Expression of pyruvate kinase M2 in human bladder cancer and its correlation with clinical parameters and prognosis

Huang CK, Huang ZC, Bai PM, Luo GC, Zhao XK, Wang XJ

OncoTargets and Therapy 2018, 11:2075-2082

Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients

Abdel-Razeq H, Saadeh SS, Abu-Nasser M, Abdulelah H, Marie L, Salam M, Al-Haj Ali B, Ibrahim M, Rimawi D

OncoTargets and Therapy 2018, 11:2091-2096

Oncogenes in immune cells as potential therapeutic targets

Zakiryanova GK, Wheeler S, Shurin MR

ImmunoTargets and Therapy 2018, 7:21-28

Basic MRI for the liver oncologists and surgeons

Vu LN, Morelli JN, Szklaruk J

Journal of Hepatocellular Carcinoma 2018, 5:37-50

Robotic versus laparoscopic gastrectomy with D2 lymph node dissection for advanced gastric cancer: a propensity score-matched analysis

Li Z, Li J, Li B, Bai B, Liu Y, Lian B, Zhao Q

Cancer Management and Research 2018, 10:705-714

The association of polymorphisms in miRNAs with nonsmall cell lung cancer in a Han Chinese population

Li C, Zhang Y, Li Y, Ma Q, Liu S, Yao Y, Tan F, Shi L, Yao Y

Cancer Management and Research 2018, 10:697-704

Cantharidin-encapsulated thermal-sensitive liposomes coated with gold nanoparticles for enhanced photothermal therapy on A431 cells

Wang SJ, Xin J, Zhang LW, Zhou YC, Yao CP, Wang B, Wang J, Zhang ZX

International Journal of Nanomedicine 2018, 13:2143-2160

Histological subtype of lung cancer affects acceptance of illness, severity of pain, and quality of life

Polański J, Chabowski M, Jankowska-Polańska B, Janczak D, Rosińczuk J

Journal of Pain Research 2018, 11:727-733

β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion

Liu S, Ding G, Zhou Z, Feng C

OncoTargets and Therapy 2018, 11:2029-2036

Crocin induces autophagic apoptosis in hepatocellular carcinoma by inhibiting Akt/mTOR activity

Yao C, Liu B, Qian X, Li L, Cao H, Guo Q, Zhou G

OncoTargets and Therapy 2018, 11:2017-2028

Determining 30-day readmission risk for heart failure patients: the Readmission After Heart Failure scale

Chamberlain RS, Sond J, Mahendraraj K, Lau CSM, Siracuse BL

International Journal of General Medicine 2018, 11:127-141

Relationship between pain outcomes and smoking history following video-assisted thoracic surgery for lobectomy: a retrospective study

Oh TK, Kim K, Jheon S, Do SH, Hwang JW, Kim JH, Jeon YT, Song IA

Journal of Pain Research 2018, 11:667-673

Inhibition of NIPBL enhances the chemosensitivity of non-small-cell lung cancer cells via the DNA damage response and autophagy pathway

Zheng L, Zhou H, Guo L, Xu X, Zhang S, Xu W, Mao W

OncoTargets and Therapy 2018, 11:1941-1948

Downregulation of miR-542-3p promotes cancer metastasis through activating TGF-β/Smad signaling in hepatocellular carcinoma

Zhang T, Liu W, Meng W, Zhao H, Yang Q, Gu SJ, Xiao CC, Jia CC, Fu BS

OncoTargets and Therapy 2018, 11:1929-1939

Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II–III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomy

Chen XX, Xia F, Luo JR, Ma JL, Yang ZZ, Zhang L, Feng Y, Shao ZM, Yu XL, Guo XM

OncoTargets and Therapy 2018, 11:1973-1980

ANLN functions as a key candidate gene in cervical cancer as determined by integrated bioinformatic analysis

Xia L, Su X, Shen J, Meng Q, Yan J, Zhang C, Chen Y, Wang H, Xu M

Cancer Management and Research 2018, 10:663-670

D-limonene exhibits antitumor activity by inducing autophagy and apoptosis in lung cancer

Yu X, Lin H, Wang Y, Lv W, Zhang S, Qian Y, Deng X, Feng N, Yu H, Qian B

OncoTargets and Therapy 2018, 11:1833-1847

Quality of life after esophageal resection

Svetanoff WJ, McGahan R, Singhal S, Bertellotti C, Mittal SK

Patient Related Outcome Measures 2018, 9:137-146

AlPcS4-PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic® F127 nanomicellar drug carriers

Xin J, Wang SJ, Wang B, Wang JZ, Wang J, Zhang LW, Xin B, Shen LJ, Zhang ZX, Yao CP

International Journal of Nanomedicine 2018, 13:2017-2036

Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis

Zhou L, Du Y, Kong L, Zhang X, Chen Q

OncoTargets and Therapy 2018, 11:1861-1869

Poorer prognosis in young female patients with non-metastatic colorectal cancer: a hospital-based analysis of 5,047 patients in China

Shen L, Mo M, Jia L, Jia H, Li Q, Liang L, Shi D, Zhang Z, Cai S, Li X, Zhu J

Cancer Management and Research 2018, 10:653-661

Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen receptor-modified T cells

Mu Q, Jiang M, Zhang Y, Wu F, Li H, Zhang W, Wang F, Liu J, Li L, Wang D, Wang W, Li S, Song H, Tang D

OncoTargets and Therapy 2018, 11:1767-1776

Hypoglycemic and antioxidant effect of Tai chi exercise training in older adults with metabolic syndrome

Mendoza-Núñez VM, Arista-Ugalde TL, Rosado-Pérez J, Ruiz-Ramos M, Santiago-Osorio E

Clinical Interventions in Aging 2018, 13:523-531

Clinicopathological characteristics and prognostic value of the cancer stem cell marker ALDH1 in ovarian cancer: a meta-analysis

Zhao W, Zang C, Zhang T, Li J, Liu R, Feng F, Lv Q, Zheng L, Tian J, Sun C

OncoTargets and Therapy 2018, 11:1821-1831

Psychometric properties of the Patient Dignity Inventory in an acute psychiatric ward: an extension study of the preliminary validation

Di Lorenzo R, Ferri P, Biffarella C, Cabri G, Carretti E, Pollutri G, Spattini L, Del Giovane C, Chochinov HM

Neuropsychiatric Disease and Treatment 2018, 14:903-913

miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells

Meng X, Fu R

OncoTargets and Therapy 2018, 11:1757-1765

Prognostic value of increased integrin-beta 1 expression in solid cancers: a meta-analysis

Sun Q, Zhou C, Ma R, Guo Q, Huang H, Hao J, Liu H, Shi R, Liu B

OncoTargets and Therapy 2018, 11:1787-1799

Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII

Lu L, Ding Y, Zhang Y, Ho RJY, Zhao Y, Zhang T, Guo C

International Journal of Nanomedicine 2018, 13:1927-1944

Prognostic significance of leukopenia during the induction phase in adult B cell acute lymphoblastic leukemia

Xing C, Liang B, Wu J, Yang Q, Hu G, Yan Y, Zhang Y, Jiang S, Yu K, Feng J

Cancer Management and Research 2018, 10:625-635

The association between long-term conditions and uptake of population-based screening for colorectal cancer: results from two English cohort studies

Kearns B, Chilcott J, Relton C, Whyte S, Woods HB, Nickerson C, Loban A

Cancer Management and Research 2018, 10:637-645

KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer

Wu Y, Wang A, Zhu B, Huang J, Lu E, Xu H, Xia W, Dong G, Jiang F, Xu L

OncoTargets and Therapy 2018, 11:1707-1720

Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers

Dou YL, Lv YL, Zhou XJ, He LF, Liu LH, Li PF, Sun YL, Wang MH, Gao MJ, Wang C

OncoTargets and Therapy 2018, 11:1743-1756

Development of dihydrochalcone-functionalized gold nanoparticles for augmented antineoplastic activity

Payne JN, Badwaik VD, Waghwani HK, Moolani HV, Tockstein S, Thompson DH, Dakshinamurthy R

International Journal of Nanomedicine 2018, 13:1917-1926

The role of propranolol as a radiosensitizer in gastric cancer treatment

Liao XH, Chaudhary P, Qiu G, Che XM, Fan L

Drug Design, Development and Therapy 2018, 12:639-645

The effects of presenting oncologic information in terms of opposites in a medical context

Burro R, Savardi U, Annunziata MA, de Paoli P, Bianchi I

Patient Preference and Adherence 2018, 12:443-459

Role and inhibition of GLI1 protein in cancer

Mastrangelo E, Milani M

Lung Cancer: Targets and Therapy 2018, 9:35-43

MiR-152 functioning as a tumor suppressor that interacts with DNMT1 in nasopharyngeal carcinoma

Lu Z, Du M, Qian L, Zhang N, Gu J, Ding K, Wu J, Zhu H, He X, Yin L

OncoTargets and Therapy 2018, 11:1733-1741

Low rate of human papillomavirus vaccination among schoolgirls in Lebanon: barriers to vaccination with a focus on mothers’ knowledge about available vaccines

Abou El-Ola MJ, Rajab MA, Abdallah DI, Fawaz IA, Awad LS, Tamim HM, Ibrahim AO, Mugharbil AM, Moghnieh RA

Therapeutics and Clinical Risk Management 2018, 14:617-626

The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study

Zhang Y, Huang J, Chen J, Yang K, Chen J, Xu L, Zhou Z, Chen M

Cancer Management and Research 2018, 10:599-611

Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib

Denlinger NM, Epperla N, William BM

Cancer Management and Research 2018, 10:615-624

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study [Corrigendum]

Restelli U, Ceresoli GL, Croce D, Evangelista L, Maffioli LS, Gianoncelli L, Bombardieri E

Cancer Management and Research 2018, 10:613-614

Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: a case series

Bernhardt D, Sterzing F, Adeberg S, Herfarth K, Katayama S, Foerster R, Hoerner-Rieber J, König L, Debus J, Rieken S

Cancer Management and Research 2018, 10:583-588

SYK expression level distinguishes control from BRCA1-mutated lymphocytes

Zahavi T, Sonnenblick A, Shimshon Y, Kadouri L, Peretz T, Salmon AY, Salmon-Divon M

Cancer Management and Research 2018, 10:589-598

Upregulated VEGFA and DLL4 act as potential prognostic genes for clear cell renal cell carcinoma

Wang X, Zhang J, Wang Y, Tu M, Wang Y, Shi G

OncoTargets and Therapy 2018, 11:1697-1706

miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer

Bao M, Song YJ, Xia JJ, Li PL, Liu Q, Wan ZR

OncoTargets and Therapy 2018, 11:1721-1732

Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy

Yang Z, Duan J, Wang J, Liu Q, Shang R, Yang X, Lu P, Xia C, Wang L, Dou K

International Journal of Nanomedicine 2018, 13:1851-1865

L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway

Bai E, Yang L, Xiang Y, Hu W, Li C, Lin J, Dai X, Liang G, Jin R, Zhao C

Cancer Management and Research 2018, 10:565-581

Oncolytic virotherapy in upper gastrointestinal tract cancers

Yokoda R, Nagalo BM, Arora M, Egan JB, Bogenberger JM, DeLeon TT, Zhou Y, Ahn DH, Borad MJ

Oncolytic Virotherapy 2018, 7:13-24

Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients

Syahruddin E, Wulandari L, Sri Muktiati N, Rima A, Soeroso N, Ermayanti S, Levi M, Hidajat H, Widjajahakim G, Utomo ARH

Lung Cancer: Targets and Therapy 2018, 9:25-34

miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect

Liu W, Kang L, Han J, Wang Y, Shen C, Yan Z, Tai Y, Zhao C

OncoTargets and Therapy 2018, 11:1643-1653

The incidence of postoperative radiotherapy-induced acute dermatitis in breast cancer and its influencing factors for Chinese women

Ding J, Guo Y, Li Q, Chen J, Hu P, Liu Q, Cao Y, Wu J

OncoTargets and Therapy 2018, 11:1665-1670

Bioinformatic analysis of prognostic value of ZW10 interacting protein in lung cancer

Yuan W, Xie S, Wang M, Pan S, Huang X, Xiong M, Xiao R, Xiong J, Zhang Q, Shao L

OncoTargets and Therapy 2018, 11:1683-1695

Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy

Boogerd LS, van der Valk MJM, Boonstra MC, Prevoo HA, Hilling DE, van de Velde CJ, Sier CF, Fariña Sarasqueta A, Vahrmeijer AL

OncoTargets and Therapy 2018, 11:1655-1664

MiR-216b suppresses colorectal cancer proliferation, migration, and invasion by targeting SRPK1

Yao YF, Li QR, Wang H

OncoTargets and Therapy 2018, 11:1671-1681

Effects of isoliquiritigenin on ovarian cancer cells

Li N, Yang L, Deng XN, Sun YN

OncoTargets and Therapy 2018, 11:1633-1642

Trastuzumab- and Fab′ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo

Duan D, Wang A, Ni L, Zhang L, Yan X, Jiang Y, Mu H, Wu Z, Sun K, Li Y

International Journal of Nanomedicine 2018, 13:1831-1840

Electrical peripheral nerve stimulation relieves bone cancer pain by inducing Arc protein expression in the spinal cord dorsal horn

Sun KF, Feng WW, Liu YP, Dong YB, Gao L, Yang HL

Journal of Pain Research 2018, 11:599-609

Tooth loss and risk of colorectal cancer: a dose–response meta-analysis of prospective cohort studies

Ma P, Dai S, Jin C, Yao Y, Zou C

OncoTargets and Therapy 2018, 11:1617-1623

Targeting DTL induces cell cycle arrest and senescence and suppresses cell growth and colony formation through TPX2 inhibition in human hepatocellular carcinoma cells

Chen YC, Chen IS, Huang GJ, Kang CH, Wang KC, Tsao MJ, Pan HW

OncoTargets and Therapy 2018, 11:1601-1616

Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer

Colombo I, Lheureux S, Oza AM

Drug Design, Development and Therapy 2018, 12:605-617

Construction and application of a liver cancer-targeting drug delivery system based on core–shell gold nanocages

Ji MF, Qiu XJ, Hou L, Huang SN, Li YM, Liu Y, Duan SF, Hu YR

International Journal of Nanomedicine 2018, 13:1773-1789

Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers

Huang W, Lang Y, Hakeem Abdul, Lei Y, Gan L, Yang X

International Journal of Nanomedicine 2018, 13:1723-1736

Lung squamous cell carcinoma associated with hypoparathyroidism with sensorineural deafness and renal dysplasia syndrome: a case report

Kojima M, Nagano T, Nakata K, Hara S, Katsurada N, Yamamoto M, Tachihara M, Kamiryo H, Kobayashi K, Usui T, Nishimura Y

OncoTargets and Therapy 2018, 11:1595-1599

Lack of association between airflow limitation and recurrence of venous thromboembolism among cancer patients with pulmonary embolism

Shin SH, Kang D, Cho J, Chang H, Kim MS, Lee SY, Lee H, Kim H, Kim DK, Kim EK, Park HY

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:937-943

Mechanical ventilation promotes lung metastasis in experimental 4T1 breast cancer lung-metastasized models

Huang YL, Pan L, Helou K, Xia QS, Parris TZ, Li HY, Xu B, Li H

Cancer Management and Research 2018, 10:545-555

Hsp90 inhibitor NMS-E973 exerts the anticancer effect against glioblastoma via induction of PUMA-mediated apoptosis

Sun L, Yang S, Chi G, Jin X

OncoTargets and Therapy 2018, 11:1583-1593

High expression of COL10A1 is associated with poor prognosis in colorectal cancer

Huang H, Li T, Ye G, Zhao L, Zhang Z, Mo D, Wang Y, Zhang C, Deng H, Li G, Liu H

OncoTargets and Therapy 2018, 11:1571-1581

Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals

Martínez del Prado P, Alvarez-López I, Domínguez-Fernández S, Plazaola A, Ibarrondo O, Galve-Calvo E, Ancizar-Lizarraga N, Gutierrez-Toribio M, Lahuerta-Martínez A, Mar J

ClinicoEconomics and Outcomes Research 2018, 10:189-199

Functional miRNAs in breast cancer drug resistance

Hu WZ, Tan CL, He YJ, Zhang GQ, Xu Y, Tang JH

OncoTargets and Therapy 2018, 11:1529-1541

Downregulation of hsa_circ_0011946 suppresses the migration and invasion of the breast cancer cell line MCF-7 by targeting RFC3

Zhou J, Zhang WW, Peng F, Sun JY, He ZY, Wu SG

Cancer Management and Research 2018, 10:535-544

Prospective study of neoadjuvant chemoradiotherapy using intensity-modulated radiotherapy and 5 fluorouracil for locally advanced rectal cancer – toxicities and response assessment

Simson DK, Mitra S, Ahlawat P, Saxena U, Kumar Sharma M, Rawat S, Singh H, Bansal B, Sripathi LK, Tanwar A

Cancer Management and Research 2018, 10:519-526

Novel long noncoding RNA GACAT3 promotes colorectal cancer cell proliferation, invasion, and migration through miR-149

Zhou W, Wang L, Miao Y, Xing R

OncoTargets and Therapy 2018, 11:1543-1552

Lifestyle in pregnancy and cryptorchidism in sons: a study within two large Danish birth cohorts

Kjersgaard C, Arendt LH, Ernst A, Lindhard MS, Olsen J, Henriksen TB, Strandberg-Larsen K, Ramlau-Hansen CH

Clinical Epidemiology 2018, 10:311-322

miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma

Wang R, Ma Q, Ji L, Yao Y, Ma M, Wen Q

OncoTargets and Therapy 2018, 11:1501-1509

Primary mucinous carcinoma of thyroid gland with prominent signet-ring-cell differentiation: a case report and review of the literature

Wang J, Guli QR, Ming XC, Zhou HT, Cui YJ, Jiang YF, Zhang D, Liu Y

OncoTargets and Therapy 2018, 11:1521-1528

Upregulated long non-coding RNAs demonstrate promising efficacy for breast cancer detection: a meta-analysis

Yu G, Zhang W, Zhu L, Xia L

OncoTargets and Therapy 2018, 11:1491-1499

Immobilization of a carbon nanomaterial-based localized drug-release system using a bispecific material-binding peptide

Kokubun K, Matsumura S, Yudasaka M, Iijima S, Shiba K

International Journal of Nanomedicine 2018, 13:1643-1652

Immunocompetence and mechanism of the DRibble-DCs vaccine for oral squamous cell carcinoma

Dong H, Su H, Chen L, Liu K, Hu HM, Yang WD, Mou YB

Cancer Management and Research 2018, 10:493-501

Nanosilica-supported liposome (protocells) as a drug vehicle for cancer therapy

Belwal VK, Singh KP

International Journal of Nanomedicine 2018, 13:125-127

Patterning artificial lipid bilayer on nanostructured surfaces

Ghosh Moulick R, Panaitov G, Choi SE, Mayer D, Offenhäusser A

International Journal of Nanomedicine 2018, 13:55-58

Peripheral inflammation/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapy

Qian Y, Tao J, Li X, Chen H, Lu Q, Yang J, Pan H, Wang C, Zhou W, Liu X

OncoTargets and Therapy 2018, 11:1423-1432

Fluorescent gold nanoclusters for efficient cancer cell targeting

Purohit R, Singh S

International Journal of Nanomedicine 2018, 13:15-17

Intensity of treatment in Swiss cancer patients at the end-of-life

Bähler C, Signorell A, Blozik E, Reich O

Cancer Management and Research 2018, 10:481-491

Radiation-induced neuropathic pain successfully treated with systemic lidocaine administration

Doo AR, Shin YS, Yoo S, Park JK

Journal of Pain Research 2018, 11:545-548

Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis

Yang X, Zhu S, Li L, Zhang L, Xian S, Wang Y, Cheng Y

OncoTargets and Therapy 2018, 11:1457-1474

Cellular internalization and antioxidant activity of cerium oxide nanoparticles in human monocytic leukemia cells

Patel P, Kansara K, Singh R, Shukla RK, Singh S, Dhawan A, Kumar A

International Journal of Nanomedicine 2018, 13:39-41

Measurement of serum PODXL concentration for detection of pancreatic cancer

Taniuchi K, Tsuboi M, Sakaguchi M, Saibara T

OncoTargets and Therapy 2018, 11:1433-1445

Medicine embraces nano: diagnostics to delivery

Singh SP, Shanker R, Sridhar S, Webster TJ

International Journal of Nanomedicine 2018, 13:1-2

Synthesis and in vitro studies of PLGA-DTX nanoconjugate as potential drug delivery vehicle for oral cancer

Gupta P, Singh M, Kumar R, Belz J, Shanker R, Dwivedi PD, Sridhar S, Singh SP

International Journal of Nanomedicine 2018, 13:67-69

In vitro analysis of PARP inhibitor nanoformulations

Baldwin P, Tangutoori S, Sridhar S

International Journal of Nanomedicine 2018, 13:59-61

In vitro cytotoxicity of GO–DOx on FaDu squamous carcinoma cell lines

Singh M, Gupta P, Baronia R, Singh P, Karuppiah S, Shanker R, Dwivedi PD, Singh SP

International Journal of Nanomedicine 2018, 13:107-111

Synthesis of biocompatible iron oxide nanoparticles as a drug delivery vehicle

Kansara K, Patel P, Shukla RK, Pandya A, Shanker R, Kumar A, Dhawan A

International Journal of Nanomedicine 2018, 13:79-82

Curcumin Ag nanoconjugates for improved therapeutic effects in cancer

Shah D, Savaliya R, Patel P, Kansara K, Pandya A, Dhawan A, Singh S

International Journal of Nanomedicine 2018, 13:75-77

Curcuminoid-loaded poly(methyl methacrylate) nanoparticles for cancer therapy

Sahu A, Solanki P, Mitra S

International Journal of Nanomedicine 2018, 13:101-105

siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy

Xia Y, Guo M, Xu TT, Li YH, Wang CB, Lin ZF, Zhao MQ, Zhu B

International Journal of Nanomedicine 2018, 13:1539-1552

Midazolam activates caspase, MAPKs and endoplasmic reticulum stress pathways, and inhibits cell cycle and Akt pathway, to induce apoptosis in TM3 mouse Leydig progenitor cells

Kang FC, Wang SC, Chang MM, Pan BS, Wong KL, Cheng KS, So EC, Huang BM

OncoTargets and Therapy 2018, 11:1475-1490

Significant improvement of bone mineral density by denosumab treatment in Japanese osteoporotic patients following breast cancer treatment

Nakamura Y, Kamimura M, Morikawa A, Taguchi A, Suzuki T, Kato H

Therapeutics and Clinical Risk Management 2018, 14:543-549

Upregulation of FOXP1 is a new independent unfavorable prognosticator and a specific predictor of lymphatic dissemination in cutaneous melanoma patients

Donizy P, Pagacz K, Marczuk J, Fendler W, Maciejczyk A, Halon A, Matkowski R

OncoTargets and Therapy 2018, 11:1413-1422

Long non-coding RNA FENDRR inhibits cell proliferation and is associated with good prognosis in breast cancer

Li Y, Zhang W, Liu P, Xu Y, Tang L, Chen W, Guan X

OncoTargets and Therapy 2018, 11:1403-1412

A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation – JOELLE study)

Castellsague J, Kuiper JG, Pottegård A, Anveden Berglind I, Dedman D, Gutierrez L, Calingaert B, van Herk-Sukel MP, Hallas J, Sundström A, Gallagher AM, Kaye JA, Pardo C, Rothman KJ, Perez-Gutthann S

Clinical Epidemiology 2018, 10:299-310

Biodistribution, pharmacokinetics, and toxicity of dendrimer-coated iron oxide nanoparticles in BALB/c mice

Salimi M, Sarkar S, Fathi S, Alizadeh AM, Saber R, Moradi F, Delavari H

International Journal of Nanomedicine 2018, 13:1483-1493

Antitumor effect of a Pt-loaded nanocomposite based on graphene quantum dots combats hypoxia-induced chemoresistance of oral squamous cell carcinoma

Wei Z, Yin XT, Cai Y, Xu WG, Song CH, Wang YF, Zhang JW, Kang A, Wang ZY, Han W

International Journal of Nanomedicine 2018, 13:1505-1524

The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles

Zheng XC, Ren W, Zhang S, Zhong T, Duan XC, Yin YF, Xu MQ, Hao YL, Li ZT, Li H, Liu M, Li ZY, Zhang X

International Journal of Nanomedicine 2018, 13:1495-1504

Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer

Cymbaluk-Płoska A, Chudecka-Głaz A, Jagodzińska A, Pius-Sadowska E, Sompolska-Rzechuła A, Machaliński B, Menkiszak J

OncoTargets and Therapy 2018, 11:1363-1372

Association of genetic variation in COMT gene with pain related to sickle cell disease in patients from the walk-PHaSST study

Zhang Y, Belfer I, Nouraie M, Zeng Q, Goel R, Chu Y, Krasiy I, Krishnamurti L

Journal of Pain Research 2018, 11:537-543

Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome

Barra S, Belgioia L, Marcenaro M, Callegari S, Pastorino A, Trapani L, Cavagnetto F, Garelli S, Corvò R

Cancer Management and Research 2018, 10:473-480

SPP1 promotes ovarian cancer progression via Integrin β1/FAK/Akt signaling pathway

Zeng B, Zhou M, Wu H, Xiong Z

OncoTargets and Therapy 2018, 11:1333-1343

Clinicopathological features and prognosis in elderly gastric cancer patients: a retrospective cohort study

Xu G, Feng F, Liu S, Wang F, Zheng G, Wang Q, Cai L, Guo M, Lian X, Zhang H

OncoTargets and Therapy 2018, 11:1353-1362

Clinical behaviors of rare variants of papillary thyroid carcinoma are associated with survival: a population-level analysis

Jiang CH, Cheng T, Zheng XC, Hong SK, Liu S, Liu JJ, Wang J, Wang SY

Cancer Management and Research 2018, 10:465-472

The trends and projections in the incidence and mortality of liver cancer in urban Shanghai: a population-based study from 1973 to 2020

Bai L, Liu ZQ, Fang QW, Yan Q, Shi OM, Bao PP, Mu LN, Chen XD, Zhang TJ

Clinical Epidemiology 2018, 10:277-288

Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers

Kebebe D, Liu Y, Wu Y, Vilakhamxay M, Liu Z, Li J

International Journal of Nanomedicine 2018, 13:1425-1442

Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy

Xie JJ, Fan ZX, Li Y, Zhang YY, Yu F, Su GH, Xie LY, Hou ZQ

International Journal of Nanomedicine 2018, 13:1381-1398

Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy

Duan X, Mu M, Yan J, Bai L, Zhong L, Zhu Y, Pan H, Zhang M, Shi J

International Journal of Nanomedicine 2018, 13:1443-1456

A rare life-threatening disease: unilateral kidney compressed by huge chronic spontaneous retroperitoneal hemorrhage

Lu HY, Wei W, Chen QW, Meng QG, Hu GH, Yi XL, Bai XZ

Therapeutics and Clinical Risk Management 2018, 14:489-492

CREB promotes laryngeal cancer cell migration via MYCT1/NAT10 axis

Zhang ZX, Zhang WN, Sun YY, Li YH, Xu ZM, Fu WN

OncoTargets and Therapy 2018, 11:1323-1331

Prognostic significance of preoperative IKBKE expression in esophageal squamous cell carcinoma

Yang WJ, Qu Y, Tan BX, Jia YB, Wang NN, Hu P, Wang JB

OncoTargets and Therapy 2018, 11:1305-1314

Adenosquamous carcinoma of the bile duct: a population-based study

Qin BD, Jiao XD, Yuan LY, Liu K, Zang YS

Cancer Management and Research 2018, 10:439-446

Combining statistical techniques to predict postsurgical risk of 1-year mortality for patients with colon cancer

Arostegui I, Gonzalez N, Fernández-de-Larrea N, Lázaro-Aramburu S, Baré M, Redondo M, Sarasqueta C, Garcia-Gutierrez S, Quintana JM

Clinical Epidemiology 2018, 10:235-251

Vascular endothelial growth factor suppresses dendritic cells function of human prostate cancer

Bai WK, Zhang W, Hu B

OncoTargets and Therapy 2018, 11:1267-1274

Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancer

Bai F, Yin Y, Chen T, Chen J, Ge M, Lu Y, Xie F, Zhang J, Wu K, Liu Y

International Journal of Nanomedicine 2018, 13:1327-1339

Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery

Han H, Chen W, Yang J, Liang X, Wang Y, Li Q, Yang Y, Li K

International Journal of Nanomedicine 2018, 13:1297-1311

Pomegranate extract-loaded solid lipid nanoparticles: design, optimization, and in vitro cytotoxicity study

Badawi NM, Teaima MH, El-Say KM, Attia DA, El-Nabarawi MA, Elmazar MM

International Journal of Nanomedicine 2018, 13:1313-1326

A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey – NOTES study

Yalcin Ş, Yildiz R, Dane F, Karaoğlu A, Öksüzoğlu B, Özyilkan Ö, Sevinç A, Özdemir F, Turna H, Uslu R, Ulay E

OncoTargets and Therapy 2018, 11:1223-1228

Targeted co-delivery of Beclin 1 siRNA and FTY720 to hepatocellular carcinoma by calcium phosphate nanoparticles for enhanced anticancer efficacy

Wu JY, Wang ZX, Zhang G, Lu X, Qiang GH, Hu W, Ji AL, Wu JH, Jiang CP

International Journal of Nanomedicine 2018, 13:1265-1280

Leukemia-related protein 16 (LRP16) promotes tumor growth and metastasis in pancreatic cancer

Mo Z, Hu MG, Yu F, Shao LJ, Fan KX, Jiao SC

OncoTargets and Therapy 2018, 11:1215-1222

Intra-articular platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis

Zhang HF, Wang CG, Li H, Huang YT, Li ZJ

Drug Design, Development and Therapy 2018, 12:445-453

Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma

Wang R, Deng D, Shao N, Xu Y, Xue L, Peng Y, Liu Y, Zhi F

OncoTargets and Therapy 2018, 11:1183-1192

Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy

Li Y, Duo Y, Bi J, Zeng X, Mei L, Bao S, He L, Shan A, Zhang Y, Yu X

International Journal of Nanomedicine 2018, 13:1241-1256

Effects of propofol-based total intravenous anesthesia on gastric cancer: a retrospective study

Zheng XY, Wang Y, Dong LL, Zhao S, Wang LP, Chen H, Xu Y, Wang GN

OncoTargets and Therapy 2018, 11:1141-1148

The efficacy and safety of alectinib in the treatment of ALK+ NSCLC: a systematic review and meta-analysis

Fan JS, Xia ZF, Zhang XL, Chen YQ, Qian RL, Liu SH, You DM, Zhang J, Luo P

OncoTargets and Therapy 2018, 11:1105-1115

TSPAN12 is overexpressed in NSCLC via p53 inhibition and promotes NSCLC cell growth in vitro and in vivo

Hu Z, Hou D, Wang X, You Z, Cao X

OncoTargets and Therapy 2018, 11:1095-1103

rs11614913 polymorphism in miRNA-196a2 and cancer risk: an updated meta-analysis

Liu Y, He A, Liu B, Zhong Y, Liao X, Yang J, Chen J, Wu J, Mei H

OncoTargets and Therapy 2018, 11:1121-1139

Genetic association between HER2 and ESR2 polymorphisms and ovarian cancer: a meta-analysis

Tang L, Li J, Bao M, Xiang J, Chen Y, Wang Y

OncoTargets and Therapy 2018, 11:1055-1066

Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion

Aguado C, Gil MDLL, Yeste Z, Giménez-Capitán A, Teixidó C, Karachaliou N, Viteri S, Rosell R, Molina-Vila MA

OncoTargets and Therapy 2018, 11:1117-1120

Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer

Jiang DG, Xiao CT, Xian TZ, Wang LT, Mao YH, Zhang JF, Pang J

OncoTargets and Therapy 2018, 11:1077-1086

Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment

Pan C, Liu Y, Zhou M, Wang W, Shi M, Xing M, Liao W

International Journal of Nanomedicine 2018, 13:1119-1137

Clinicopathologic characteristics and prognosis of proximal and distal gastric cancer

Yu X, Hu F, Li C, Yao Q, Zhang H, Xue Y

OncoTargets and Therapy 2018, 11:1037-1044

Forkhead box K2 inhibits the proliferation, migration, and invasion of human glioma cells and predicts a favorable prognosis

Wang B, Zhang XB, Wang W, Zhu ZZ, Tang F, Wang D, Liu X, Zhuang H, Yan XL

OncoTargets and Therapy 2018, 11:1067-1075

CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis

Zhang Y, Xu L, Peng M

OncoTargets and Therapy 2018, 11:1045-1054

Reversine, a substituted purine, exerts an inhibitive effect on human renal carcinoma cells via induction of cell apoptosis and polyploidy

Cheng L, Wang H, Guo KC, Wang ZC, Zhang ZY, Shen C, Chen L, Lin J

OncoTargets and Therapy 2018, 11:1025-1035

Prognostic significance of Epstein–Barr virus DNA in NK/T-cell lymphoma: a meta-analysis

Fei Q, Tian X, Wu J, Zhu H, Wang Y, Peng F, Zhang W, Yin L, He X

OncoTargets and Therapy 2018, 11:997-1004

Women’s experience of acute skin toxicity following radiation therapy in breast cancer

Andersen ER, Eilertsen G, Myklebust AM, Eriksen S

Journal of Multidisciplinary Healthcare 2018, 11:139-148

Quality of life of young Chinese breast cancer patients after adjuvant chemotherapy

Yeo W, Mo FKF, Pang E, Suen JJS, Koh J, Yip CHW, Yip CCH, Li L, Loong HHF, Liem GS

Cancer Management and Research 2018, 10:383-389

Adhesion, proliferation, and apoptosis in different molecular portraits of breast cancer treated with silver nanoparticles and its pathway-network analysis

Rodríguez-Razón CM, Yañez-Sánchez I, Ramos-Santillan VO, Velásquez-Ordóñez C, Gutiérrez-Rubio SA, García-García MR, López-Roa RI, Sánchez-Hernández PE, Daneri-Navarro A, García-Iglesias T

International Journal of Nanomedicine 2018, 13:1081-1095

Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines

Sipos E, Dobos N, Rozsa D, Fodor K, Olah G, Szabo Z, Szekvolgyi L, Schally AV, Halmos G

OncoTargets and Therapy 2018, 11:933-941

Role of ubenimex as an anticancer drug and its synergistic effect with Akt inhibitor in human A375 and A2058 cells

Wang X, Liu Y, Wu R, Guo F, Zhang L, Cui M, Wu X, Zhang Y, Liu W

OncoTargets and Therapy 2018, 11:943-953

The investigation for potential modifier genes in patients with neurofibromatosis type 1 based on next-generation sequencing

Yang F, Xu S, Liu RW, Shi T, Li XF, Li XB, Chen G, Liu HY, Zhou QH, Chen J

OncoTargets and Therapy 2018, 11:919-932

Computed tomography colonography versus colonoscopy for the diagnosis of colorectal cancer: a systematic review and meta-analysis

Duarte RB, Bernardo WM, Sakai CM, Silva GLR, Guedes HG, Kuga R, Ide E, Ishida RK, Sakai P, de Moura EGH

Therapeutics and Clinical Risk Management 2018, 14:349-360

Spotlight on the utility of the Oncotype DX® breast cancer assay

Siow ZR, De Boer RH, Lindeman GJ, Mann GB

International Journal of Women's Health 2018, 10:89-100

Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma

Sheng XR, Xing SG, Wang RD, Chen K, Jia WD

OncoTargets and Therapy 2018, 11:909-917

Surgical resection improves long-term survival of patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages

Guo H, Wu T, Lu Q, Li M, Guo JY, Shen Y, Wu Z, Nan KJ, Lv Y, Zhang XF

Cancer Management and Research 2018, 10:361-369

Origanum vulgare mediated green synthesis of biocompatible gold nanoparticles simultaneously possessing plasmonic, antioxidant and antimicrobial properties

Benedec D, Oniga I, Cuibus F, Sevastre B, Stiufiuc G, Duma M, Hanganu D, Iacovita C, Stiufiuc R, Lucaciu CM

International Journal of Nanomedicine 2018, 13:1041-1058

Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review

Bi MH, Yang JR, Wang YP, Zhang HR, Gao ZY, Zhou HR, Shi MH

OncoTargets and Therapy 2018, 11:883-890

Patients with osteosarcoma and soft tissue sarcoma might become "cancer refugees" in some Japanese regional cities

Yamane H, Kunisada T, Ozaki T, Ochi N, Honda Y, Nagasaki Y, Nakagawa N, Yamagishi T, Nakanishi H, Takigawa N

Cancer Management and Research 2018, 10:353-359

New developments in the management of head and neck cancer – impact of pembrolizumab

Saleh K, Eid R, Haddad FGH, Khalife-Saleh N, Kourie HR

Therapeutics and Clinical Risk Management 2018, 14:295-303

Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release

Hakeem A, Zahid F, Zhan G, Yi P, Yang H, Gan L, Yang X

International Journal of Nanomedicine 2018, 13:1029-1040

The role of calgranulin B gene on the biological behavior of squamous cervical cancer in vitro and in vivo

Zhang W, Chen M, Cheng H, Shen Q, Wang Y, Zhu X

Cancer Management and Research 2018, 10:323-338

Effects of four single nucleotide polymorphisms of EZH2 on cancer risk: a systematic review and meta-analysis

Ling Z, You Z, Hu L, Zhang L, Wang Y, Zhang M, Zhang G, Chen S, Xu B, Chen M

OncoTargets and Therapy 2018, 11:851-865

Interleukin-33 enhanced the migration and invasiveness of human lung cancer cells

Yang Z, Gao X, Wang J, Xu L, Zheng Y, Xu Y

OncoTargets and Therapy 2018, 11:843-849

Developments in the management of advanced soft-tissue sarcoma – olaratumab in context

Moroncini G, Maccaroni E, Fiordoliva I, Pellei C, Gabrielli A, Berardi R

OncoTargets and Therapy 2018, 11:833-842

Increased proportions of HIV-infected women met cervical cancer screening guideline in 2016

Mohammed DY, Shukla P, Babayants Y, Sison R, Slim J

International Journal of Women's Health 2018, 10:83-87

Poly(lactic-co-glycolic acid)-loaded nanoparticles of betulinic acid for improved treatment of hepatic cancer: characterization, in vitro and in vivo evaluations

Kumar P, Singh AK, Raj V, Rai A, Keshari AK, Kumar D, Maity B, Prakash A, Maiti S, Saha S

International Journal of Nanomedicine 2018, 13:975-990

UK medical students’ perceptions, attitudes, and interest toward medical leadership and clinician managers

Rouhani MJ, Burleigh EJ, Hobbis C, Dunford C, Osman NI, Gan C, Gibbons NB, Ahmed HU, Miah S

Advances in Medical Education and Practice 2018, 9:119-124

Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence

Brett J, Boulton M, Fenlon D, Hulbert-Williams NJ, Walter FM, Donnelly P, Lavery BA, Morgan A, Morris C, Watson EK

Patient Preference and Adherence 2018, 12:291-300

Clinical significance of quantitative HER2 gene amplification as related to its predictive value in breast cancer patients in neoadjuvant setting

Wu Z, Xu S, Zhou L, Yin W, Lin Y, Du Y, Wang Y, Jiang Y, Yin K, Zhang J, Lu J

OncoTargets and Therapy 2018, 11:801-808

Combination of CRP and NLR: a better predictor of postoperative survival in patients with gastric cancer

Guo J, Chen S, Chen Y, Li S, Xu D

Cancer Management and Research 2018, 10:315-321

Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles

Colzani B, Pandolfi L, Hoti A, Iovene PA, Natalello A, Avvakumova S, Colombo M, Prosperi D

International Journal of Nanomedicine 2018, 13:957-973

Potential role of coenzyme Q10 in health and disease conditions

Rodick TC, Seibels DR, Babu JR, Huggins KW, Ren G, Mathews ST

Nutrition and Dietary Supplements 2018, 10:1-11

The association between HOTAIR polymorphisms and cancer susceptibility: an updated systemic review and meta-analysis

Min L, Mu X, Tong A, Qian Y, Ling C, Yi T, Zhao X

OncoTargets and Therapy 2018, 11:791-800

ISL1 is upregulated in breast cancer and promotes cell proliferation, invasion, and angiogenesis

Li L, Sun F, Chen X, Zhang M

OncoTargets and Therapy 2018, 11:781-789

Redox-sensitive micelles composed of disulfide-linked Pluronic-linoleic acid for enhanced anticancer efficiency of brusatol

Zhang J, Fang X, Li Z, Chan HF, Lin ZX, Wang Y, Chen M

International Journal of Nanomedicine 2018, 13:939-956

The effect of exercise on cancer-related fatigue in cancer survivors: a systematic review and meta-analysis

Kessels E, Husson O, van der Feltz-Cornelis CM

Neuropsychiatric Disease and Treatment 2018, 14:479-494

Choosing wisely after publication of level I evidence in breast cancer radiotherapy

Niska JR, Keole SR, Pockaj BA, Halyard MY, Patel SH, Northfelt DW, Gray RJ, Wasif N, Vargas CE, Wong WW

Breast Cancer: Targets and Therapy 2018, 10:31-37

PCORnet’s Collaborative Research Groups

Pletcher MJ, Forrest CB, Carton TW

Patient Related Outcome Measures 2018, 9:91-95

EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles

Tsai WH, Yu KH, Huang YC, Lee CI

International Journal of Nanomedicine 2018, 13:903-916

Molecular features of giant-cell carcinoma of the lung: a case report and literature review

Li X, Zhang ZH, Liu JH, Wang D, Wei S, Chen J

OncoTargets and Therapy 2018, 11:751-756

Raptor mediates the antiproliferation of cardamonin by mTORC1 inhibition in SKOV3 cells

Shi D, Zhu Y, Niu P, Zhou J, Chen H

OncoTargets and Therapy 2018, 11:757-767

Neoadjuvant chemotherapy among patients treated for nonmetastatic breast cancer in a population with a high HIV prevalence in Johannesburg, South Africa

Ruff P, Cubasch H, Joffe M, Rosenbaum E, Murugan N, Tsai MC, Ayeni O, Crew KD, Jacobson JS, Neugut AI

Cancer Management and Research 2018, 10:279-286

Bone metastasis pattern in initial metastatic breast cancer: a population-based study

Xiong Z, Deng G, Huang X, Li X, Xie X, Wang J, Shuang Z, Wang X

Cancer Management and Research 2018, 10:287-295

Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis

Mahtani RL, Parisi M, Glück S, Ni Q, Park S, Pelletier C, Faria C, Braiteh F

Cancer Management and Research 2018, 10:249-256

Expression of Nemo-like kinase in cervical squamous cell carcinoma: a clinicopathological study

Yang W, Gu L, Yang C, Liu T

OncoTargets and Therapy 2018, 11:743-749

Gastric cancer: epidemiology, prevention, classification, and treatment

Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP

Cancer Management and Research 2018, 10:239-248

Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity

Dou XQ, Wang H, Zhang J, Wang F, Xu GL, Xu CC, Xu HH, Xiang SS, Fu J, Song HF

International Journal of Nanomedicine 2018, 13:763-776

Efficacy and safety of COX-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: a meta-analysis

Dai P, Li J, Ma XP, Huang J, Meng JJ, Gong P

OncoTargets and Therapy 2018, 11:721-730

Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysis

Pu N, Li JA, Xu YL, Lee WL, Fang Y, Han X, Zhao GC, Zhang L, Nuerxiati A, Yin HL, Wu WC, Lou WH

Cancer Management and Research 2018, 10:227-238

Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration

Dian LH, Hu YJ, Lin JY, Zhang JY, Yan Y, Cui YN, Su ZB, Lu WL

International Journal of Nanomedicine 2018, 13:719-731

Nanosilver: new ageless and versatile biomedical therapeutic scaffold

Ullah Khan S, Saleh TA, Wahab A, Khan MHU, Khan D, Ullah Khan W, Rahim A, Kamal S, Ullah Khan F, Fahad S

International Journal of Nanomedicine 2018, 13:733-762

PUMA mediates the anti-cancer effect of osimertinib in colon cancer cells [Corrigendum]

Guo L, Huang S, Wang X

OncoTargets and Therapy 2018, 11:687-688

Early diagnostic potential of APC hypermethylation in esophageal cancer

Wang B, Song H, Jiang H, Fu Y, Ding X, Zhou C

Cancer Management and Research 2018, 10:181-198

Advances in the treatment of soft tissue sarcoma: focus on eribulin

Koliou P, Karavasilis V, Theochari M, Pollack SM, Jones RL, Thway K

Cancer Management and Research 2018, 10:207-216

Role of MLH1 methylation in esophageal cancer carcinogenesis and its clinical significance

Li J, Ye D, Wang L, Peng Y, Li Q, Deng H, Zhou C

OncoTargets and Therapy 2018, 11:651-663

Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis

Tang LN, Zhang CL, He HR, Pan ZY, Fan D, He YL, You HS, Li YJ

OncoTargets and Therapy 2018, 11:665-675

Effects of core needle biopsy and subsequent neoadjuvant chemotherapy on molecular alterations and outcome in breast cancer

Xie L, Li X, Wang Q, Zhou J, Shen J, Luo L, Lu Y, Wang L

OncoTargets and Therapy 2018, 11:677-685

The application of a three-dimensional visualized seed planning and navigation system in 125I seed implantation for pancreatic cancer

Hu YY, Qi EP, Liu FY, Lu YH, Tan SL, Sun Y, Han ZY, Liang P, Yu XL

OncoTargets and Therapy 2018, 11:619-627

ALDH1A2 suppresses epithelial ovarian cancer cell proliferation and migration by downregulating STAT3

Wang Y, Shao F, Chen L

OncoTargets and Therapy 2018, 11:599-608

pH-responsive charge-reversal polymer-functionalized boron nitride nanospheres for intracellular doxorubicin delivery

Feng SN, Zhang HJ, Zhi CY, Gao XD, Nakanishi H

International Journal of Nanomedicine 2018, 13:641-652

Role of intestinal flora in colorectal cancer from the metabolite perspective: a systematic review

Han S, Gao J, Zhou Q, Liu S, Wen C, Yang X

Cancer Management and Research 2018, 10:199-206

LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1

Shang M, Wang X, Zhang Y, Gao Z, Wang T, Liu R

OncoTargets and Therapy 2018, 11:639-649

Identification of genomic expression differences between right-sided and left-sided colon cancer based on bioinformatics analysis

Peng Q, Lin K, Chang T, Zou L, Xing P, Shen Y, Zhu Y

OncoTargets and Therapy 2018, 11:609-618

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date

Criscitiello C, Viale G, Curigliano G, Goldhirsch A

Breast Cancer: Targets and Therapy 2018, 10:23-29

Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells

Liang G, Kan S, Zhu Y, Feng S, Feng W, Gao S

International Journal of Nanomedicine 2018, 13:585-599

The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review

Tong X, Wang D, Liu S, Ma Y, Li Z, Tian P, Fan H

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:409-418

Dysregulation of Neuregulin-1/ErbB signaling in the hippocampus of rats after administration of doxorubicin

Liao D, Guo Y, Xiang D, Dang R, Xu P, Cai H, Cao L, Jiang P

Drug Design, Development and Therapy 2018, 12:231-239

Replacing sedentary time with physical activity: a 15-year follow-up of mortality in a national cohort

Dohrn IM, Kwak L, Oja P, Sjöström M, Hagströmer M

Clinical Epidemiology 2018, 10:179-186

Copolymer micelles function as pH-responsive nanocarriers to enhance the cytotoxicity of a HER2 aptamer in HER2-positive breast cancer cells

Shen Y, Zhang J, Hao W, Wang T, Liu J, Xie Y, Xu S, Liu H

International Journal of Nanomedicine 2018, 13:537-553

Systematic review of health state utility values for acute myeloid leukemia

Forsythe A, Brandt PS, Dolph M, Patel S, Rabe APJ, Tremblay G

ClinicoEconomics and Outcomes Research 2018, 10:83-92

Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients

Wang LY, Cui JJ, Guo AX, Yin JY

OncoTargets and Therapy 2018, 11:529-538

Solute carrier transporters: potential targets for digestive system neoplasms

Xie J, Zhu XY, Liu LM, Meng ZQ

Cancer Management and Research 2018, 10:153-166

Treatment and outcomes of non-small-cell lung cancer patients with high comorbidity

Rios J, Gosain R, Goulart BHL, Huang B, Oechsli MN, McDowell JK, Chen Q, Tucker T, Kloecker GH

Cancer Management and Research 2018, 10:167-175

Quantification of heart, pericardium, and left ventricular myocardium movements during the cardiac cycle for thoracic tumor radiotherapy

Tong Y, Yin Y, Lu J, Liu T, Chen J, Cheng P, Gong G

OncoTargets and Therapy 2018, 11:547-554

Nomogram for predicting survival in patients with pancreatic cancer

Song W, Miao DL, Chen L

OncoTargets and Therapy 2018, 11:539-545

Perioperative outcome of elderly versus younger patients undergoing major hepatic or pancreatic surgery

Lu Q, Lu JW, Wu Z, Liu XM, Li JH, Dong J, Yin GZ, Lv Y, Zhang XF

Clinical Interventions in Aging 2018, 13:133-141

Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer

Belzile O, Huang X, Gong J, Carlson J, Schroit AJ, Brekken RA, Freimark BD

ImmunoTargets and Therapy 2018, 7:1-14

Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex® nanoparticles for docetaxel delivery in ovarian cancer

Ghassami E, Varshosaz J, Jahanian-Najafabadi A, Minaiyan M, Rajabi P, Hayati E

International Journal of Nanomedicine 2018, 13:493-504

The prognostic role of Gas6/Axl axis in solid malignancies: a meta-analysis and literature review

Zhang S, Xu XS, Yang JX, Guo JH, Chao TF, Tong YX

OncoTargets and Therapy 2018, 11:509-519

Strongly enhanced colorectal cancer risk stratification by combining family history and genetic risk score

Weigl K, Chang-Claude J, Knebel P, Hsu L, Hoffmeister M, Brenner H

Clinical Epidemiology 2018, 10:143-152

Association of clinicopathologic characteristics and outcomes with EZH2 expression in patients with breast cancer in East Azerbaijan, Iran

Boostani F, Dolatkhah R, Fakhrjou A, Farassati F, Sanaat Z

OncoTargets and Therapy 2018, 11:449-457

Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma

Chen JW, Huang CQ, Chen K, Li SM, Zhang X, Cheng J, Cai MY, Xiao Y

OncoTargets and Therapy 2018, 11:441-448

The effects of black cohosh on the regulation of estrogen receptor (ERα) and progesterone receptor (PR) in breast cancer cells

Szmyd M, Lloyd V, Hallman K, Aleck K, Mladenovik V, McKee C, Morse M, Bedgood T, Dinda S

Breast Cancer: Targets and Therapy 2018, 10:1-11

The relationship between the PD-1/PD-L1 pathway and DNA mismatch repair in cervical cancer and its clinical significance

Feng YC, Ji WL, Yue N, Huang YC, Ma XM

Cancer Management and Research 2018, 10:105-113

A comparison of QuantStudio™ 3D Digital PCR and ARMS-PCR for measuring plasma EGFR T790M mutations of NSCLC patients

Feng Q, Gai F, Sang Y, Zhang J, Wang P, Wang Y, Liu B, Lin D, Yu Y, Fang J

Cancer Management and Research 2018, 10:115-121

Radiation-induced secondary malignancies for nasopharyngeal carcinoma: a pilot study of patients treated via IMRT or VMAT

Lee HF, Lan JH, Chao PJ, Ting HM, Chen HC, Hsu HC, Lee TF

Cancer Management and Research 2018, 10:131-141

Association between body mass index and breast cancer risk: evidence based on a dose–response meta-analysis

Liu K, Zhang W, Dai Z, Wang M, Tian T, Liu X, Kang H, Guan H, Zhang S, Dai Z

Cancer Management and Research 2018, 10:143-151

The role of brigatinib in crizotinib-resistant non-small cell lung cancer

Mezquita L, Planchard D

Cancer Management and Research 2018, 10:123-130

Magnetic immunoassay using CdSe/ZnS quantum dots as fluorescent probes to detect the level of DNA methyltransferase 1 in human serum sample

Yu F, Xiong YM, Yu SC, He LL, Niu SS, Wu YM, Liu J, Qu LB, Liu LE, Wu YJ

International Journal of Nanomedicine 2018, 13:429-437

Neoadjuvant chemoradiotherapy followed by surgery in patients with unresectable locally advanced colon cancer: a prospective observational study

Chang H, Yu X, Xiao W, Wang QX, Zhou WH, Zeng ZF, Ding PR, Li L, Gao YH

OncoTargets and Therapy 2018, 11:409-418

Prognostic role of HSF1 overexpression in solid tumors: a pooled analysis of 3,159 patients

Wan T, Shao J, Hu B, Liu G, Luo P, Zhou Y

OncoTargets and Therapy 2018, 11:383-393

Comparison of FOLFOX and DOF regimens as first-line treatment in East Asian patients with advanced gastric cancer

Liu M, Hu G, Wang Y, Guo J, Liu L, Han X, Wang Z

OncoTargets and Therapy 2018, 11:375-381

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going

Omarini C, Guaitoli G, Pipitone S, Moscetti L, Cortesi L, Cascinu S, Piacentini F

Cancer Management and Research 2018, 10:91-103

Risk of empyema in patients with COPD

Lu HY, Liao KM

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:317-324

Prognostic role of HSPs in human gastrointestinal cancer: a systematic review and meta-analysis

Ge H, Yan Y, Guo L, Tian F, Wu D

OncoTargets and Therapy 2018, 11:351-359

The clinical characteristics and prognostic analysis of Chinese advanced NSCLC patients based on circulating tumor DNA sequencing

Rao C, Nie L, Miao X, Xu Y, Li B, Zhang T

OncoTargets and Therapy 2018, 11:337-344

Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma

Feun LG, Wangpaichitr M, Li YY, Kwon D, Richman SP, Hosein PJ, Savaraj N

Journal of Hepatocellular Carcinoma 2018, 5:9-15

Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine

Jahan ST, Sadat SMA, Haddadi A

International Journal of Nanomedicine 2018, 13:367-386

High-frequency deregulated expression of Wnt signaling pathway members in breast carcinomas

Khan Z, Arafah M, Shaik JP, Mahale A, Alanazi MS

OncoTargets and Therapy 2018, 11:323-335

A novel tumor suppressor gene NCOA5 is correlated with progression in papillary thyroid carcinoma

Zheng Z, Wang Q, Zhang W, Zhang X, Huang D

OncoTargets and Therapy 2018, 11:307-311

Comparative study of clinical efficacy using three-dimensional and two-dimensional laparoscopies in the treatment of distal gastric cancer

Liu JG, Zhou HT, Qin HQ, Ru HM, Huang JH, Liang SY, Mo XW, Tang WZ

OncoTargets and Therapy 2018, 11:301-306

Toxic elements as biomarkers for breast cancer: a meta-analysis study

Jouybari L, Saei Ghare Naz M, Sanagoo A, Kiani F, Sayehmiri F, Sayehmiri K, Hasanpour Dehkordi A

Cancer Management and Research 2018, 10:69-79

Ultrasound-mediated cavitation does not decrease the activity of small molecule, antibody or viral-based medicines

Myers R, Grundy M, Rowe C, Coviello CM, Bau L, Erbs P, Foloppe J, Balloul JM, Story C, Coussios CC, Carlisle R

International Journal of Nanomedicine 2018, 13:337-349

Micelle-templated, poly(lactic-co-glycolic acid) nanoparticles for hydrophobic drug delivery

Nabar GM, Mahajan KD, Calhoun MA, Duong AD, Souva MS, Xu J, Czeisler C, Puduvalli VK, Otero JJ, Wyslouzil BE, Winter JO

International Journal of Nanomedicine 2018, 13:351-366

Incidental prostate cancer: a 10-year review of a tertiary center, Tehran, Iran

Abedi AR, Fallah-Karkan M, Allameh F, Ranjbar A, Shadmehr A

Research and Reports in Urology 2018, 10:1-6

Vulvar carcinoma: dilemma, debates, and decisions

Mitra S, Kumar Sharma M, Kaur I, Khurana R, Batra Modi K, Narang R, Mandal A, Dutta S

Cancer Management and Research 2018, 10:61-68

Detection of circulating tumor cells in liquid biopsy from Ewing sarcoma patients

Benini S, Gamberi G, Cocchi S, Garbetta J, Alberti L, Righi A, Gambarotti M, Picci P, Ferrari S

Cancer Management and Research 2018, 10:49-60

Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles

Zhang W, Song Y, Eldi P, Guo X, Hayball JD, Garg S, Albrecht H

International Journal of Nanomedicine 2018, 13:293-305

Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer

Zhang P, Zhou H, Lu K, Lu Y, Wang Y, Feng T

OncoTargets and Therapy 2018, 11:291-299

Young age increases risk for lymph node positivity but decreases risk for non-small cell lung cancer death

Xia W, Wang A, Jin M, Mao Q, Xia W, Dong G, Chen B, Ma W, Xu L, Jiang F

Cancer Management and Research 2018, 10:41-48

KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth

Wang Y, Zang J, Zhang D, Sun Z, Qiu B, Wang X

OncoTargets and Therapy 2018, 11:201-209

The reciprocal relationship between coping mechanisms and lung cancer diagnosis: findings of a prospective study

Oancea C, Suciu C, Timar B, Papava I, Raica M, Burlacu O

Cancer Management and Research 2018, 10:33-40

Transcriptional profiling of NCI/ADR-RES cells unveils a complex network of signaling pathways and molecular mechanisms of drug resistance

Vert A, Castro J, Ribó M, Vilanova M, Benito A

OncoTargets and Therapy 2018, 11:221-237

RACK1 induces chemotherapy resistance in esophageal carcinoma by upregulating the PI3K/AKT pathway and Bcl-2 expression

Liu B, Wang C, Chen P, Cheng B, Cheng Y

OncoTargets and Therapy 2018, 11:211-220

miR-99a-5p acts as tumor suppressor via targeting to mTOR and enhances RAD001-induced apoptosis in human urinary bladder urothelial carcinoma cells

Tsai TF, Lin JF, Chou KY, Lin YC, Chen HE, Hwang TIS

OncoTargets and Therapy 2018, 11:239-252

Nano-graphene oxide composite for in vivo imaging

Jang SC, Kang S, Lee JY, Oh SY, Vilian ATE, Lee I, Han Y, Park JH, Cho WS, Roh C, Huh YS

International Journal of Nanomedicine 2018, 13:221-234

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer

Veldore VH, Choughule A, Routhu T, Mandloi N, Noronha V, Joshi A, Dutt A, Gupta R, Vedam R, Prabhash K

Lung Cancer: Targets and Therapy 2018, 9:1-11

Effects of marital status on survival of hepatocellular carcinoma by race/ethnicity and gender

Wu W, Fang D, Shi D, Bian X, Li L

Cancer Management and Research 2018, 10:23-32

Cancer stem cells, the ultimate targets in cancer therapy

Shabbir A, Esfandyari T, Farassati F

OncoTargets and Therapy 2018, 11:183-184

The effects of naloxone on human breast cancer progression: in vitro and in vivo studies on MDA.MB231 cells

Bimonte S, Barbieri A, Cascella M, Rea D, Palma G, Del Vecchio V, Forte CA, Del Prato F, Arra C, Cuomo A

OncoTargets and Therapy 2018, 11:185-191

Radiotherapy for esophageal carcinoma: dose, response and survival

Luo Y, Mao Q, Wang X, Yu J, Li M

Cancer Management and Research 2018, 10:13-21

A patient with classic biphasic pulmonary blastoma harboring CD74–ROS1 fusion responds to crizotinib

Meng Z, Chen P, Zang F, Liu Y, Xu X, Su Y, Chen J, Lin L, Zhang L, Zhang T

OncoTargets and Therapy 2018, 11:157-161

Preparation of anastrozole loaded PEG-PLA nanoparticles: evaluation of apoptotic response of breast cancer cell lines

Alyafee YA, Alaamery M, Bawazeer S, Almutairi MS, Alghamdi B, Alomran N, Sheereen A, Daghestani M, Massadeh S

International Journal of Nanomedicine 2018, 13:199-208

Assessment of the cardiac safety between cetuximab and panitumumab as single therapy in Chinese chemotherapy-refractory mCRC

Tang XM, Chen H, Li Q, Song YL, Zhang SP, Xu XS, Xu YW, Chen SL

OncoTargets and Therapy 2018, 11:123-129

Does breast density measured through population-based screening independently increase breast cancer risk in Asian females?

Park B, Cho HM, Lee EH, Song S, Suh M, Choi KS, Kang BJ, Ko K, Yi A, Jung HK, Cha JH, Jun JK

Clinical Epidemiology 2018, 10:61-70

Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment

Wang D, Xu X, Zhang K, Sun B, Wang L, Meng L, Liu Q, Zheng C, Yang B, Sun H

International Journal of Nanomedicine 2018, 13:187-198

The putative tumor suppressor, miR-199a, regulated by Snail, modulates clear cell renal cell carcinoma aggressiveness by repressing ROCK1

Zhang X, Li P, Ding Z, Wang H, Wang J, Han L, Ding S

OncoTargets and Therapy 2018, 11:103-112

Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy

Xia Y, Xu T, Wang C, Li Y, Lin Z, Zhao M, Zhu B

International Journal of Nanomedicine 2018, 13:143-159

The RNASEL −1385G/A polymorphism is associated with risk of prostate cancer in Africans

Liu X, Zheng D, Lu G, Yang B

OncoTargets and Therapy 2018, 11:97-102

Using a chronic hepatitis B Registry to support population-level liver cancer prevention in Sydney, Australia

Robotin MC, Masgoret X, Porwal M, Goldsbury D, Khoo C, George J

Clinical Epidemiology 2018, 10:41-49

Inhibition of cancer cell migration with CuS@mSiO2-PEG nanoparticles by repressing MMP-2/MMP-9 expression

Deng G, Zhou F, Wu Z, Zhang F, Niu K, Kang Y, Liu X, Wang Q, Wang Y, Wang Q

International Journal of Nanomedicine 2018, 13:103-116

Upregulated LAMB3 increases proliferation and metastasis in thyroid cancer

Wang Y, Jin Y, Bhandari A, Yao Z, Yang F, Pan Y, Zheng Z, Lv S, Wang O

OncoTargets and Therapy 2018, 11:37-46

Four-miRNA signature as a prognostic tool for lung adenocarcinoma

Lin Y, Lv Y, Liang R, Yuan C, Zhang J, He D, Zheng X, Zhang J

OncoTargets and Therapy 2018, 11:29-36

Enhanced antitumor efficacy of doxorubicin-encapsulated halloysite nanotubes

Li K, Zhang Y, Chen M, Hu Y, Jiang W, Zhou L, Li S, Xu M, Zhao Q, Wan R

International Journal of Nanomedicine 2018, 13:19-30

Safety concerns with the Centers for Disease Control opioid calculator

Fudin J, Raouf M, Wegrzyn EL, Schatman ME

Journal of Pain Research 2018, 11:1-4

Programmed death-ligand 1 expression correlates with diminished CD8+ T cell infiltration and predicts poor prognosis in anal squamous cell carcinoma patients

Zhao Y, Sun WP, Peng J, Deng Y, Fang Y, Huang J, Zhang H, Wan D, Lin J, Pan Z

Cancer Management and Research 2018, 10:1-11

Opinions, practice patterns, and perceived barriers to lung cancer screening among attending and resident primary care physicians

Henderson LM, Jones LM, Marsh MW, Brenner AT, Goldstein AO, Benefield TS, Greenwood-Hickman MA, Molina PL, Rivera MP, Reuland DS

Risk Management and Healthcare Policy 2017, 10:189-195

Emerging treatment options for ovarian cancer: focus on rucaparib

Mariappan L, Jiang XY, Jackson J, Drew Y

International Journal of Women's Health 2017, 9:913-924

Clinical significance of miR-34a expression in thyroid diseases – an 18F-FDG PET-CT study

Chen L, Yang C, Feng J, Liu X, Tian Y, Zhao L, Xie R, Liu C, Zhao S, Sun H

Cancer Management and Research 2017, 9:903-913

Thermal camera as a pain monitor

Erel VK, Özkan HS

Journal of Pain Research 2017, 10:2827-2832

Ganglion blocks as a treatment of pain: current perspectives

Gunduz OH, Kenis-Coskun O

Journal of Pain Research 2017, 10:2815-2826

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases

Cantatore FP, Maruotti N, Corrado A, Ribatti D

Biologics: Targets and Therapy 2017, 11:123-128

Expression profile analysis of long noncoding RNA in ER-positive subtype breast cancer using microarray technique and bioinformatics

Peng J, Zhang L, Yuan CW, Zhou LH, Xu SG, Lin YP, Zhang J, Yin WJ, Lu JS

Cancer Management and Research 2017, 9:891-901

ZNF259 inhibits non-small cell lung cancer cells proliferation and invasion by FAK-AKT signaling

Shan Y, Cao W, Wang T, Jiang G, Zhang Y, Yang X

Cancer Management and Research 2017, 9:879-889

Bevacizumab in the treatment of NSCLC: patient selection and perspectives

Russo AE, Priolo D, Antonelli G, Libra M, Mccubrey JA, Ferraù F

Lung Cancer: Targets and Therapy 2017, 8:259-269

Seven-microRNA panel for lung adenocarcinoma early diagnosis in patients presenting with ground-glass nodules

He Y, Yang Y, Kuang P, Ren S, Rozeboom L, Rivard CJ, Li X, Zhou C, Hirsch FR

OncoTargets and Therapy 2017, 10:5915-5926

Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel

Zhang X, Wu Y, Zhang M, Mao J, Wu Y, Zhang Y, Yao J, Xu C, Guo W, Yu B

International Journal of Nanomedicine 2017, 12:8779-8799

Observation of different tumor motion magnitude within liver and estimate of internal motion margins in postoperative patients with hepatocellular carcinoma

Zhao YT, Liu ZK, Wu QW, Dai JR, Zhang T, Jia AY, Jin J, Wang SL, Li YX, Wang WH

Cancer Management and Research 2017, 9:839-848

Prognostic role and clinical significance of trophoblast cell surface antigen 2 in various carcinomas

Xu P, Zhao Y, Liu K, Lin S, Liu X, Wang M, Yang P, Tian T, Zhu Y, Dai Z

Cancer Management and Research 2017, 9:821-837

Integrative analysis of lncRNAs and miRNAs with coding RNAs associated with ceRNA crosstalk network in triple negative breast cancer

Yuan NJ, Zhang G, Bie FJ, Ma M, Ma Y, Jiang X, Wang Y, Hao X

OncoTargets and Therapy 2017, 10:5883-5897

High expression of CIP2A protein is associated with tumor aggressiveness in stage I–III NSCLC and correlates with poor prognosis

Cha GQ, Xu JY, Xu XY, Li B, Lu S, Nanding AB, Hu SL, Liu SL

OncoTargets and Therapy 2017, 10:5907-5914

miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α

Feng X, Liu N, Deng S, Zhang DD, Wang KX, Lu MS

OncoTargets and Therapy 2017, 10:5899-5906

Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy

Omote N, Hashimoto N, Morise M, Sakamoto K, Miyazaki S, Ando A, Nakahara Y, Hasegawa Y

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3541-3547

Deletion and downregulation of MTAP contribute to the motility of esophageal squamous carcinoma cells

Cheng X, Liu Z, Shang L, Cai H, Zhang Y, Cai Y, Xu X, Hao J, Wang M

OncoTargets and Therapy 2017, 10:5855-5862

Comparison of survival outcomes between radical hysterectomy and definitive radiochemotherapy in stage IB1 and IIA1 cervical cancer

Wu SG, Zhang WW, He ZY, Sun JY, Wang Y, Zhou J

Cancer Management and Research 2017, 9:813-819

Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance

Peng R, Huang X, Zhang C, Yang X, Xu Y, Bai D

OncoTargets and Therapy 2017, 10:5863-5872

Gut microbiota–derived short-chain fatty acids and kidney diseases

Li L, Ma L, Fu P

Drug Design, Development and Therapy 2017, 11:3531-3542

Preventive effect of Oenothera rosea on N-methyl-N-nitrosourea- (NMU) induced gastric cancer in rats

Almora-Pinedo Y, Arroyo-Acevedo J, Herrera-Calderon O, Chumpitaz-Cerrate V, Hañari-Quispe R, Tinco-Jayo A, Franco-Quino C, Figueroa-Salvador L

Clinical and Experimental Gastroenterology 2017, 10:327-332

Tolerability of oral sorafenib in pet dogs with a diagnosis of cancer

Foskett A, Manley C, Naramore R, Gordon IK, Stewart BM, Khanna C

Veterinary Medicine: Research and Reports 2017, 8:97-102

Pleomorphic lobular carcinoma: is it more similar to a classic lobular cancer or to a high-grade ductal cancer?

Costarelli L, Campagna D, Ascarelli A, Cavaliere F, Colavito MH, Ponzani T, Broglia L, La Pinta M, Manna E, Fortunato L

Breast Cancer: Targets and Therapy 2017, 9:581-586

Regulation profile of the intestinal peptide transporter 1 (PepT1)

Wang CY, Liu S, Xie XN, Tan ZR

Drug Design, Development and Therapy 2017, 11:3511-3517

The clinicopathological significance of HES1 promoter hypomethylation in patients with colorectal cancer

Wu Y, Gong L, Xu J, Mou Y, Xu X, Qian Z

OncoTargets and Therapy 2017, 10:5827-5834

Chemotherapy induces ovarian cancer cell repopulation through the caspase 3-mediated arachidonic acid metabolic pathway

Cui LZ, Zhao YW, Pan Y, Zheng X, Shao D, Jia Y, He K, Li K, Chen L

OncoTargets and Therapy 2017, 10:5817-5826

The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor

Chen Y, Guo W, Fan J, Chen Y, Zhang X, Chen X, Luo P

Cancer Management and Research 2017, 9:801-811

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study

Restelli U, Ceresoli GL, Croce D, Evangelista L, Maffioli LS, Gianoncelli L, Bombardieri E

Cancer Management and Research 2017, 9:789-800

Low expression of GATA3 promotes cell proliferation and metastasis in gastric cancer

Wei S, Zhong L, Wang X, Zhang W

Cancer Management and Research 2017, 9:769-780

Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer

Vadhan-Raj S, Dahl NV, Bernard K, Li Z, Strauss WE

Journal of Blood Medicine 2017, 8:199-209

Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer

Tokiwa S, Shimmura H, Nomura S, Watanabe R, Kurita M, Yoshida N, Yamashita K, Nishikawa Y, Kouzmenko A, Kato S

Research and Reports in Urology 2017, 9:225-232

Variability in the therapeutic management of advanced ovarian cancer patients: a five-country survey of oncologists

Audibert C, Perlaky A, Stuntz M, Glass D

Drug Design, Development and Therapy 2017, 11:3471-3479

Prognostic role of CD82/KAI1 in multiple human malignant neoplasms: a meta-analysis of 31 studies

Zhu J, Miao C, Liu S, Tian Y, Zhang C, Liang C, Xu A, Cao Q, Wang Z

OncoTargets and Therapy 2017, 10:5805-5816

The combination astemizole–gefitinib as a potential therapy for human lung cancer

Chávez-López MDG, Zúñiga-García V, Hernández-Gallegos E, Vera E, Chasiquiza-Anchatuña CA, Viteri-Yánez M, Sanchez-Ramos J, Garrido E, Camacho J

OncoTargets and Therapy 2017, 10:5795-5803

Sites of metastasis and overall survival in esophageal cancer: a population-based study

Wu SG, Zhang WW, He ZY, Sun JY, Chen YX, Guo L

Cancer Management and Research 2017, 9:781-788

Can 18F-FDG PET predict the grade of malignancy in thymic epithelial tumors? An evaluation of only resected tumors

Nakagawa K, Takahashi S, Endo M, Ohde Y, Kurihara H, Terauchi T

Cancer Management and Research 2017, 9:761-768

CircRNA_100782 regulates pancreatic carcinoma proliferation through the IL6-STAT3 pathway

Chen G, Shi Y, Zhang Y, Sun J

OncoTargets and Therapy 2017, 10:5783-5794

Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy

Zhong W, Zhang L, Ma J, Shao S, Lin R, Li X, Xiong G, Fang D, Zhou L

OncoTargets and Therapy 2017, 10:5775-5782

The current status of immunobased therapies for metastatic renal-cell carcinoma

Sathianathen NJ, Krishna S, Anderson JK, Weight CJ, Gupta S, Konety BR, Griffith TS

ImmunoTargets and Therapy 2017, 6:83-93

Hopea odorata extract inhibits hepatocellular carcinoma via induction of caspase-dependent apoptosis

Nguyen ST, Huynh KL, Nguyen HL, Nguyen Thi Thanh M, Nguyen Trung N, Nguyen Xuan H, Ngoc KP, Truong Dinh K, Pham PV

OncoTargets and Therapy 2017, 10:5765-5774

Differential radiation response between normal astrocytes and glioma cells revealed by comparative transcriptome analysis

Gong L, Gu JC, Ge JW, Wu X, Zhang C, Yang C, Weng WJ, Gao GY, Feng JF, Mao Q

OncoTargets and Therapy 2017, 10:5755-5764

The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort

Wacker ME, Kitzing K, Jörres RA, Leidl R, Schulz H, Karrasch S, Karch A, Koch A, Vogelmeier CF, Holle R

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3437-3448

Effect of statins on breast cancer recurrence and mortality: a review

Van Wyhe RD, Rahal OM, Woodward WA

Breast Cancer: Targets and Therapy 2017, 9:559-565

Efficacy of trastuzumab beyond progression as second-line chemotherapy for HER2-positive advanced gastric cancer

Sato Y, Yamashita H, Yagi K, Aikou S, Nishida M, Takenaka Y, Nomura S, Seto Y

Gastrointestinal Cancer: Targets and Therapy 2017, 7:39-45

Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma

Qi X, Jia B, Zhao X, Yu D

OncoTargets and Therapy 2017, 10:5745-5754

Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer

Huang L, Liu Q, Chen S, Shao ZM

OncoTargets and Therapy 2017, 10:5739-5744

Efficacy of thermoablation in treating cervical precancerous lesions in a low-resource setting

Tran PL, Kenfack B, Tincho Foguem E, Viviano M, Temogne L, Tebeu P, Catarino R, Benski AC, Vassilakos P, Petignat P

International Journal of Women's Health 2017, 9:879-886

Ex vivo distribution of gold nanoparticles in choroidal melanoma

Kanavi MR, Asadi S, Ahmadieh H

International Journal of Nanomedicine 2017, 12:8527-8529

Maternal diabetes and incidence of childhood cancer – a nationwide cohort study and exploratory genetic analysis

Deleskog A, den Hoed M, Tettamanti G, Carlsson S, Ljung R, Feychting M, Brooke HL

Clinical Epidemiology 2017, 9:633-642

Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma

Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M

Cancer Management and Research 2017, 9:741-750

Predictive value of interim PET/CT visual interpretation in the prognosis of patients with aggressive non-Hodgkin’s lymphoma

Liao CC, Qin YY, Tan XH, Hu JJ, Tang Q, Rong Y, Cen H, Li LQ

OncoTargets and Therapy 2017, 10:5727-5738

Low expression of DAB2IP predicts an unfavorable prognosis in human bladder carcinoma

Zheng L, Chen K, Zhu L, Su D, Cheng G

OncoTargets and Therapy 2017, 10:5719-5726

Induction of apoptosis in HeLa cancer cells by an ultrasonic-mediated synthesis of curcumin-loaded chitosan–alginate–STPP nanoparticles

Ahmadi F, Ghasemi-Kasman M, Ghasemi S, Gholamitabar Tabari M, Pourbagher R, Kazemi S, Alinejad-Mir A

International Journal of Nanomedicine 2017, 12:8545-8556

Transcriptome-wide elucidation of liposomal formulations for anticancer drug delivery

Li Y, Wang M, Huang B, Ping Y, You J, Gao J

International Journal of Nanomedicine 2017, 12:8557-8572

Cytokines and depression in cancer patients and caregivers

Li M, Kouzmina E, McCusker M, Rodin D, Boutros PC, Paige CJ, Rodin G

Neuropsychiatric Disease and Treatment 2017, 13:2903-2911

The burden of selected cancers in the US: health behaviors and health care resource utilization

Iadeluca L, Mardekian J, Chander P, Hopps M, Makinson GT

Cancer Management and Research 2017, 9:721-730

Antitumor effects of pristimerin on human osteosarcoma cells in vitro and in vivo

Mori Y, Shirai T, Terauchi R, Tsuchida S, Mizoshiri N, Hayashi D, Arai Y, Kishida T, Mazda O, Kubo T

OncoTargets and Therapy 2017, 10:5703-5710

Diagnostic significance of circulating long noncoding RNA PCAT6 in patients with non-small cell lung cancer

Wan L, Zhang L, Fan K, Wang JJ

OncoTargets and Therapy 2017, 10:5695-5702

Expression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancer

Li P, Dong J, Zhou X, Sun W, Huang H, Chen T, Ye B, Zheng Z, Lu M

OncoTargets and Therapy 2017, 10:5711-5718

The coexpression of multi-immune inhibitory receptors on T lymphocytes in primary non-small-cell lung cancer

Guo WJ, Liu SH, Zhang XL, Chen YT, Qian RL, Zou ZY, Chen X, Luo P

Drug Design, Development and Therapy 2017, 11:3367-3376

MicroRNA-211 promotes non-small-cell lung cancer proliferation and invasion by targeting MxA

Kang M, Shi J, Peng N, He S

OncoTargets and Therapy 2017, 10:5667-5675

Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer

Xiao BY, Peng JH, Zhang RX, Xu J, Wang YC, Fang YJ, Lin JZ, Pan ZZ, Wu XJ

Cancer Management and Research 2017, 9:701-708

Association between the IL-6 gene polymorphism and tuberculosis risk: a meta-analysis

Wang H, Pang C, Zeng N, Wan C, Shen Y, Wen F

Infection and Drug Resistance 2017, 10:445-454

PBX3 is associated with proliferation and poor prognosis in patients with cervical cancer

Li H, Sun G, Liu C, Wang J, Jing R, Wang J, Zhao X, Xu X, Yang Y

OncoTargets and Therapy 2017, 10:5685-5694

Microtubule-targeting agents can sensitize cancer cells to ionizing radiation by an interphase-based mechanism

Markowitz D, Ha G, Ruggieri R, Symons M

OncoTargets and Therapy 2017, 10:5633-5642

Mesenchymal phenotype of circulating tumor cells is associated with distant metastasis in breast cancer patients

Zhang SR, Wu TC, Peng XG, Liu J, Liu F, Wu SY, Liu SY, Dong Y, Xie SJ, Ma SL

Cancer Management and Research 2017, 9:691-700

Anticancer effect of dentatin and dentatin-hydroxypropyl-β-cyclodextrin complex on human colon cancer (HT-29) cell line

AL-Abboodi AS, Rasedee A, Abdul AB, Taufiq-Yap YH, Alkaby WA, Ghaji MS, Waziri PM, Al-Qubaisi MS

Drug Design, Development and Therapy 2017, 11:3309-3319

Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma

Feng SD, Mao ZM, Liu CY, Nie YS, Sun B, Guo MG, Su CQ

OncoTargets and Therapy 2017, 10:5591-5604

RKIP reduction enhances radioresistance by activating the Shh signaling pathway in non-small-cell lung cancer

Xie SY, Li G, Han C, Yu YY, Li N

OncoTargets and Therapy 2017, 10:5605-5619

Epidemiology of ovarian cancers in Zaria, Northern Nigeria: a 10-year study

Zayyan MS, Ahmed SA, Oguntayo AO, Kolawole AO, Olasinde TA

International Journal of Women's Health 2017, 9:855-860

Lymphocyte-to-monocyte ratio before chemoradiotherapy represents a prognostic predictor for locally advanced rectal cancer

Deng YX, Lin JZ, Peng JH, Zhao YJ, Sui QQ, Wu XJ, Lu ZH, Gao YH, Zeng ZF, Pan ZZ

OncoTargets and Therapy 2017, 10:5575-5583

Clinical application of carbon nanoparticles in curative resection for colorectal carcinoma

Wang LY, Li JH, Zhou X, Zheng QC, Cheng X

OncoTargets and Therapy 2017, 10:5585-5589

Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis

Zhao F, Ge YZ, Zhou LH, Xu LW, Xu Z, Ping WW, Wang M, Zhou CC, Wu R, Jia RP

OncoTargets and Therapy 2017, 10:5551-5559

Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals

Wang Z, Xie H, Guo LP, Cai QL, Shang ZQ, Jiang N, Niu YJ

Cancer Management and Research 2017, 9:679-689

The relationship of SSRI and SNRI usage with interstitial lung disease and bronchiectasis in an elderly population: a case–control study

Rosenberg T, Lattimer R, Montgomery P, Wiens C, Levy L

Clinical Interventions in Aging 2017, 12:1977-1984

The clinical significance of CXCL5 in non-small cell lung cancer

Wu K, Yu S, Liu Q, Bai X, Zheng X, Wu K

OncoTargets and Therapy 2017, 10:5561-5573

Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ

Cui J, Chen S, Bo Q, Wang S, Zhang N, Yu M, Wang W, Han J, Zhu Y, Shi B

OncoTargets and Therapy 2017, 10:5541-5550

The relationship between IGF2BP2 and PPARG polymorphisms and susceptibility to esophageal squamous-cell carcinomas in the eastern Chinese Han population

Qiu H, Wang Y, Kang M, Ding H, Liu C, Tang W, Xiao Z, Chen Y

OncoTargets and Therapy 2017, 10:5525-5532

Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies

Rehman M, Ihsan A, Madni A, Bajwa SZ, Shi D, Webster TJ, Khan WS

International Journal of Nanomedicine 2017, 12:8325-8336

Comorbidity index in central cancer registries: the value of hospital discharge data

Lichtensztajn DY, Giddings BM, Morris CR, Parikh-Patel A, Kizer KW

Clinical Epidemiology 2017, 9:601-609

The crossroads of breast cancer progression: insights into the modulation of major signaling pathways

Velloso FJ, Bianco AFR, Farias JO, Torres NEC, Ferruzo PY, Anschau V, Jesus-Ferreira HC, Chang TH, Sogayar MC, Zerbini LF, Correa RG

OncoTargets and Therapy 2017, 10:5491-5524

Cytomembranic PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma

Zheng L, Cao C, Cheng G, Hu Q, Chen X

OncoTargets and Therapy 2017, 10:5483-5487

Differences of statin activity in 2D and 3D pancreatic cancer cell cultures

Paškevičiūtė M, Petrikaitė V

Drug Design, Development and Therapy 2017, 11:3273-3280

In silico-based identification of human α-enolase inhibitors to block cancer cell growth metabolically

Lung J, Chen KL, Hung CH, Chen CC, Hung MS, Lin YC, Wu CY, Lee KD, Shih NY, Tsai YH

Drug Design, Development and Therapy 2017, 11:3281-3290

Enhanced recovery programs in lung cancer surgery: systematic review and meta-analysis of randomized controlled trials

Li S, Zhou K, Che G, Yang M, Su J, Shen C, Yu P

Cancer Management and Research 2017, 9:657-670

Biotransport kinetics and intratumoral biodistribution of malonodiserinolamide-derivatized [60]fullerene in a murine model of breast adenocarcinoma

Lapin NA, Vergara LA, Mackeyev Y, Newton JM, Dilliard SA, Wilson LJ, Curley SA, Serda RE

International Journal of Nanomedicine 2017, 12:8289-8307

Expression of minichromosome maintenance genes in renal cell carcinoma

Zhong HB, Chen B, Neves H, Xing JC, Ye YX, Lin Y, Zhuang GH, Zhang SD, Huang JY, Kwok HF

Cancer Management and Research 2017, 9:637-647

A retrospective study on analgesic requirements for thoracoscopic surgery postoperative pain

Kuroda H, Mizuno H, Dejima H, Watanabe K, Yoshida T, Naito Y, Sakao Y

Journal of Pain Research 2017, 10:2643-2648

Curcumin potentiates the potent antitumor activity of ACNU against glioblastoma by suppressing the PI3K/AKT and NF-κB/COX-2 signaling pathways

Zhao J, Zhu J, Lv X, Xing J, Liu S, Chen C, Xu Y

OncoTargets and Therapy 2017, 10:5471-5482

Identification of COX5B as a novel biomarker in high-grade glioma patients

Hu T, Xi J

OncoTargets and Therapy 2017, 10:5463-5470

Male occult triple-negative breast cancer with dermatomyositis: a case report and review of the literature

Zhang L, Zhang C, Yang Z, He M, Zhang L, Ezzat S, Liang X

OncoTargets and Therapy 2017, 10:5459-5462

Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study

Dong F, Shen Y, Gao F, Xu T, Wang X, Zhang X, Zhong S, Zhang M, Chen S, Shen Z

Cancer Management and Research 2017, 9:611-626

Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma

Li Z, Li Y, Yan S, Fu J, Zhou Q, Huang X, Shen L

OncoTargets and Therapy 2017, 10:5445-5458

The effect of CYP2D6 *10 polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis

Lu J, Li H, Guo P, Shen R, Luo Y, Ge Q, Shi WF, Li Y, Zhu W

OncoTargets and Therapy 2017, 10:5429-5437

In vitro study on anti-cancer properties of genistein in tongue cancer

Ardito F, Pellegrino MR, Perrone D, Troiano G, Cocco A, Lo Muzio L

OncoTargets and Therapy 2017, 10:5405-5415

Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery

Liu K, Chen W, Yang T, Wen B, Ding D, Keidar M, Tang J, Zhang W

International Journal of Nanomedicine 2017, 12:8239-8255

The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis

Chen X, Cheng J, Huang A, Zhang X, Wang J, Fan J, Zhou J, Yang X

OncoTargets and Therapy 2017, 10:5363-5375

Training surgeons in shared decision-making with cancer patients aged 65 years and older: a pilot study

Geessink NH, Schoon Y, Olde Rikkert MGM, van Goor H

Cancer Management and Research 2017, 9:591-600

Topical application of ST266 reduces UV-induced skin damage

Guan L, Suggs A, Galan E, Lam M, Baron ED

Clinical, Cosmetic and Investigational Dermatology 2017, 10:459-471

Photodynamic therapy by conjugation of cell-penetrating peptide with fluorochrome

Park CK, Kim YH, Hwangbo SH, Cho HS

International Journal of Nanomedicine 2017, 12:8185-8196

Exome and transcriptome sequencing identifies loss of PDLIM2 in metastatic colorectal cancers

Oh BY, Cho J, Hong HK, Bae JS, Park WY, Joung JG, Cho YB

Cancer Management and Research 2017, 9:581-589

Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function

Li Y, Wang X, O’Mara E, Dimopoulos MA, Sonneveld P, Weisel KC, Matous J, Siegel DS, Shah JJ, Kueenburg E, Sternas L, Cavanaugh C, Zaki M, Palmisano M, Zhou S

Clinical Pharmacology: Advances and Applications 2017, 9:133-145

Novel production method of innovative antiangiogenic and antitumor small peptides in Escherichia coli

Setrerrahmane S, Yu J, Hao J, Zheng H, Xu H

Drug Design, Development and Therapy 2017, 11:3207-3220

Primary site surgery for metastatic adrenocortical carcinoma improves survival outcomes: an analysis of a population-based database

Wang S, Gao W, Chen S, Bai L, Luo L, Zheng X, Luo Y

OncoTargets and Therapy 2017, 10:5311-5315

Amatuximab and novel agents targeting mesothelin for solid tumors

Baldo P, Cecco S

OncoTargets and Therapy 2017, 10:5337-5353

A time for new north–south relationships in global health

Kim JU, Oleribe O, Njie R, Taylor-Robinson SD

International Journal of General Medicine 2017, 10:401-408

65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer

Schuette W, Schneider CP, Engel-Riedel W, Schumann C, Kohlhaeufl M, Serke MHU, Hoeffken G, Kortsik C, Reck M

Lung Cancer: Targets and Therapy 2017, 8:217-229

UNBS5162 inhibits proliferation of human retinoblastoma cells by promoting cell apoptosis

Wang B, Shen J, Wang J

OncoTargets and Therapy 2017, 10:5303-5309

Analysis of the factors affecting the safety of robotic stereotactic body radiation therapy for hepatocellular carcinoma patients

Liu XJ, Song YC, Liang P, Su TS, Zhang HJ, Zhao XZ, Yuan ZY, Wang P

OncoTargets and Therapy 2017, 10:5289-5295

Skin-derived mesenchymal stem cells as quantum dot vehicles to tumors

Dapkute D, Steponkiene S, Bulotiene D, Saulite L, Riekstina U, Rotomskis R

International Journal of Nanomedicine 2017, 12:8129-8142

PUMA mediates the anti-cancer effect of osimertinib in colon cancer cells

Guo L, Huang S, Wang X

OncoTargets and Therapy 2017, 10:5281-5288

Prevention and treatment of acute and chronic radiodermatitis

Seité S, Bensadoun RJ, Mazer JM

Breast Cancer: Targets and Therapy 2017, 9:551-557

Characteristics and prognostic factors of colorectal mucinous adenocarcinoma with signet ring cells

Kong XQ, Zhang XQ, Huang YX, Tang LR, Peng QQ, Li JL

Cancer Management and Research 2017, 9:573-580

S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma

Katono K, Sato Y, Kobayashi M, Nagashio R, Ryuge S, Igawa S, Ichinoe M, Murakumo Y, Saegusa M, Masuda N

OncoTargets and Therapy 2017, 10:5273-5279

Validation of Chinese version of the 4-item Trust in Nurses Scale in patients with cancer

Zhao L, Wang R, Liu S, Yan J

Patient Preference and Adherence 2017, 11:1891-1896

Association of GEMIN4 gene polymorphism and the risk of cancer: a meta-analysis

Wu N, Zhang X, Tian J, Yu S, Qiao Y

OncoTargets and Therapy 2017, 10:5263-5271

Clinical aspects of foot health and their influence on quality of life among breast cancer survivors: a case–control study

Palomo-López P, Rodríguez-Sanz D, Becerro-de-Bengoa-Vallejo R, Losa-Iglesias ME, Guerrero-Martín J, Calvo-Lobo C, López-López D

Cancer Management and Research 2017, 9:545-551

Nifuratel, a novel STAT3 inhibitor with potent activity against human gastric cancer cells

Zheng HL, Hong H, Zhang LL, Cai X, Hu M, Cai YP, Zhou B, Lin JY, Zhao CG, Hu WL

Cancer Management and Research 2017, 9:565-572

Squarticles as the nanoantidotes to sequester the overdosed antidepressant for detoxification

Chen CH, Huang TH, Elzoghby AO, Wang PW, Chang CW, Fang JY

International Journal of Nanomedicine 2017, 12:8071-8083

Development and validation of a panel of five proteins as blood biomarkers for early detection of colorectal cancer

Chen H, Qian J, Werner S, Cuk K, Knebel P, Brenner H

Clinical Epidemiology 2017, 9:517-526

Placenta-derived exosomes: potential biomarkers of preeclampsia

Pillay P, Moodley K, Moodley J, Mackraj I

International Journal of Nanomedicine 2017, 12:8009-8023

Pregnancy and live birth after follicle-stimulating hormone treatment for an infertile couple including a male affected by Sertoli cell-only syndrome

Paulis G, Paulis L, Romano G, Concas C, Di Sarno M, Pagano R, Di Filippo A, Di Petrillo ML

Research and Reports in Urology 2017, 9:203-208

Concomitant psychiatric symptoms and impaired quality of life in women with cervical cancer: a critical review

Klügel S, Lücke C, Meta A, Schild-Suhren M, Malik E, Philipsen A, Müller HHO

International Journal of Women's Health 2017, 9:795-805

Dietary nutrients associated with preservation of lung function in Hispanic and non-Hispanic white smokers from New Mexico

Leng S, Picchi MA, Tesfaigzi Y, Wu G, Gauderman WJ, Xu F, Gilliland FD, Belinsky SA

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3171-3181

nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy

Thomas M, Spigel DR, Jotte RM, McCleod M, Socinski MA, Page RD, Gressot L, Knoble J, Juan O, Morgensztern D, Isla D, Kim ES, West H, Ko A, Ong TJ, Trunova N, Gridelli C

Lung Cancer: Targets and Therapy 2017, 8:207-216

Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia

Altanerova U, Babincova M, Babinec P, Benejova K, Jakubechova J, Altanerova V, Zduriencikova M, Repiska V, Altaner C

International Journal of Nanomedicine 2017, 12:7923-7936

αvβ3 integrin-targeted micellar mertansine prodrug effectively inhibits triple-negative breast cancer in vivo

Zhong P, Gu X, Cheng R, Deng C, Meng F, Zhong Z

International Journal of Nanomedicine 2017, 12:7913-7921

Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice

Smilowitz HM, Tarmu LJ, Sanders MM, Taylor JA III, Choudhary D, Xue C, Dyment NA, Sasso D, Deng X, Hainfeld JF

International Journal of Nanomedicine 2017, 12:7937-7946

Matrine suppresses the migration and invasion of NSCLC cells by inhibiting PAX2-induced epithelial-mesenchymal transition

Yang J, He D, Peng Y, Zhong HZ, Deng YH, Yu Z, Guan C, Zuo Y, Xu Z

OncoTargets and Therapy 2017, 10:5209-5217

Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis

Gao XL, Zhang M, Tang YL, Liang XH

OncoTargets and Therapy 2017, 10:5219-5228

Canine scent detection of canine cancer: a feasibility study

Dorman DC, Foster ML, Fernhoff KE, Hess PR

Veterinary Medicine: Research and Reports 2017, 8:69-76

Photoactivatable RNAi for cancer gene therapy triggered by near-infrared-irradiated single-walled carbon nanotubes

Ren XL, Lin J, Wang XF, Liu X, Meng EJ, Zhang R, Sang YX, Zhang ZZ

International Journal of Nanomedicine 2017, 12:7885-7896

Current status of poly(ADP-ribose) polymerase inhibitors and future directions

Ohmoto A, Yachida S

OncoTargets and Therapy 2017, 10:5195-5208

High expression of eIF3d is associated with poor prognosis in patients with gastric cancer

He JQ, Wang XF, Cai JH, Wang W, Qin XY

Cancer Management and Research 2017, 9:539-544

Multifunctional gold nanorods and docetaxel-encapsulated liposomes for combined thermo- and chemotherapy

Hua H, Zhang N, Liu D, Song L, Liu T, Li S, Zhao Y

International Journal of Nanomedicine 2017, 12:7869-7884

The expression profile and clinical significance of circRNA0003906 in colorectal cancer

Zhuo F, Lin HS, Chen ZX, Huang ZJ, Hu JP

OncoTargets and Therapy 2017, 10:5187-5193

LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis

Wang P, Chen D, Ma H, Li Y

OncoTargets and Therapy 2017, 10:5137-5149

Frequency and clinical relevance of EGFR mutations and EML4–ALK translocations in octogenarians with non-small cell lung cancer

Tufman A, Kahnert K, Duell T, Kauffmann-Guerrero D, Milger K, Schneider C, Stump J, Syunyaeva Z, Huber RM, Reu S

OncoTargets and Therapy 2017, 10:5179-5186

Impact of hypertrophic pulmonary osteoarthropathy on patients with lung cancer

Fang YH, Hsu CC, Hsieh MJ, Hung MS, Tsai YH, Lin YC

OncoTargets and Therapy 2017, 10:5173-5177

Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France

Pignata M, Chouaid C, Le Lay K, Luciani L, McConnachie C, Gordon J, Roze S

ClinicoEconomics and Outcomes Research 2017, 9:655-668

Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan

Isobe H, Mori K, Minato K, Katsura H, Taniguchi K, Arunachalam A, Kothari S, Cao X, Kato T

Lung Cancer: Targets and Therapy 2017, 8:191-206

Self-assembled albumin nanoparticles for combination therapy in prostate cancer

Lian H, Wu J, Hu Y, Guo H

International Journal of Nanomedicine 2017, 12:7777-7787

Surface-enhanced Raman scattering investigation of targeted delivery and controlled release of gemcitabine

Santiago T, DeVaux RS, Kurzatkowska K, Espinal R, Herschkowitz JI, Hepel M

International Journal of Nanomedicine 2017, 12:7763-7776

The matrix metalloproteinase and insulin-like growth factor system in oral cancer – a prospective clinical study

Schiegnitz E, Kämmerer PW, Schön H, Gülle C, Berres M, Sagheb K, Al-Nawas B

OncoTargets and Therapy 2017, 10:5099-5105

Long noncoding RNA and mRNA profiling in MDA-MB-231 cells following RNAi-mediated knockdown of SIRT7

Chen KL, Li L, Wang YR, Li CM, Badri TM, Wang GL

OncoTargets and Therapy 2017, 10:5115-5128

Overexpression of MPC1 inhibits the proliferation, migration, invasion, and stem cell-like properties of gastric cancer cells

Zhou X, Xiong ZJ, Xiao SM, Zhou J, Ding Z, Tang LC, Chen XD, Xu R, Zhao P

OncoTargets and Therapy 2017, 10:5151-5163

Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer

Ichiki M, Wataya H, Yamada K, Tsuruta N, Takeoka H, Okayama Y, Sasaki J, Hoshino T

OncoTargets and Therapy 2017, 10:5107-5113

Association of PTEN expression with biochemical recurrence in prostate cancer: results based on previous reports

Xie HJ, Xie B, Liu CY, Wang J, Xu Y

OncoTargets and Therapy 2017, 10:5089-5097

10H-3,6-Diazaphenothiazine induces G2/M phase cell cycle arrest and caspase-dependent apoptosis and inhibits cell invasion of A2780 ovarian carcinoma cells through the regulation of NF-κB and (BIRC6-XIAP) complexes

Zhang J, Ming C, Zhang W, Okechukwu PN, Morak-Młodawska B, Pluta K, Jeleń M, Akim AM, Ang KP, Ooi KK

Drug Design, Development and Therapy 2017, 11:3045-3063

Enhanced antitumor efficacy of poly(D,L-lactide-co-glycolide)-based methotrexate-loaded implants on sarcoma 180 tumor-bearing mice

Gao L, Xia L, Zhang R, Duan D, Liu X, Xu J, Luo L

Drug Design, Development and Therapy 2017, 11:3065-3075

Supercritical carbon dioxide-developed silk fibroin nanoplatform for smart colon cancer therapy

Xie MB, Fan DJ, Li Y, He XW, Chen XM, Chen YF, Zhu JX, Xu GB, Wu XJ, Lan P

International Journal of Nanomedicine 2017, 12:7751-7761

Evaluating the biological risk of functionalized multiwalled carbon nanotubes and functionalized oxygen-doped multiwalled carbon nanotubes as possible toxic, carcinogenic, and embryotoxic agents

Lara-Martínez LA, Massó F, Palacios González E, García-Pelaéz I, Contreras-Ramos A, Valverde M, Rojas E, Cervantes-Sodi F, Hernández-Gutiérrez S

International Journal of Nanomedicine 2017, 12:7695-7707

Osseointegration of layer-by-layer polyelectrolyte multilayers loaded with IGF1 and coated on titanium implant under osteoporotic condition

Xing H, Wang X, Xiao SS, Zhang G, Li M, Wang P, Shi Q, Qiao P, E L, Liu H

International Journal of Nanomedicine 2017, 12:7709-7720

FcγRIIA and IIIA polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer

Wang D, Wei X, Wang Z, Lu Y, Shi S, Wang N, Qiu M, Wang F, Wang RJ, Li Y, Xu R

OncoTargets and Therapy 2017, 10:5065-5076

A pilot study of subjective well-being in colorectal cancer patients and their caregivers

Graham J, Spiliopoulou P, Arbuckle R, Bridge JA, Cassidy J

Patient Related Outcome Measures 2017, 8:111-119

Partial hepatectomy for spontaneous tumor rupture in patients with hepatocellular carcinoma: a retrospective cohort study

Zhu Q, Qiao G, Xu C, Guo D, Tang J, Duan R, Li Y

Cancer Management and Research 2017, 9:525-537

Targeted delivery of ginsenoside compound K using TPGS/PEG-PCL mixed micelles for effective treatment of lung cancer

Yang L, Zhang Z, Hou J, Jin X, Ke Z, Liu D, Du M, Jia X, Lv H

International Journal of Nanomedicine 2017, 12:7653-7667

Iron oxide magnetic nanoparticles combined with actein suppress non-small-cell lung cancer growth in a p53-dependent manner

Wang MS, Chen L, Xiong YQ, Xu J, Wang JP, Meng ZL

International Journal of Nanomedicine 2017, 12:7627-7651

Novel strategy of stents in thyroid mass: a case series report of managing severely dyspneic patients

Bhandari A, Wang Y, Lv S, Xia E, Wang O

OncoTargets and Therapy 2017, 10:4997-5004

Treatment decision-making among breast cancer patients in Malaysia

Nies YH, Islahudin F, Chong WW, Abdullah N, Ismail F, Ahmad Bustamam RS, Wong YF, Saladina JJ, Mohamed Shah N

Patient Preference and Adherence 2017, 11:1767-1777

Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis

Zhuan-Sun Y, Huang F, Feng M, Zhao X, Chen W, Zhu Z, Zhang S

OncoTargets and Therapy 2017, 10:5005-5012

Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4

Buzzoni R, Carnaghi C, Strosberg J, Fazio N, Singh S, Herbst F, Ridolfi A, Pavel ME, Wolin EM, Valle JW, Oh DY, Yao JC, Pommier R

OncoTargets and Therapy 2017, 10:5013-5030

A 3-year retrospective review of mortality in women of reproductive age in a tertiary health facility in Port Harcourt, Nigeria

Orazulike NC, Alegbeleye JO, Obiorah CC, Nyengidiki TK, Uzoigwe SA

International Journal of Women's Health 2017, 9:769-775

5H-benzo[h]thiazolo[2,3-b]quinazolines ameliorate NDEA-induced hepatocellular carcinogenesis in rats through IL-6 downregulation along with oxidative and metabolic stress reduction

Keshari AK, Singh AK, Kumar U, Raj V, Rai A, Kumar P, Kumar D, Maity B, Nath S, Prakash A, Saha S

Drug Design, Development and Therapy 2017, 11:2981-2995

Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study

Xu J, Liu X, Yang S, Zhang X, Shi Y

OncoTargets and Therapy 2017, 10:4989-4995

Novel biomolecule lycopene-reduced graphene oxide-silver nanoparticle enhances apoptotic potential of trichostatin A in human ovarian cancer cells (SKOV3)

Zhang XF, Huang FH, Zhang GL, Bai DP, Massimo DF, Huang YF, Gurunathan S

International Journal of Nanomedicine 2017, 12:7551-7575

Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring

Chang Y, Tolani B, Nie XH, Zhi XY, Hu M, He B

Therapeutics and Clinical Risk Management 2017, 13:1363-1374

Mutation analysis and copy number alterations of KIF23 in non-small-cell lung cancer exhibiting KIF23 over-expression

Vikberg AL, Vooder T, Lokk K, Annilo T, Golovleva I

OncoTargets and Therapy 2017, 10:4969-4979

Upregulation of long noncoding RNA LOC440040 promotes tumor progression and predicts poor prognosis in patients with prostate cancer

Zhang C, Liu C, Wu J, Zheng Y, Xu H, Cheng G, Hua L

OncoTargets and Therapy 2017, 10:4945-4954

Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer

Song X, Ju R, Xiao Y, Wang X, Liu S, Fu M, Liu J, Gu L, Li X, Cheng L

International Journal of Nanomedicine 2017, 12:7433-7451

Polysaccharide-based nanoparticles for co-loading mitoxantrone and verapamil to overcome multidrug resistance in breast tumor

Xu Y, Asghar S, Gao S, Chen Z, Huang L, Yin L, Ping Q, Xiao Y

International Journal of Nanomedicine 2017, 12:7337-7350

Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation

Qiu X, Cao K, Lin T, Chen W, Yuan A, Wu J, Hu Y, Guo H

International Journal of Nanomedicine 2017, 12:7365-7374

Bioresponsive cancer-targeted polysaccharide nanosystem to inhibit angiogenesis

Yang F, Fang XY, Jiang WT, Chen TF

International Journal of Nanomedicine 2017, 12:7419-7431

Interleukin-1 receptor antagonist inhibits angiogenesis via blockage IL-1α/PI3K/NF-κB pathway in human colon cancer cell

Ma J, Sun X, Guo T, Su H, Chen Q, Gong Z, Qi J, Zhao X

Cancer Management and Research 2017, 9:481-493

EGFR T790M: revealing the secrets of a gatekeeper

Ko B, Paucar D, Halmos B

Lung Cancer: Targets and Therapy 2017, 8:147-159

NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2

Ding N, Wu H, Tao T, Peng E

OncoTargets and Therapy 2017, 10:4905-4915

Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib

Koutsoukos K, Bamias A, Tzannis K, Espinosa Montaño M, Bozionelou V, Christodoulou C, Stefanou D, Kalofonos H, Duran I, Papazisis K

OncoTargets and Therapy 2017, 10:4885-4893

Psychological intervention improves life quality of patients with laryngeal cancer

Li XL, Li JJ, Shi YX, Wang T, Zhang AL, Shao N, Wang ZH

Patient Preference and Adherence 2017, 11:1723-1727

Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors

Din FU, Aman W, Ullah I, Qureshi OS, Mustapha O, Shafique S, Zeb A

International Journal of Nanomedicine 2017, 12:7291-7309

Reductive nanocomplex encapsulation of cRGD-siRNA conjugates for enhanced targeting to cancer cells

Zhou Z, Liu S, Zhang Y, Yang X, Ma Y, Guan Z, Wu Y, Zhang L, Yang ZJ

International Journal of Nanomedicine 2017, 12:7255-7272

Styrene maleic acid-encapsulated RL71 micelles suppress tumor growth in a murine xenograft model of triple negative breast cancer

Martey O, Nimick M, Taurin S, Sundararajan V, Greish K, Rosengren RJ

International Journal of Nanomedicine 2017, 12:7225-7237

Emerging combination therapies for metastatic colorectal cancer – impact of trifluridine/tipiracil

Puthiamadathil JM, Weinberg BA

Cancer Management and Research 2017, 9:461-469

Risk of cancer after lung transplantation for COPD

Ekström M, Riise GC, Tanash HA

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2841-2847

Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study

Kitahata R, Nakajima S, Uchida H, Hayashida T, Takahashi M, Nio S, Hirano J, Nagaoka M, Suzuki T, Jinno H, Kitagawa Y, Mimura M

Neuropsychiatric Disease and Treatment 2017, 13:2489-2496

TERT-CLPTM1 locus polymorphism (rs401681) is associated with the prognosis of hepatocellular carcinoma

Lee HW, Park W, Heo Y, Park TI, Park SY, Lee J

OncoTargets and Therapy 2017, 10:4853-4858

Theranostics in nuclear medicine practice

Yordanova A, Eppard E, Kürpig S, Bundschuh RA, Schönberger S, Gonzalez-Carmona M, Feldmann G, Ahmadzadehfar H, Essler M

OncoTargets and Therapy 2017, 10:4821-4828

Low dose of kaempferol suppresses the migration and invasion of triple-negative breast cancer cells by downregulating the activities of RhoA and Rac1

Li S, Yan T, Deng R, Jiang X, Xiong H, Wang Y, Yu Q, Wang X, Chen C, Zhu Y

OncoTargets and Therapy 2017, 10:4809-4819

Significant association of the EXO1 rs851797 polymorphism with clinical outcome of ovarian cancer

Shi T, Jiang R, Wang P, Xu Y, Yin S, Cheng X, Zang R

OncoTargets and Therapy 2017, 10:4841-4851

Understanding institutional stakeholders’ perspectives on multidrug-resistant bacterial organism at the end of life: a qualitative study

Heckel M, Herbst FA, Adelhardt T, Tiedtke JM, Sturm A, Stiel S, Ostgathe C

Clinical Interventions in Aging 2017, 12:1605-1613

ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy

Song F, Zhang J, Li S, Wu J, Jin T, Qin J, Wang Y, Wang M, Xu J

OncoTargets and Therapy 2017, 10:4859-4867

Surgical resection of a primary tumor improves survival of metastatic pancreatic cancer: a population-based study

Tao LY, Yuan CH, Ma ZL, Jiang B, Xiu DR

Cancer Management and Research 2017, 9:471-479

In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts

Sreeranganathan M, Uthaman S, Sarmento B, Mohan CG, Park IK, Jayakumar R

International Journal of Nanomedicine 2017, 12:7165-7182

Drug tendering: drug supply and shortage implications for the uptake of biosimilars

Dranitsaris G, Jacobs I, Kirchhoff C, Popovian R, Shane LG

ClinicoEconomics and Outcomes Research 2017, 9:573-584

Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma

Li YJ, Yang X, Zhang WB, Yi C, Wang F, Li P

Cancer Management and Research 2017, 9:443-451

HOXD-AS1 functions as an oncogenic ceRNA to promote NSCLC cell progression by sequestering miR-147a

Wang Q, Jiang S, Song A, Hou S, Wu Q, Qi L, Gao X

OncoTargets and Therapy 2017, 10:4753-4763

Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma?

Rabinowits G

OncoTargets and Therapy 2017, 10:4803-4807

Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management

Berry S, Lin WV, Sadaka A, Lee AG

Eye and Brain 2017, 9:23-28

Sitting time and occupational and recreational physical activity in relation to the risk of esophageal squamous cell carcinoma

Chen P, Song Q, Han J, Xu H, Chen T, Xu J, Cheng Y

OncoTargets and Therapy 2017, 10:4787-4794

Clinicopathological features and prognoses in younger and older patients with gastric cancer

Song S, Li C, Li S, Cong X, Xue Y

OncoTargets and Therapy 2017, 10:4795-4802

The new era of nanotechnology, an alternative to change cancer treatment

Jurj A, Braicu C, Pop LA, Tomuleasa C, Gherman CD, Berindan-Neagoe I

Drug Design, Development and Therapy 2017, 11:2871-2890

Role of poly(ε-caprolactone) lipid-core nanocapsules on melanoma–neutrophil crosstalk

Drewes CC, Alves ACS, Hebeda CB, Copetti I, Sandri S, Uchiyama MK, Araki K, Guterres SS, Pohlmann AR, Farsky SH

International Journal of Nanomedicine 2017, 12:7153-7163

Risk factor assessment in high-risk, bacillus Calmette–Guérin-treated, non-muscle-invasive bladder cancer

Holz S, Albisinni S, Gilsoul J, Pirson M, Duthie V, Quackels T, Vanden Bossche M, Roumeguère T

Research and Reports in Urology 2017, 9:195-202

Therapy preferences of patients with lung and colon cancer: a discrete choice experiment

Schmidt K, Damm K, Vogel A, Golpon H, Manns MP, Welte T, Graf von der Schulenburg JM

Patient Preference and Adherence 2017, 11:1647-1656

DNA hypermethylated status and gene expression of PAX1/SOX1 in patients with colorectal carcinoma

Huang J, Tan ZR, Yu J, Li H, Lv Q, Shao Y, Zhou H

OncoTargets and Therapy 2017, 10:4739-4751

Yttrium-90 radioembolization of unresectable hepatocellular carcinoma – a single center experience

Meyer C, Pieper CC, Ahmadzadehfar H, Lampe NA, Matuschek EME, Maschke TA, Enkirch SJ, Essler M, Spengler U, Schild HH

OncoTargets and Therapy 2017, 10:4773-4785

Challenging the standard of care in advanced melanoma: focus on pembrolizumab

Abdul-Karim RM, Cowey CL

Cancer Management and Research 2017, 9:433-442

Molecular classification of esophagogastric junction carcinoma correlated with prognosis

Zou L, Wu Y, Ma K, Fan Y, Dong D, Geng N, Li E

OncoTargets and Therapy 2017, 10:4765-4772

RNAi-mediated knockdown of CAIX enhances the radiosensitivity of nasopharyngeal carcinoma cell line, CNE-2

Jiang L, Xu G, Li Z, Zeng X, Li Z, Liu J, Mei L, Li X

OncoTargets and Therapy 2017, 10:4701-4709

Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors

Ma Z, Huang H, Xu Y, He X, Wang J, Hui B, Ji H, Zhou J, Wang K

OncoTargets and Therapy 2017, 10:4711-4717

Robot-assisted versus conventional laparoscopic operation in anus-preserving rectal cancer: a meta-analysis

Cui Y, Li C, Xu Z, Wang Y, Sun Y, Xu H, Li Z, Sun Y

Therapeutics and Clinical Risk Management 2017, 13:1247-1257

Clinical significance of SLP-2 in hepatocellular carcinoma tissues and its regulation in cancer cell proliferation, migration, and EMT

Huang Y, Chen Y, Lin X, Lin Q, Han M, Guo G

OncoTargets and Therapy 2017, 10:4665-4673

The effects of nonsteroidal anti-inflammatory drugs in the incident and recurrent risk of hepatocellular carcinoma: a meta-analysis

Pang Q, Jin H, Qu K, Man Z, Wang Y, Yang S, Zhou L, Liu H

OncoTargets and Therapy 2017, 10:4645-4656

DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy

Carloni S, Gallerani G, Tesei A, Scarpi E, Verdecchia GM, Virzì S, Fabbri F, Arienti C

OncoTargets and Therapy 2017, 10:4657-4664

Targeting the androgen receptor in triple-negative breast cancer: current perspectives

Mina A, Yoder R, Sharma P

OncoTargets and Therapy 2017, 10:4675-4685

Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer

Ahmed MSU, Salam AB, Yates C, Willian K, Jaynes J, Turner T, Abdalla MO

International Journal of Nanomedicine 2017, 12:6973-6984

NANOG as an adverse predictive marker in advanced non–small cell lung cancer treated with platinum-based chemotherapy

Chang B, Park MJ, Choi SI, In KH, Kim CH, Lee SH

OncoTargets and Therapy 2017, 10:4625-4633

Polymer–lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells

Li J, Xu WQ, Yuan XL, Chen HW, Song H, Wang BQ, Han J

International Journal of Nanomedicine 2017, 12:6909-6921

Effect of inhibitors of endocytosis and NF-kB signal pathway on folate-conjugated nanoparticle endocytosis by rat Kupffer cells

Tang H, Chen H, Jia Y, Liu X, Han Z, Wang A, Liu Q, Li X, Feng X

International Journal of Nanomedicine 2017, 12:6937-6947

EGFR with TKI-sensitive mutations in exon 19 is highly expressed and frequently detected in Chinese patients with lung squamous carcinoma

Memon AA, Zhang HP, Gu Y, Luo Q, Shi JJ, Deng Z, Ma J, Ma W

OncoTargets and Therapy 2017, 10:4607-4613

Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis

Meng Q, Shi S, Liang C, Liang D, Xu W, Ji S, Zhang B, Ni Q, Xu J, Yu X

OncoTargets and Therapy 2017, 10:4591-4598

Profile of trifluridine/tipiracil hydrochloride in the treatment of metastatic colorectal cancer: efficacy, safety, and place in therapy

Sunakawa Y, Izawa N, Mizukami T, Horie Y, Hirakawa M, Arai H, Ogura T, Tsuda T, Nakajima TE

OncoTargets and Therapy 2017, 10:4599-4605

MRI-guided targeting delivery of doxorubicin with reduction-responsive lipid-polymer hybrid nanoparticles

Wu B, Lu S, Deng K, Yu H, Cui C, Zhang Y, Wu M, Zhuo RX, Xu H, Huang S

International Journal of Nanomedicine 2017, 12:6871-6882

Case report of a KIT-mutated melanoma patient with an excellent response to apatinib and temozolomide combination therapy

Luo C, Shen JY, Ying J, Fang XH, Wang XH, Fu ZX, Liu P

OncoTargets and Therapy 2017, 10:4553-4557

CYP19A1 gene polymorphism and colorectal cancer etiology in Saudi population: case–control study

Al-Mukaynizi FB, Alanazi M, Al-Daihan S, Parine NR, Almadi M, Aljebreen A, Azzam N, Alharbi O, Arafah M, Warsy A

OncoTargets and Therapy 2017, 10:4559-4567

A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia

Bainer RO, Trendowski MR, Cheng C, Pei D, Yang W, Paugh SW, Goss KH, Skol AD, Pavlidis P, Pui CH, Gilliam TC, Evans WE, Onel K

Cancer Management and Research 2017, 9:397-410

Green synthesis of selenium nanoparticles using Acinetobacter sp. SW30: optimization, characterization and its anticancer activity in breast cancer cells

Wadhwani SA, Gorain M, Banerjee P, Shedbalkar UU, Singh R, Kundu GC, Chopade BA

International Journal of Nanomedicine 2017, 12:6841-6855

Depression and family support in breast cancer patients

Su JA, Yeh DC, Chang CC, Lin TC, Lai CH, Hu PY, Ho YF, Chen VC, Wang TN, Gossop M

Neuropsychiatric Disease and Treatment 2017, 13:2389-2396

Clinicopathological significance of HSP27 in gastric cancer: a meta-analysis

Ge H, He X, Guo L, Yang X

OncoTargets and Therapy 2017, 10:4543-4551

Anaplastic lymphoma kinase inhibition in metastatic non-small cell lung cancer: clinical impact of alectinib

Muller IB, de Langen AJ, Giovannetti E, Peters GJ

OncoTargets and Therapy 2017, 10:4535-4541

Assessment and treatment of breakthrough cancer pain: from theory to clinical practice

Vellucci R, Mediati RD, Gasperoni S, Mammucari M, Marinangeli F, Romualdi P

Journal of Pain Research 2017, 10:2147-2155

Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy

Liao X, Huang K, Huang R, Liu X, Han C, Yu L, Yu T, Yang C, Wang X, Peng T

OncoTargets and Therapy 2017, 10:4493-4506

Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer

Tang Y, Qiao G, Xu E, Xuan Y, Liao M, Yin G

OncoTargets and Therapy 2017, 10:4527-4534

The non-small cell lung cancer EGFR extracellular domain mutation, M277E, is oncogenic and drug-sensitive

Yu S, Zhang Y, Pan YJ, Cheng C, Sun YH, Chen HQ

OncoTargets and Therapy 2017, 10:4507-4515

Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor

Wang S, Huang W, Li K, Yao Y, Yang X, Bai H, Sun W, Liu C, Ma Y

International Journal of Nanomedicine 2017, 12:6813-6825

Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment

Zhang L, Yao M, Yan W, Liu X, Jiang B, Qian Z, Gao Y, Lu XJ, Chen X, Wang Q

International Journal of Nanomedicine 2017, 12:6759-6769

Dermopathy associated with cetuximab and panitumumab: investigation of the usefulness of moisturizers in its management

Watanabe S, Nakamura M, Takahashi H, Hara M, Ijichi K, Kawakita D, Morita A

Clinical, Cosmetic and Investigational Dermatology 2017, 10:353-361

Targeted inhibition of the phosphoinositide 3-kinase impairs cell proliferation, survival, and invasion in colon cancer

Yang F, Gao JY, Chen H, Du ZH, Zhang XQ, Gao W

OncoTargets and Therapy 2017, 10:4413-4422

Prognostic immune-related gene models for breast cancer: a pooled analysis

Zhao J, Wang Y, Lao Z, Liang S, Hou J, Yu Y, Yao H, You N, Chen K

OncoTargets and Therapy 2017, 10:4423-4433

Oncogenic role of microRNA-20a in human multiple myeloma

Wang T, Tao W, Zhang L, Li SL

OncoTargets and Therapy 2017, 10:4465-4474

Cervical level IIb metastases in squamous cell carcinoma of the oral cavity: a systematic review and meta-analysis

Kou Y, Zhao T, Huang S, Liu J, Duan W, Wang Y, Wang Z, Li D, Ning C, Sun C

OncoTargets and Therapy 2017, 10:4475-4483

Fabrication, optimization, and characterization of umbelliferone β-D-galactopyranoside-loaded PLGA nanoparticles in treatment of hepatocellular carcinoma: in vitro and in vivo studies

Kumar V, Bhatt PC, Rahman M, Kaithwas G, Choudhry H, Al-Abbasi FA, Anwar F, Verma A

International Journal of Nanomedicine 2017, 12:6747-6758

miR-509-5p inhibits cellular proliferation and migration via targeting MDM2 in pancreatic cancer cells

Li X, Li Y, Wan L, Chen R, Chen F

OncoTargets and Therapy 2017, 10:4455-4464

Marketed drugs used for the management of hypercholesterolemia as anticancer armament

Papanagnou P, Stivarou T, Papageorgiou I, Papadopoulos GE, Pappas A

OncoTargets and Therapy 2017, 10:4393-4411

Cationic lipid-based nanoparticles mediate functional delivery of acetate to tumor cells in vivo leading to significant anticancer effects

Brody LP, Sahuri-Arisoylu M, Parkinson JR, Parkes HG, So PW, Hajji N, Thomas EL, Frost GS, Miller AD, Bell JD

International Journal of Nanomedicine 2017, 12:6677-6685

Delivery of paeonol by nanoparticles enhances its in vitro and in vivo antitumor effects

Chen C, Jia F, Hou Z, Ruan S, Lu Q

International Journal of Nanomedicine 2017, 12:6605-6616

Genetic variants in long noncoding RNA H19 contribute to the risk of breast cancer in a southeast China Han population

Lin Y, Fu F, Chen Y, Qiu W, Lin S, Yang P, Huang M, Wang C

OncoTargets and Therapy 2017, 10:4369-4378

An acceptance-based intervention for children and adolescents with cancer experiencing acute pain – a single-subject study

Thorsell Cederberg J, Dahl J, von Essen L, Ljungman G

Journal of Pain Research 2017, 10:2195-2203

A pilot evaluation of a computer-based psychometric test battery designed to detect impairment in patients with cirrhosis

Cook NA, Kim JU, Pasha Y, Crossey MME, Schembri AJ, Harel BT, Kimhofer T, Taylor-Robinson SD

International Journal of General Medicine 2017, 10:281-289

Polymeric mixed micelles loaded mitoxantrone for overcoming multidrug resistance in breast cancer via photodynamic therapy

Li ZY, Cai Y, Zhao YQ, Yu H, Zhou HY, Chen MW

International Journal of Nanomedicine 2017, 12:6595-6604

Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt’s lymphoma and acute lymphoblastic leukemia

Weagel EG, Meng W, Townsend MH, Velazquez EJ, Brog RA, Boyer MW, Weber KS, Robison RA, O'Neill KL

OncoTargets and Therapy 2017, 10:4355-4367

Radium 223 dichloride for prostate cancer treatment

Deshayes E, Roumiguie M, Thibault C, Beuzeboc P, Cachin F, Hennequin C, Huglo D, Rozet F, Kassab-Chahmi D, Rebillard X, Houédé N

Drug Design, Development and Therapy 2017, 11:2643-2651

Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations

Rapoport BL, Aapro M, Chasen MR, Jordan K, Navari RM, Schnadig I, Schwartzberg L

Drug Design, Development and Therapy 2017, 11:2621-2629

The challenge of perioperative pain management in opioid-tolerant patients

Coluzzi F, Bifulco F, Cuomo A, Dauri M, Leonardi C, Melotti RM, Natoli S, Romualdi P, Savoia G, Corcione A

Therapeutics and Clinical Risk Management 2017, 13:1163-1173

Composite iron oxide–Prussian blue nanoparticles for magnetically guided T1-weighted magnetic resonance imaging and photothermal therapy of tumors

Kale SS, Burga RA, Sweeney EE, Zun Z, Sze RW, Tuesca A, Subramony JA, Fernandes R

International Journal of Nanomedicine 2017, 12:6413-6424

Zinc oxide nanoparticles induce apoptosis and autophagy in human ovarian cancer cells

Bai D, Zhang X, Zhang G, Huang Y, Gurunathan S

International Journal of Nanomedicine 2017, 12:6521-6535

SIRT1 gene polymorphisms and risk of lung cancer

Lv Y, Lin SY, Peng F

Cancer Management and Research 2017, 9:381-386

Adequacy of cancer-related pain management and predictors of undertreatment at referral to a pain clinic

Reis-Pina P, Lawlor PG, Barbosa A

Journal of Pain Research 2017, 10:2097-2107

Docetaxel-titanate nanotubes enhance radiosensitivity in an androgen-independent prostate cancer model

C Mirjolet, Boudon J, Loiseau A, Chevrier S, Boidot R, Oudot A, Collin B, Martin E, Joy PA, Millot N, Créhange G

International Journal of Nanomedicine 2017, 12:6357-6364

Improvement of survival for non-small cell lung cancer over time

Xia W, Yu X, Mao Q, Xia W, Wang A, Dong G, Chen B, Ma W, Xu L, Jiang F

OncoTargets and Therapy 2017, 10:4295-4303

Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors

Creelan BC, Gabrilovich DI, Gray JE, Williams CC, Tanvetyanon T, Haura EB, Weber JS, Gibney GT, Markowitz J, Proksch JW, Reisman SA, McKee MD, Chin MP, Meyer CJ, Antonia SJ

OncoTargets and Therapy 2017, 10:4239-4250

Bacterial membrane vesicles as novel nanosystems for drug delivery

Jain S, Pillai J

International Journal of Nanomedicine 2017, 12:6329-6341

Apatinib in the treatment of advanced lung adenocarcinoma with KRAS mutation

Zeng D, Wang C, Huang J, Jiang J

OncoTargets and Therapy 2017, 10:4269-4272

Effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia

Wang C, Hsu CH, Li Z, Hwang LP, Lin YC, Chou PT, Lin YY

International Journal of Nanomedicine 2017, 12:6273-6287

Continuous EGFR tyrosine kinase inhibitor treatment with or without chemotherapy beyond gradual progression in non-small cell lung cancer patients

Peng L, Wang YN, Tang YM, Zeng L, Liu JF, Zeng Z, Liu J, Shi P, Ye XH, Zhao Q

OncoTargets and Therapy 2017, 10:4261-4267

Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer

Liang S, Xu K, Niu L, Wang X, Liang Y, Zhang M, Chen J, Lin M

OncoTargets and Therapy 2017, 10:4273-4281

miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples

Braicu OL, Budisan L, Buiga R, Jurj A, Achimas-Cadariu P, Pop LA, Braicu C, Irimie A, Berindan-Neagoe I

OncoTargets and Therapy 2017, 10:4225-4238

LEF1-AS1, a long non-coding RNA, promotes malignancy in glioblastoma

Wang J, Liu X, Yan C, Liu J, Wang S, Hong Y, Gu A, Zhao P

OncoTargets and Therapy 2017, 10:4251-4260

A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data

Kern DM, Barron JJ, Wu B, Ganetsky A, Willey VJ, Quimbo RA, Fisch MJ, Singer J, Nguyen A, Mamtani R

Pragmatic and Observational Research 2017, 8:149-155

HPIP: a predictor of lymph node metastasis and poor survival in cervical cancer

Cao S, Sun J, Lin S, Zhao L, Wu D, Liang T, Sheng W

OncoTargets and Therapy 2017, 10:4205-4211

EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer

Li Y, Duo Y, Bao SY, He L, Ling K, Luo J, Zhang Y, Huang H, Zhang H, Yu X

International Journal of Nanomedicine 2017, 12:6239-6257

Photothermal ablation of inflammatory breast cancer tumor emboli using plasmonic gold nanostars

Crawford BM, Shammas RL, Fales AM, Brown DA, Hollenbeck ST, Vo-Dinh T, Devi GR

International Journal of Nanomedicine 2017, 12:6259-6272

Drug delivery approaches for breast cancer

Singh SK, Singh S, Lillard JW Jr, Singh R

International Journal of Nanomedicine 2017, 12:6205-6218

Paeoniflorin suppresses pancreatic cancer cell growth by upregulating HTRA3 expression

Li YJ, Gong LL, Qi RL, Sun Q, Xia XX, He HH, Ren JS, Zhu ON, Zhuo DB

Drug Design, Development and Therapy 2017, 11:2481-2491

Updating the landscape of direct-to-consumer pharmacogenomic testing

Filipski KK, Murphy JD, Helzlsouer KJ

Pharmacogenomics and Personalized Medicine 2017, 10:229-232

Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer

Zhou YF, Wang SH, Ying XH, Wang YF, Geng PW, Deng AP, Yu ZH

International Journal of Nanomedicine 2017, 12:6153-6168

Gold nanoparticles enlighten the future of cancer theranostics

Guo J, Rahme K, He Y, Li L, Holmes JD, O'Driscoll CM

International Journal of Nanomedicine 2017, 12:6131-6152

miRNA-221 of exosomes originating from bone marrow mesenchymal stem cells promotes oncogenic activity in gastric cancer

Ma M, Chen S, Liu Z, Xie H, Deng H, Shang S, Wang X, Xia M, Zuo C

OncoTargets and Therapy 2017, 10:4161-4171

Enhancement of antitumor activity by using a fully human gene encoding a single-chain fragmented antibody specific for carcinoembryonic antigen

Shibaguchi H, Luo N, Shirasu N, Kuroki M, Kuroki M

OncoTargets and Therapy 2017, 10:3979-3990

AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells

Lee D, Yu EJ, Ham I, Hur H, Kim Y

OncoTargets and Therapy 2017, 10:4153-4159

New developments in the management of relapsed/refractory multiple myeloma – the role of ixazomib

Richardson PG, Kumar S, Laubach JP, Paba-Prada C, Gupta N, Berg D, van de Velde H, Moreau P

Journal of Blood Medicine 2017, 8:107-121

Sensitization of gastric cancer cells to alkylating agents by glaucocalyxin B via cell cycle arrest and enhanced cell death

Ur Rahman MS, Zhang L, Wu LY, Xie YQ, Li CC, Cao J

Drug Design, Development and Therapy 2017, 11:2431-2441

Metformin: a review of its potential indications

Wang YW, He SJ, Feng X, Cheng J, Luo YT, Tian L, Huang Q

Drug Design, Development and Therapy 2017, 11:2421-2429

Cytotoxicity induced by carbon nanotubes in experimental malignant glioma

Romano-Feinholz S, Salazar-Ramiro A, Muñoz Sandoval E, Magaña-Maldonado R, Hernández Pedro N, Rangel López E, González Aguilar A, Sanchez-Garcia A, Sotelo J, Pérez de la Cruz V, Pineda B

International Journal of Nanomedicine 2017, 12:6005-6026

Response to crizotinib in a lung adenocarcinoma patient harboring a novel SLC34A2-ROS1 fusion variant

Zhao Z, Song ZJ, Wang XW, Sun HF, Yang XM, Yuan Y, Yu P

OncoTargets and Therapy 2017, 10:4129-4133

Targeting thyroid cancer with acid-triggered release of doxorubicin from silicon dioxide nanoparticles

Li SJ, Zhang DQ, Sheng SH, Sun H

International Journal of Nanomedicine 2017, 12:5993-6003

Liposomal curcumin and its application in cancer

Feng T, Wei Y, Lee RJ, Zhao L

International Journal of Nanomedicine 2017, 12:6027-6044

Hyaluronic acid-functionalized bismuth oxide nanoparticles for computed tomography imaging-guided radiotherapy of tumor

Du FY, Lou JM, Jiang R, Fang ZZ, Zhao XF, Niu YY, Zou SQ, Zhang MM, Gong AH, Wu CY

International Journal of Nanomedicine 2017, 12:5973-5992

Increased risk of breast cancer in neurofibromatosis type 1: current insights

Howell SJ, Hockenhull K, Salih Z, Evans DG

Breast Cancer: Targets and Therapy 2017, 9:531-536

Clinical staging of malignant pleural mesothelioma: current perspectives

Bonomi M, De Filippis C, Lopci E, Gianoncelli L, Rizzardi G, Cerchiaro E, Bortolotti L, Zanello A, Ceresoli GL

Lung Cancer: Targets and Therapy 2017, 8:127-139

Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review

Ahn JS, Lin J, Ogawa S, Yuan C, O'Brien T, Le BHC, Bothwell AM, Moon H, Hadjiat Y, Ganapathi A

Journal of Pain Research 2017, 10:1963-1972

Establishment of a biophysical model to optimize endoscopic targeting of magnetic nanoparticles for cancer treatment

Roeth AA, Slabu I, Baumann M, Alizai PH, Schmeding M, Guentherodt G, Schmitz-Rode T, Neumann UP

International Journal of Nanomedicine 2017, 12:5933-5940

Head and neck cancer: improving outcomes with a multidisciplinary approach

Lo Nigro C, Denaro N, Merlotti A, Merlano M

Cancer Management and Research 2017, 9:363-371

Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy

Santarpia M, Liguori A, Karachaliou N, Gonzalez-Cao M, Daffinà MG, D'Aveni A, Marabello G, Altavilla G, Rosell R

Lung Cancer: Targets and Therapy 2017, 8:109-125

Chest reconstruction using a custom-designed polyethylene 3D implant after resection of the sternal manubrium

Lipińska J, Kutwin L, Wawrzycki M, Olbrzymek L, Jabłoński S

OncoTargets and Therapy 2017, 10:4099-4103

Performing all major surgical procedures robotically will prolong wait times for surgery

Shinder BM, Farber NJ, Weiss RE, Jang TL, Kim IY, Singer EA, Elsamra SE

Robotic Surgery: Research and Reviews 2017, 4:87-91

CT-guided 125I interstitial brachytherapy for pelvic recurrent cervical carcinoma after radiotherapy

Tong L, Liu P, Huo B, Guo Z, Ni H

OncoTargets and Therapy 2017, 10:4081-4088

Safety and efficacy of nimotuzumab combined with chemoradiotherapy in Chinese patients with locally advanced cervical cancer

Chen Y, Tang W, Pan X, Wu C, Cao Y, Yang W

OncoTargets and Therapy 2017, 10:4113-4119

Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals

Ortendahl JD, Pulgar SJ, Mirakhur B, Cox D, Bentley TGK, Phan AT

ClinicoEconomics and Outcomes Research 2017, 9:495-503

Clinical outcome following DIAM implantation for symptomatic lumbar internal disk disruption: a 3-year retrospective analysis [Corrigendum]

Lu K, Liliang PC, Wang HK, Chen JS, Chen TY, Huang R, Chen HJ

Journal of Pain Research 2017, 10:1931-1932

Onychomadesis associated with chemotherapy: case report and mini literature review

Li A, Li Y, Ge L, Li P, Li W

Drug Design, Development and Therapy 2017, 11:2373-2376

An integrated analysis for long noncoding RNAs and microRNAs with the mediated competing endogenous RNA network in papillary renal cell carcinoma

Huang CG, Yuan NJ, Wu LY, Wang XF, Dai JQ, Song P, Li FX, Xu CB, Zhao XH

OncoTargets and Therapy 2017, 10:4037-4050

The role of desmosomes in carcinogenesis

Zhou G, Yang L, Gray A, Srivastava AK, Li C, Zhang G, Cui T

OncoTargets and Therapy 2017, 10:4059-4063

Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer

Lv RB, Wang QG, Liu C, Liu F, Zhao Q, Han JG, Ren DL, Liu B, Li CL

OncoTargets and Therapy 2017, 10:4051-4057

Surveying the effect of a self-care education program on severity of nausea and emesis in colorectal cancer patients under chemotherapy

Karimi S, Makhsosi BR, Seyedi-Andi SJ, Behzadi M, Moghofeh Y, Mohammadinasrabadi K, Abdi A, Ahmadi P

Journal of Multidisciplinary Healthcare 2017, 10:301-307

Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy

Chen L, Hao Y, Zhu LH, Li S, Zuo YJ, Zhang YX, Song HJ, Xue YW

OncoTargets and Therapy 2017, 10:4007-4016

Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem

Hughes T, O'Connor T, Techasen A, Namwat N, Loilome W, Andrews RH, Khuntikeo N, Yongvanit P, Sithithaworn P, Taylor-Robinson SD

International Journal of General Medicine 2017, 10:227-237

Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling

Abdel-Aziz HA, Eldehna WM, Keeton AB, Piazza GA, Kadi AA, Attwa MW, Abdelhameed AS, Attia MI

Drug Design, Development and Therapy 2017, 11:2333-2346

Vaginal cuff brachytherapy in endometrial cancer – a technically easy treatment?

Sabater S, Andres I, Lopez-Honrubia V, Berenguer R, Sevillano M, Jimenez-Jimenez E, Rovirosa A, Arenas M

Cancer Management and Research 2017, 9:351-362

Co-delivery nanocarriers targeting folate receptor and encapsulating 2-deoxyglucose and α-tocopheryl succinate enhance anti-tumor effect in vivo

Lei X, Li K, Liu Y, Wang ZY, Ruan BJ, Wang L, Xiang A, Wu D, Lu Z

International Journal of Nanomedicine 2017, 12:5701-5715

A comprehensive analysis of association of medical history with airflow limitation: a cross-sectional study

Nishida Y, Takahashi Y, Tezuka K, Yamazaki K, Yada Y, Nakayama T, Asai S

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2363-2371

Fibrous sheath interacting protein 1 overexpression is associated with unfavorable prognosis in bladder cancer: a potential therapeutic target

Sun M, Zhao W, Zeng Y, Zhang D, Chen Z, Liu C, Wu B

OncoTargets and Therapy 2017, 10:3949-3956

Fucosyltransferase VII promotes proliferation via the EGFR/AKT/mTOR pathway in A549 cells

Liang J, Gao W, Cai L

OncoTargets and Therapy 2017, 10:3971-3978

Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinoma

Li J, Wang L

OncoTargets and Therapy 2017, 10:3965-3969

Therapies for acute myeloid leukemia: vosaroxin

Sayar H, Bashardoust P

OncoTargets and Therapy 2017, 10:3957-3963

Prognosis of neutrophil-to-lymphocyte ratio in clinical early-stage tongue (cT1/T2N0) cancer

Wu CN, Chuang HC, Lin YT, Fang FM, Li SH, Chien CY

OncoTargets and Therapy 2017, 10:3917-3924

Bystander signaling via oxidative metabolism

Sawal HA, Asghar K, Bureik M, Jalal N

OncoTargets and Therapy 2017, 10:3925-3940

microRNA-130a is an oncomir suppressing the expression of CRMP4 in gastric cancer

Zhou Y, Li R, Yu H, Wang R, Shen Z

OncoTargets and Therapy 2017, 10:3893-3905

Endocytotic uptake of HPMA-based polymers by different cancer cells: impact of extracellular acidosis and hypoxia

Gündel D, Allmeroth M, Reime S, Zentel R, Thews O

International Journal of Nanomedicine 2017, 12:5571-5584

SHP2 overexpression enhances the invasion and metastasis of ovarian cancer in vitro and in vivo

Hu ZQ, Li J, Gao Q, Wei S, Yang B

OncoTargets and Therapy 2017, 10:3881-3891

Exploring cellular uptake of iron oxide nanoparticles associated with rhodium citrate in breast cancer cells

Chaves NL, Estrela-Lopis I, Böttner J, Lopes CAP, Guido BC, de Souza AR, Báo SN

International Journal of Nanomedicine 2017, 12:5511-5523

Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel

Paolini M, Poul L, Berjaud C, Germain M, Darmon A, Bergère M, Pottier A, Levy L, Vibert E

International Journal of Nanomedicine 2017, 12:5537-5556

A practical guide to the handling and administration of talimogene laherparepvec in Europe

Harrington KJ, Michielin O, Malvehy J, Pezzani Grüter I, Grove L, Frauchiger AL, Dummer R

OncoTargets and Therapy 2017, 10:3867-3880

Intracellular trafficking of new anticancer therapeutics: antibody–drug conjugates

Kalim M, Chen J, Wang S, Lin C, Ullah S, Liang K, Ding Q, Chen S, Zhan JB

Drug Design, Development and Therapy 2017, 11:2265-2276

Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma

Liu W, Hu J, Zhou K, Chen F, Wang Z, Liao B, Dai Z, Cao Y, Fan J, Zhou J

OncoTargets and Therapy 2017, 10:3843-3851

Outcomes of adding induction chemotherapy to concurrent chemoradiotherapy for stage T3N0-1 nasopharyngeal carcinoma: a propensity-matched study

Lan XW, Xiao Y, Zou XB, Zhang XM, OuYang PY, Xie FY

OncoTargets and Therapy 2017, 10:3853-3860

Markers of oxidative/nitrosative stress and inflammation in lung tissue of rats exposed to different intravenous iron compounds

Toblli JE, Cao G, Giani JF, Dominici FP, Angerosa M

Drug Design, Development and Therapy 2017, 11:2251-2263

Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer

Roviello G, Corona SP, Bonetta A, Cappelletti MR, Generali D

OncoTargets and Therapy 2017, 10:3811-3815

Elevated expression of neuropilin-2 associated with unfavorable prognosis in hepatocellular carcinoma

Dong X, Guo W, Zhang S, Wu T, Sun Z, Yan S, Zheng S

OncoTargets and Therapy 2017, 10:3827-3833

Reducing rectal injury in men receiving prostate cancer radiation therapy: current perspectives

Serrano NA, Kalman NS, Anscher MS

Cancer Management and Research 2017, 9:339-350

Comparative analysis of essential oil composition of Iranian and Indian Nigella sativa L. extracted using supercritical fluid extraction and solvent extraction

Ghahramanloo KH, Kamalidehghan B, Akbari Javar H, Teguh Widodo R, Majidzadeh K, Noordin MI

Drug Design, Development and Therapy 2017, 11:2221-2226

Surface-enhanced Raman spectroscopy of serum accurately detects prostate cancer in patients with prostate-specific antigen levels of 4–10 ng/mL

Chen N, Rong M, Shao X, Zhang H, Liu S, Dong B, Xue W, Wang T, Li T, Pan J

International Journal of Nanomedicine 2017, 12:5399-5407

The role of mediastinoscopy in the diagnosis of non-lung cancer diseases

Onat S, Ates G, Avci A, Yildiz T, Birak A, Akgul Ozmen C, Ulku R

Therapeutics and Clinical Risk Management 2017, 13:939-943

Cost analysis of adverse events associated with non-small cell lung cancer management in France

Chouaid C, Loirat D, Clay E, Millier A, Godard C, Fannan A, Lévy-Bachelot L, Angevin E

ClinicoEconomics and Outcomes Research 2017, 9:443-449

A synthetic urinary probe–coated nanoparticles sensitive to fibroblast activation protein α for solid tumor diagnosis

Feng XW, Wang QF, Liao YH, Zhou X, Wang YD, Liu WL, Zhang G

International Journal of Nanomedicine 2017, 12:5359-5372

MDM2 promoter del1518 polymorphism and cancer risk: evidence from 22,931 subjects

Hua WF, Zhang A, Duan P, Zhu J, Zhao Y, He J, Zhang Z

OncoTargets and Therapy 2017, 10:3773-3780

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review

Sacco R, Tapete G, Simonetti N, Sellitri R, Natali V, Melissari S, Cabibbo G, Biscaglia L, Bresci G, Giacomelli L

Journal of Hepatocellular Carcinoma 2017, 4:105-110

In situ imaging of quantum dot-AZD4547 conjugates for tracking the dynamic behavior of fibroblast growth factor receptor 3

Hwang G, Kim H, Yoon H, Song C, Lim D, Sim T, Lee J

International Journal of Nanomedicine 2017, 12:5345-5357

Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-co-glycolic acid) nanobubbles for ultrasound imaging and therapy of prostate cancer

Wu M, Wang Y, Wang YR, Zhang MB, Luo YK, Tang J, Wang ZG, Wang D, Hao L, Wang ZB

International Journal of Nanomedicine 2017, 12:5313-5330

KIAA1522 overexpression promotes tumorigenicity and metastasis of esophageal cancer cells through potentiating the ERK activity

Xie ZH, Yu J, Shang L, Zhu YQ, Hao JJ, Cai Y, Xu X, Zhang Y, Wang MR

OncoTargets and Therapy 2017, 10:3743-3754

Volumetric modulated arc therapy for treatment of solid tumors: current insights

Macchia G, Deodato F, Cilla S, Cammelli S, Guido A, Ferioli M, Siepe G, Valentini V, Morganti AG, Ferrandina G

OncoTargets and Therapy 2017, 10:3755-3772

Initial construct validity evidence of a virtual human application for competency assessment in breaking bad news to a cancer patient

Guetterman TC, Kron FW, Campbell TC, Scerbo MW, Zelenski AB, Cleary JF, Fetters MD

Advances in Medical Education and Practice 2017, 8:505-512

Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma

Liu XJ, Li L, Liu XJ, Li Y, Zhao CY, Wang RQ, Zhen YS

International Journal of Nanomedicine 2017, 12:5255-5269

Cost of illness of urothelial bladder cancer in Italy

Gerace C, Montorsi F, Tambaro R, Cartenì G, De Luca S, Tucci M, Martorana G, Basso U, Cardosi L, Teruzzi C

ClinicoEconomics and Outcomes Research 2017, 9:433-442

The prognostic value of decreased miR-101 in various cancers: a meta-analysis of 12 studies

Hu J, Wu C, Zhao X, Liu C

OncoTargets and Therapy 2017, 10:3709-3718

Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma

Liao X, Huang R, Liu X, Han C, Yu L, Wang SJ, Sun N, Li B, Ning X, Peng T

OncoTargets and Therapy 2017, 10:3719-3732

Foxj2 overexpression is associated with poor prognosis, progression, and metastasis in nasopharyngeal carcinoma

Shan Y, Chang T, Shi S, Tang M, Bao L, Li L, You B, You Y

OncoTargets and Therapy 2017, 10:3733-3741

Intracellular “activated” two-photon photodynamic therapy by fluorescent conveyor and photosensitizer co-encapsulating pH-responsive micelles against breast cancer

Luo L, Zhong H, Liu S, Deng L, Luo Y, Zhang Q, Zhu Y, Tian Y, Sun Y, Tian X

International Journal of Nanomedicine 2017, 12:5189-5201

Prognostic and predictive values of PD-L1 expression in patients with digestive system cancer: a meta-analysis

Dai C, Wang M, Lu J, Dai Z, Lin S, Yang P, Tian T, Liu X, Min WL, Dai Z

OncoTargets and Therapy 2017, 10:3625-3634

miR-203 as a novel biomarker for the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis

Ye H, Hao H, Wang J, Chen R, Huang Z

OncoTargets and Therapy 2017, 10:3685-3696

Survivorship of patients with head and neck cancer receiving care in a tertiary health facility in Nigeria

Okwor VC, Fagbamigbe AF, Fawole OI

Cancer Management and Research 2017, 9:331-338

Thyroid cancer in a patient with Lynch syndrome – case report and literature review

Fazekas-Lavu M, Parker A, Spigelman AD, Scott RJ, Epstein RJ, Jensen M, Samaras K

Therapeutics and Clinical Risk Management 2017, 13:915-918

Premenstrual syndrome (PMS) among high school students

Buddhabunyakan N, Kaewrudee S, Chongsomchai C, Soontrapa S, Somboonporn W, Sothornwit J

International Journal of Women's Health 2017, 9:501-505

Case report: bilateral tunneled epidural catheters to prevent unilateral analgesia for cancer-related pain

Padalia RB, Reeves CJ, Shah N, Patel AA, Padalia DM

Local and Regional Anesthesia 2017, 10:79-82

A54 peptide-mediated functionalized gold nanocages for targeted delivery of DOX as a combinational photothermal-chemotherapy for liver cancer

Huang S, Li C, Wang WP, Li HJ, Sun Z, Song C, Li B, Duan SF, Hu YR

International Journal of Nanomedicine 2017, 12:5163-5176

Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study

Gao L, Li SH, Tian YX, Zhu QQ, Chen G, Pang YY, Hu XH

OncoTargets and Therapy 2017, 10:3667-3683

Clinical targeting recombinant immunotoxins for cancer therapy

Li M, Liu ZS, Liu XL, Hui Q, Lu SY, Qu LL, Li YS, Zhou Y, Ren HL, Hu P

OncoTargets and Therapy 2017, 10:3645-3665

Exploring the acceptability of human papillomavirus self-sampling among Muslim immigrant women

Lofters AK, Vahabi M, Fardad M, Raza A

Cancer Management and Research 2017, 9:323-329

Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo

Lu JJ, Xu Y, Zhao Z, Ke XN, Wei X, Kang J, Zong X, Mao HL, Liu PS

OncoTargets and Therapy 2017, 10:3579-3589

Impact of combined treatment with nimesulide and cisplatin on oral carcinoma cells

Barac A, Mitulovic G, Hallström S, Zehetmayer S, Grasl MC, Erovic BM

OncoTargets and Therapy 2017, 10:3607-3616

The impact of examined lymph node count on survival in squamous cell carcinoma and adenocarcinoma of the uterine cervix

Zhou J, Zhang WW, Wu SG, He ZY, Sun JY, Wang Y, Chen QH

Cancer Management and Research 2017, 9:315-322

Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer

Shen L, Wu X, Tan J, Gu M, Teng Y, Wang Z, Yue W

OncoTargets and Therapy 2017, 10:3545-3556